Same review, same sources, same scoring — the summary and the reasoning open together on each row.
4. Willow
$199/mo — one figure, printed on the product page and the price sheet alike, which the seller calls HSA and FSA eligible
Summary, strengths and trade-offs10 points
Willow prints a monthly figure for every dose of its compounded semaglutide and tirzepatide, sells each as a weekly shot or a tablet that dissolves under the tongue, adds an NAD+ injection, and names the five pharmacies that fill its orders.
Strengths
- Prints a monthly figure for every dose of every GLP-1 product it sells, on one help-center page
- Lists five partner compounding pharmacies, each with a street address, in its terms
- Names its operating company and the medical practice its physicians work through
- Publishes a list of the states it serves
- Opens each tablet at the price its injection opens at
Trade-offs
- Its FAQ and its help center print state lists that disagree on Wyoming and Puerto Rico
- Tirzepatide injection climbs in price as the dose goes up
- Publishes two refund policies with different cutoffs
- Adds a monthly platform fee if the prescription is filled at an outside pharmacy
- Does not accept patients who have diabetes
5. Wellorithm
$200/mo — printed as "$150 first month" then "$200/mo*", with "Only $15/shot*, homekit included."; the footnote reads "*Price shown applies to 500mg (2.5mL) 3-month plan paid upfront or with buy now, pay later programs." $200 is the recurring rate and the first month is $150
Summary, strengths and trade-offs10 points
Wellorithm prints a monthly figure on each brand-name GLP-1 page and lists its compounded semaglutide and tirzepatide on a separate checkout storefront, while the GLP-1 landing page it leads with shows no price at all.
Strengths
- Prints a per-month figure on its own page for each brand-name GLP-1, with a no-membership-fee statement beside it
- Lists compounded semaglutide and tirzepatide with three-month supply totals as well as single figures
- Names three physicians and the medical practice behind its checkout storefront
- Its terms spell out the refund guarantee in full: the weight-loss threshold, the time frame and how to verify it
- States in its terms that it serves all 50 states plus D.C.
Trade-offs
- The main GLP-1 landing page prints no price, and its pricing button scrolls to a section without one
- The compounded prices sit on a separate storefront behind a login link, and its promotional pages show a different tirzepatide figure
- The guarantee advertised on the landing page does not match the one in its terms
- Brand-name prices carry a footnote tying them to a three-month upfront plan at a strength that belongs to its NAD+ product
- Names no compounding pharmacy on any page
6. Live Vital
$149 — per month as the seller states it, on a 3-month protocol priced at $447 in total ("$149 /mo" over "3 month protocol ($447 total)"); the page does not say how the total is charged
Summary, strengths and trade-offs6 points
Live Vital lists one of the deeper peptide menus in this roster — tesamorelin, CJC-1295, ipamorelin, BPC-157, TB-500, GHK-Cu, MOTS-C, glutathione and NAD+ — alongside its GLP-1 line, with coverage across all 50 states.
Strengths
- Lists tesamorelin, CJC-1295, ipamorelin, BPC-157, TB-500, GHK-Cu and MOTS-C on one menu, across the growth-hormone axis and the recovery peptides
- Operates across all 50 states
- States plainly that its non-GLP-1 peptides lack FDA approval, rather than staying silent on the point
Trade-offs
- The pharmacy that fills prescriptions is described only as "a licensed US pharmacy," not named
- Every price is a monthly figure tied to a fixed protocol total, and the pages do not say how that total is charged
- CJC-1295 and ipamorelin are sold only as one combined protocol, so neither has a price of its own
7. Embody
$99/mo — printed as "In Stock · Fixed price of $99/month" for "Compounded NAD+ Injections", beside "500mg-1000mg injections available"; the same page prices a nasal spray at the same figure
Summary, strengths and trade-offs9 points
Embody sells compounded semaglutide and tirzepatide from a store that prices every supply length, and runs separate offer pages for sermorelin, NAD+ and glutathione at one flat monthly figure each, though its offer page, its store and its terms print three different prices for the same GLP-1.
Strengths
- Names four dispensing pharmacies with their addresses and phone numbers on every page
- Prints a total and a per-month rate for every supply length of both GLP-1s, and the two agree
- Prices sermorelin, NAD+ and glutathione each on its own page, with the period printed beside the figure
- Names its operating company, its street address and its governing law
Trade-offs
- Its GLP-1 offer page, its store and its terms print three different prices for the same injection
- The offer-page figure matches the store's twelve-month rate, and the offer page never says so
- Every payment is final; a multi-month plan is not refunded even for months never shipped
- Its own pages disagree on which states it serves
- Names no clinician; care is attributed to a network
8. HealthRX.com
$134/mo — per month on the monthly subscription, "$134 billed monthly" for a one-month 15 mL bottle; the 12-month cadence works out to $107 a month, billed at $1,287, and a one-time 1-month supply is $149
Summary, strengths and trade-offs10 points
HealthRX.com runs one of the widest priced peptide catalogs on this roster, publishing a figure for ten tracked compounds, per vial on its guide pages and as monthly subscriptions in its shop — including semax, epitalon and MOTS-c, which almost nobody prices — and answering its own service-area question with all 50 states.
Strengths
- Prices ten tracked compounds, four of which almost nothing else on this roster prices at all
- Answers its own service-area question with a plain "All 50 US states" rather than a pharmacy licensure claim
- States the vial size and strength beside every guide-page figure, so the unit is never left to inference
- Offers a monthly subscription and a one-time supply side by side on each shop product page
- Publishes a LegitScript certificate number on the page rather than only a seal image
Trade-offs
- Its guide page and its shop page publish different glutathione prices on the same day, and neither cites the other
- The shop page prints a "$122/month equivalent" that is a twelve-month total resolved to a month
- Describes the pharmacy only as "a US-licensed 503A compounding pharmacy" and never names one
- Several compound guide pages send their eligibility button to the weight-loss program rather than to the compound
- Publishes no operating company under a corporate suffix on any page read
9. Shed
$144/mo — "NAD+ Nasal Spray / Starting at $144/month / Nasal method / Taken daily / 1 month supply"; the same block prices two other preparations of the same compound at "NAD+ Injections / Starting at $169/month" and "Oral NAD+ Tablets / Starting at $169/month"
Summary, strengths and trade-offs8 points
Shed prices four of the compounds compared here, states the supply period on every one, and is the clearest case on this roster of a seller whose own page prints three different figures for a single product.
Strengths
- Prices four of the compounds compared here, more than all but a handful of sellers on this roster
- States the supply period and the dosing frequency beside every figure
- Prices three separate NAD+ preparations rather than quoting one figure for all of them
- Names its operating company, its street address and its governing law in its own terms
Trade-offs
- Prints three different figures for its GHK-Cu product, two of which are divisions of a quarterly total
- Puts a GLP-1 comparison price on the sermorelin page, where a careless reader will take it for sermorelin’s
- Names no compounding pharmacy on any page read
- Makes no statement about which states it serves
10. Pallas Health
$79 — A first-month FLOOR and NOTHING ELSE — "Available as a clinician-prescribed injection or nasal spray, from $79 for your first month." No ongoing rate is published for this compound anywhere on the page, so what a second month costs is not stated
Summary, strengths and trade-offs8 points
Pallas deliberately does not sell the peptides this market is built on, publishes an essay explaining why, and corrects the category error the whole vertical makes: "NAD+ — a coenzyme, not a peptide."
Strengths
- Explains in its own words why it does not sell the peptides most of this market advertises
- Corrects the category error the vertical repeats, saying plainly that the coenzyme is not a peptide
- Prints the twelve-week charge and its own derived monthly average as two separate numbers
- Publishes per-state pages, which most of this roster does not
Trade-offs
- Publishes no ongoing rate for its coenzyme line — only a first-month floor
- The advertised monthly figure is arithmetic on a quarterly charge, and the word "average" is easy to lose
- Names no dispensing pharmacy, describing them by license class only
- Its catalog is two compounds, which is the point but is still a narrow menu
11. Oak
$133/mo — per month, billed monthly on a non-recurring basis; the panel prints a struck-through $200 beside it
Summary, strengths and trade-offs8 points
Oak prices four tracked peptides once a reader follows its own home-page links into its checkout, where each carries a struck-through former figure and a live one.
Strengths
- Prices four tracked compounds, tesamorelin and glutathione among them, rather than the growth-hormone line alone
- States the supply length on the two compounds where it differs from a month
- Says its longevity billing is monthly and non-recurring rather than a subscription
- Shows the former figure alongside the current one instead of quietly replacing it
Trade-offs
- Publishes no peptide figure on its marketing site; every price sits inside the checkout
- Its checkout answers 200 at a nonsense path, so a status check alone would not catch a bad address
- Names no dispensing pharmacy on either of its hosts
- Publishes no state list and no corporate entity
12. System Labs
$149/mo — per month, ongoing rate (after a $89 first-month intro)
Summary, strengths and trade-offs6 points
System Labs is a peptide-only storefront with no GLP-1 line, selling NAD+, glutathione, sermorelin and a topical GHK-Cu cream, LegitScript-verified but without a named pharmacy partner or a published state list.
Strengths
- Carries a LegitScript verification seal
- Sells a genuinely peptide-focused menu rather than treating peptides as a GLP-1 add-on
- Its GHK-Cu cream is priced flat, with no strikethrough figure or first-month teaser
Trade-offs
- The compounding pharmacy is described only as "US-based," never named
- Which states it ships to is not published anywhere on the site
- Most of its other peptide prices are shown as a struck-through renewal rate beside a first-month promo, so the ongoing cost takes a second look to find
13. CoreAge Rx
$93 — starting at
Summary, strengths and trade-offs5 points
CoreAge Rx runs a flat-price compounded model — one dose, one price, no ladder that climbs as you titrate up — and ships to all 50 states with a LegitScript seal on its NAD+ and sermorelin lines.
Strengths
- LegitScript-verified pharmacy standards, applied across its peptide catalog as well as its GLP-1 line
- One price per compound regardless of dose, so titrating up does not raise the monthly cost
- Ships to all 50 states with 24/7 support
Trade-offs
- The compounding pharmacy that fills prescriptions is not named on the site
- A newer brand with a thinner independent-review history than longer-running competitors
14. DudeMeds
$279 — one payment for a three-month supply: the checkout prints "$93 /mo" and "Total Billed: $279", and the tile reads "*One-Time Payment of $279 ($93 x 3)"
Summary, strengths and trade-offs10 points
DudeMeds sells compounded and brand-name semaglutide and tirzepatide plus two NAD+ preparations, and most of its plans are a prepaid block of months shown as a per-month figure, with the full charge printed underneath.
Strengths
- Prints the full one-time charge under the per-month figure on every commit-kit tile, and again as "Total Billed" at checkout
- States plainly that there is no membership fee and no doctor fee, and that shipping is free
- Lets anyone open the checkout page for a plan and see the total before creating an account
- Offers a month-by-month semaglutide refill for patients already in treatment
- Names brand-name Wegovy, Ozempic, Mounjaro and Zepbound beside its compounded versions
Trade-offs
- Its shop catalog advertises a starting semaglutide figure no plan carries, and a brand figure its own tiles and checkouts do not charge
- Semaglutide and brand-name first orders are prepaid blocks of three or four months, and the terms say the first three months are owed even if treatment stops
- Names no dispensing pharmacy, only third-party licensed and 503B pharmacies as a category
- Its two legal documents name different states of incorporation for the same company
- Makes a fifty-state claim only for its erectile-dysfunction service, and none for the compounds compared here
15. Lttl
$99/mo — plans start at, per month; the nasal spray and oral liquid carry the same figure
Summary, strengths and trade-offs8 points
Lttl prices four NAD+ formats at the same figure and undercuts most of this roster on glutathione, but every number it prints is a plan floor rather than a rate.
Strengths
- Prices the injectable, nasal and oral NAD+ formats identically
- Attaches a month to every figure on the homepage
- Says its medications are "compounded by certified U.S. pharmacies"
- Publishes its glutathione figure rather than folding it into a bundle
Trade-offs
- Every figure is a floor — "plans start at" — with no ceiling published
- Publishes no operating company on any page read
- Describes an "FDA-Registered Pharmacy" without naming one
- Its first-month discount is advertised as a code with no stated expiry
16. Bodybuilding Health+
$129/mo — starting at, per month, as the home-page card states it; this seller's sermorelin product page shows that a home-page card figure here can be a first-month rate contradicted by the product page, and the NAD+ product page was not read
Summary, strengths and trade-offs9 points
Bodybuilding Health+ prices seven compounds compared here on plan ladders, and two of those ladders cost more per month the longer you commit — including the tirzepatide lane the seller itself badges "Best Value".
Strengths
- Prices seven compounds compared here, the widest priced menu among the sellers added in this pass
- Publishes a full plan ladder for both GLP-1 lines with the per-month figure and the total saving printed on each lane
- Names its operating company and a street address in its footer and terms, and names the governing law
- Its sermorelin product page states that the headline figure is a first-month rate, which the home-page card does not
Trade-offs
- Its own tirzepatide ladder charges more per month on the twelve-month lane than on the six-month lane, while badging the twelve-month lane "Best Value"
- The home page and the sermorelin product page disagree about whether the advertised figure is a first-month rate or a plan rate
- The FAQ says all fifty states and the terms say the service is available in certain states and to contact customer service for the list
- No compounding pharmacy is named and no lab work is described as included
- A Florida address in the footer and Georgia named as the governing law, which are two different states to keep track of
17. RNK Health
$129/mo — from, per month; the nasal and liposomal formats carry the same figure
Summary, strengths and trade-offs8 points
RNK Health names its own professional corporations in its terms and charges the same figure for injectable, nasal and liposomal NAD+.
Strengths
- Names RNK Health LLC and the professional entities its clinicians work for
- Prices injectable, nasal and liposomal NAD+ at one figure
- States a monthly period on every treatment tile
- Publishes a one-price summary — "One Price. Zero Hassle." — with what it includes
Trade-offs
- Describes "independent, licensed third-party pharmacies" without naming one
- Publishes no state list
- No certificate of analysis is reachable
- Its lab-panel and peptide prices sit in the same list, which makes the peptide figure easy to misread
18. MyDrHank
$137/mo — "NAD+ Nasal SprayRx... From / $137 / /mo"; the same page adds "Clinical evidence for nasal and injectable NAD+ delivery is limited."
Summary, strengths and trade-offs8 points
MyDrHank prices five preparations of three compounds compared here at flat monthly rates, and publishes every one of them only after its scripts run — the address alone serves the same short shell for a real product and for a path that does not exist.
Strengths
- Prices five preparations of three compounds at flat monthly rates on their own pages
- Prices both a needle and a needle-free form of two compounds separately
- Says on its own NAD+ pages that the clinical evidence for those routes is limited
- Falls back to the homepage for an unknown product rather than rendering an empty product page
Trade-offs
- Publishes nothing in the page itself — every figure exists only after its scripts run
- Serves the identical document for a real product and for a path that does not exist
- Prefixes every figure with "From", so none of the five is a settled charge
- Names no compounding pharmacy on a product page or in its terms
19. MangoRx
$200/mo — the treatment block prints "Starting at" above "$200 Monthly"
Summary, strengths and trade-offs8 points
MangoRx prints one figure per peptide on the compound’s own page — sermorelin and NAD+ each carry a starting monthly rate in the treatment block — and its FAQ describes the compounder by state and accreditation without ever naming it.
Strengths
- Each peptide has its own page, and the figure sits in the treatment block under the compound name rather than behind an intake
- One starting rate per compound, stated with the word Monthly beside it
- Free provider visits and shipping are stated sitewide rather than added at checkout
- The FAQ answers its own state question directly instead of implying nationwide coverage
Trade-offs
- The compounding pharmacy is described by state and accreditation but never named
- Neither figure appears in the served HTML — both live in a hydration payload until the page renders
- No list of the states served is published anywhere on the site
- The bloodwork answers all describe a different product line, so nothing says whether labs matter here
20. Gala GLP-1
$118 — the effective rate on a twelve-month plan billed $1,417 up front
Summary, strengths and trade-offs8 points
Gala GLP-1 prices NAD+ and sermorelin by the twenty-eight-day supply and says so, and charges at checkout before a clinician has seen the intake — refunding in full if nothing can be prescribed.
Strengths
- Prints the supply length — twenty-eight days — rather than letting the reader assume a month
- Says its compounded GLP-1 is not FDA-approved, in its own footnote
- States its charging model plainly, including the full refund if nothing is prescribed
- Prices NAD+ and sermorelin individually rather than behind a longevity floor
Trade-offs
- Its weight-loss figures cover both molecules at once, so neither drug has a price
- Its own FAQ and its product pages give different GLP-1 entry prices on different plan terms
- Names no dispensing pharmacy
- Its efficacy counters render as zeroes, so those pages state no readable figure
21. Your Era
$170 — from — the product card and the catalog row both print this as a floor per month
Summary, strengths and trade-offs8 points
Your Era prices NAD+ as a floor per month on its catalog row and repeats the same figure on the card above it, but publishes nothing else a reader can check before the intake.
Strengths
- Prints the same figure on the card and in the catalog row, so the two do not contradict each other
- Separates its NAD+ line from its weight-loss lines rather than pricing them as one program
- Links a third-party verification listing for its own domain in the footer
- Keeps the whole priced catalog on one screen a reader can compare at once
Trade-offs
- Publishes no terms page and no FAQ; both addresses return not-found
- Names no dispensing pharmacy anywhere on the readable surface
- Publishes no state list and no corporate entity
- Prices one tracked compound only, as a floor, with no dose or form stated
22. Luvo Health
$199 — from the same grid: "NAD+ Injection $199 $10 /week", under a header reading "4 WEEKS". Identical to this seller's growth-hormone figure to the dollar. The same grid prices its weight-loss and hormone lines the same way
Summary, strengths and trade-offs8 points
Luvo Health prices everything in a grid headed "4 WEEKS" whose unit label reads "per week", with two figures on every row and no sentence anywhere explaining what the second one is.
Strengths
- Puts its entire catalog on one pricing page with a figure against every line, including lines it does not otherwise advertise
- Carries a wider peptide list than most sellers on this roster, including a tissue-repair peptide and a gonadotropin-releasing analogue
- Names the operating company in the first line of its terms and again in the page heading
- States the period in the grid header rather than leaving it out entirely
Trade-offs
- The header says four weeks and the unit label says per week — the page contradicts itself about its own billing period
- Two figures per row with nothing on the page saying what the second one buys
- Four-week billing means thirteen charges a year, which no comparison table with a monthly column will show
- No pharmacy named, no certificate of analysis, no state coverage list
23. Sprout Health
$249 — the plan line reads "$199 your first month, then auto renews at $249 every 4 weeks"; the hero above it prints "Starting at $249/ month" and "Now from $199 first month". Four weeks, not a calendar month, is the cycle the plan line names
Summary, strengths and trade-offs8 points
Sprout Health sells one compound compared here, publishes both its introductory and its renewal figure in the same sentence, and names the three states it cannot ship to — while carrying a federal warning letter over the sale of unapproved drugs online.
Strengths
- Names the three states it cannot ship to instead of leaving coverage to an intake
- Prints the introductory figure and the renewal figure in the same sentence, with the renewal interval attached
- States the strength per vial on the same page as the price
- Names its operating company and its governing law in its own terms
Trade-offs
- Carries a federal warning letter over the unlawful sale of unapproved and misbranded drugs online
- The headline says a month while the plan line says every four weeks, which is a thirteenth charge a year
- The compounding pharmacy is described but never named
- Only one of the compounds this site tracks is sold
24. PeterMD
$369 — the price of two vials the page calls an "8-10 Week Supply" — a range, so nothing on the page supports a per-month figure for this product
Summary, strengths and trade-offs7 points
PeterMD is the only seller compared here that publishes a state exclusion list per compound rather than a single coverage claim, and it names no operating company at all.
Strengths
- Prints a per-compound state exclusion sentence in each product page header, which no other seller compared here does
- Names the supply length beside each figure, in weeks, rather than implying a calendar month
- Names Oklahoma as the governing law and states that the arbitration agreement is governed by the Federal Arbitration Act
Trade-offs
- No operating company is named on the home page, in the terms, in either privacy policy or on the about page
- The NAD+ supply length is published as a range of eight to ten weeks, so no honest per-month figure exists for it
- The longer sermorelin lane is advertised as a reduction against a stated former price, and nothing on the page establishes what that former price was charged at
- The compounding pharmacy that fills an order is not named
25. Trellis Vitality
$129/mo — treatment plans starting at, per month
Summary, strengths and trade-offs8 points
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Strengths
- Names its dispensing pharmacy, VialsRX in Houston, with a street address and phone number
- Includes at-home biomarker panels and a 90-day re-test rather than relying on scale weight alone
- No membership or consult fee is layered on top of the monthly peptide price
- Accepts HSA/FSA funds
Trade-offs
- Several headline statistics — a stated biomarker-improvement rate and an average annual-savings figure — are unsourced and cannot be independently checked
- Its cited patient-satisfaction rating names no review platform, so it cannot be verified against a public record
- The prescribing network it uses also serves several unrelated telehealth brands, so the clinical layer is not exclusive to Trellis
- Refunds are decided per order rather than under a stated policy
26. Idgie Health
$133/mo — per month on the 3-month plan, charged as $399 on the day you order and then every 3 months; this is below the "From $154/mo" the catalog prints for NAD+
Summary, strengths and trade-offs11 points
Idgie Health prices NAD+, glutathione, sermorelin, GHK-Cu and both GLP-1s by plan length, prints the full charge for every multi-month plan, and names its prescribing physician and its pharmacy.
Strengths
- Each priced product page shows the checkout total for its quarterly and six-month plans beside the per-month rate
- Sells NAD+ as an injection and a nasal spray, and prices sermorelin as an injection and as a troche with a per-strength table
- Discloses who prescribes (Dr. Sean Arora of Arora Health & Aesthetics, with an NPI number) and who dispenses (VialsRX, with a Houston address)
- States that no membership fee applies, and lists what the plan price covers
- Renewals can be stopped from the patient account or through the care team
Trade-offs
- The NAD+ injection page prints two different monthly rates for its six-month plan: the per-month figure and the amount charged do not agree
- Money paid for a quarterly or six-month term is not refundable under a policy that calls every sale final
- Its shipping policy contradicts the product pages on both cost and delivery time
- Template text has leaked between products: the NAD+ injection page's compounding note is about tirzepatide
- No strength is published for the NAD+, glutathione or sermorelin injections
- A state page claims every state, while the older terms of service restrict some services to unnamed states
27. Precision Telemed
$149/mo — the ongoing rate, read as "NAD+ Injection Cost: $139.99 First Month, $149/mo After" and restated in the FAQ as "Your first month is $139.99 … Month two onwards is $149/mo"; the first month is cheaper, not more expensive, and the page states the figure "covers your NAD+ prescription, physician oversight, and free shipping"
Summary, strengths and trade-offs8 points
Precision Telemed names the pharmacy that fills its orders, names the prescribing medical group separately from the platform company, and prints a first-month rate and an ongoing rate as two different numbers.
Strengths
- Names the filling pharmacy, its license class and its accreditations, which almost nothing else on this roster does
- Separates the platform company from the prescribing medical group and names both
- Prints the first-month rate and the ongoing rate as two distinct numbers rather than one blended figure
- States a fifty-state footprint three times, including as a direct answer in its own FAQ
Trade-offs
- Says "every batch tested for potency, sterility, and purity" and publishes no certificate for any batch
- The sermorelin figure appears only as a cross-sell line on the coenzyme page, with no product page behind it in this pass
- The $400–$600 per-session figures on the page describe IV clinics generally, not this seller, and a reader skimming will mix them up
- No state-by-state detail sits behind the fifty-state claim
28. Auren Rx
$179/mo — per month, auto-refill membership (vs. $209/mo with no commitment)
Summary, strengths and trade-offs7 points
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
Strengths
- Names its prescribing group and pharmacy with full street addresses and phone numbers, rare in this category
- Carries a verifiable LegitScript seal
- The first visit is free and nothing is charged until a clinician reviews and approves the order
- An auto-refill plan can be paused rather than fully canceled
Trade-offs
- Its homepage headline price applies to a microdose track; the standard compounded dose costs more
- Its homepage teasers disagree with its own product pages on two of four peptides: NAD+ and glutathione are each advertised lower in the nav than the product page charges
- The listed New York address is a mail-forwarding suite, not a clinic
29. Renlo Health
$179/mo — a starting price, billed monthly: the product page prints "$179 / PER MONTH" and "Billed monthly. Cancel anytime, no fee.", and the homepage lists NAD+ as "Starting at $179/mo"; the seller's NAD+ cost guide and state pages print a lower "Starting monthly price" of $149, and $119 per month on a 3-month plan
Summary, strengths and trade-offs10 points
Renlo Health prices compounded semaglutide, tirzepatide, NAD+ and glutathione at one figure per drug regardless of dose and names its pharmacy, but its own pages attach two different meanings to the GLP-1 headline price.
Strengths
- Names the pharmacy that fills its prescriptions, VialsRx of Houston, with a street address and phone number
- Names the physician who leads its care and the medical group its prescribers work through
- Keeps each treatment at one price whatever the dose, including NAD+ and glutathione
- Says every price includes the medication, supplies, provider care and shipping, with no membership or consultation fee
- Lists all fifty states plus Washington, D.C. by name
Trade-offs
- The GLP-1 headline price is described as a monthly rate on the product pages and as a first-month offer on a second page of the same site
- Its NAD+ product page and its NAD+ cost guide print different starting prices
- The lowest per-month figures belong to a 3-month plan whose billing schedule is never stated
- The NAD+ and glutathione pages advertise a four-month money-back guarantee, but the refund policy limits it to weight management programs
- No strength or dose is published for NAD+ or glutathione, and lab work is not included
30. CareBareRX
$199/mo — starting at, per month, in the seller's own words ("From $199/mo"); the figure is printed on the home page and in the sitewide treatment strip, and the NAD+ product page itself carries no figure
Summary, strengths and trade-offs10 points
CareBareRX names four pharmacies, its physicians with NPI numbers and the company behind the brand, then prints its NAD+ and GLP-1 prices everywhere except its own product pages.
Strengths
- Names four partner pharmacies in its FAQ, each with a street address and phone number: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx
- Names its physicians and their medical group, with NPI numbers a reader can look up
- Names two companies in its own terms — the operator and the brand — with the brand's state of incorporation and a street address
- States that its treatments are eligible for FSA and HSA payment, which most sellers here do not address at all
- Says what its listed prices include: the telehealth consultations, the prescription and shipping
Trade-offs
- No product page prints a price, so the NAD+ figure lives only on the home page and in a sitewide strip
- The same strip disagrees with itself between pages: the brand-name Ozempic card carries two different figures, and so do its hair and sexual-health cards
- The semaglutide and tirzepatide bundles sit on a page the navigation does not link to, and each card labels a three-month bundle and a monthly rate at once
- Its consent form says every program auto-renews unless you cancel before the charge, with no refunds or exchanges
- Its terms say the service is available only in certain states, which contradicts the all-50-states answer in its FAQ
31. Lavender Sky Health
$165 — for a 1000 mg injection from the named pharmacy, with no billing period stated; the same page runs 1000 mg from $200 at Red Rock to $280 at Hallandale and 2000 mg from $195 at Strive, which the page labels "(best price)", to $375 at South Lake; medication pricing shown excludes the consultation fee, which is priced separately
Summary, strengths and trade-offs10 points
Lavender Sky Health publishes a price for every peptide it sells against the specific pharmacy that would fill it — nine pharmacies named, quantity by quantity — and states plainly that none of those figures includes the consultation fee it prices separately.
Strengths
- Names the pharmacy that would fill every single price it publishes, across nine pharmacies, which no other seller compared here does
- Prints the quantity beside every figure — milliliters, milligrams, grams or tablet count — so each number describes a stated amount
- States sitewide that the medication figures exclude the consultation fee, and then publishes what that consultation costs on a page of its own
- Publishes a per-pharmacy and per-formulation shipping-exclusion list rather than a single coverage sentence, which is the most detailed footprint disclosure compared here
- Names its operating company and a street address in its own privacy and HIPAA notices
Trade-offs
- Not one peptide figure on the pricing page states a billing period, so none of them is a monthly cost
- Almost every peptide price is hidden until a toggle is clicked: the pricing page renders about a fifth of its text closed, and a reader who does not operate the control sees no peptide price at all
- Its governing-law clause names no state — it reads "the laws of the state applicable to the patient's care" — so there is no forum a reader can identify in advance
- The all-fifty-states claim and the shipping-exclusion matrix have to be read together, and several products are unavailable in a dozen or more states depending on which pharmacy fills them
- Several published lines are marked temporarily unavailable or out of stock, including the cheapest nasal-spray option
32. Premier Hormone Health & Wellness
$99/mo — printed as "$99 / month" on the general wellness page's NAD+ injections card; the card names no dose and does not say what the monthly figure includes
Summary, strengths and trade-offs8 points
Premier draws the line between the platform company and the medical practice more explicitly than anything else on this roster. Its peptides are priced on catalog cards, and its sermorelin page prints no figure.
Strengths
- States that the company is a non-clinical platform and that the practices it supports are independently owned
- Prints a figure and its period on every card of its peptide and general wellness catalogs
- Prices sermorelin and tesamorelin separately for men and for women, each as a monthly starting figure
- Says its compounding pharmacies are US-based and describes the standards claimed
Trade-offs
- Its peptide figures are starting prices on catalog cards, and no card says what its figure includes
- The sermorelin page itself prints no figure and says only that the initial assessment will outline all costs
- Names no dispensing pharmacy
- Its state coverage is a one-line footer claim of serving all states, with no list behind it
33. Fella Health
$129/mo — the monthly plan; six months paid in full is $594, which the seller restates as $99 a month
Summary, strengths and trade-offs8 points
Fella Health names two pharmacies and includes lab work in its NAD+ program fee, and publishes no price for either weight-loss molecule on any page a reader reaches before its quiz.
Strengths
- Names two dispensing pharmacies, one with a contact address
- Includes lab work and medication in the published NAD+ program fee
- States in its own words that compounded medicines are not FDA-approved
- Prints the prepaid total beside the effective monthly rate
Trade-offs
- Shows weight-loss prices only after its quiz, and different versions of its plan screen show different prices
- Before its quiz, publishes no price for either weight-loss molecule, only a bundled daily floor covering both
- Its treatment cards advertise the six-month NAD+ rate rather than the monthly one
- Makes no state-coverage claim; its state pages are marketing pages, not an availability list
34. TeleZen MD
$148/mo — per month after the first month, which is $98 — the plan block reads "Compounded NAD+ Nose Spray / 300 MG/15 ML Monthly Plan / $98 first month / $148 /month after"
Summary, strengths and trade-offs8 points
TeleZen MD, a Florida limited liability company, publishes a first-month rate and the ongoing rate for four compounds, and puts a quarterly, semi-annual and annual lane beside the monthly one on its NAD+ and glutathione pages.
Strengths
- Prints the first-month rate and the ongoing rate together on every treatment page, rather than the introductory one alone
- Publishes four plan lengths on the NAD+ and glutathione pages with the total charge shown next to each per-month figure
- Answers the coverage question directly in its FAQ instead of leaving state availability to the intake
- Prices the nasal-spray route separately from the injection at two strengths
Trade-offs
- Says outright that patients do not choose the dispensing pharmacy and that its pharmacy partners may change at any time
- Names no pharmacy anywhere, describing them only as independent licensed 503A facilities
- Runs three stacked promotional codes on the same page, so the figure a reader sees first is rarely the plan rate
- Describes no lab work as included at any plan length
35. Bionomy
$149/mo — per month
Summary, strengths and trade-offs8 points
Bionomy names its two dispensing pharmacies and publishes a full 48-state list with the two it does not serve, which is more than almost any seller here does.
Strengths
- Names both dispensing pharmacies — Strive Pharmacy and Absolute Pharmacy — instead of describing one
- Publishes the full 48-state list and names the two states it will not ship to
- Says its intake will tell an out-of-state reader before any clinical data is shared
- Attaches "/mo" to every peptide figure on its homepage
Trade-offs
- Publishes no operating company on any page read
- Does not serve Alaska or Hawaii
- Publishes no certificate of analysis for any compound
- Its clinical claims cite a 2018 journal paper rather than anything about its own product
36. He & She MD
$149/mo — per month on the twelve-month plan; one month is $229
Summary, strengths and trade-offs8 points
He & She MD is one of the few sellers on this roster that names its dispensing pharmacies outright, and one whose plans page and product pages publish different prices for the same shorter plans.
Strengths
- Names both dispensing pharmacies, one with a street address and a telephone number
- Publishes a full plan ladder — one, three, six and twelve months — beside every peptide
- Says what the plan price includes: medication, supplies, shipping and provider support
- Prices glutathione and MOTS-C, which most sellers on this roster do not price at all
Trade-offs
- Its plans page and its product pages price the same shorter GLP-1 plans differently
- Its oral tirzepatide price table is labeled as sermorelin pricing
- Its cheapest rate on every ladder requires committing to twelve months
- The forty-four-state number belongs to its pharmacy, not to its own service, and no state list is published
37. Trava Health
$158.93/mo — per month at 100 mg; a quarterly package is advertised at a lower total
Summary, strengths and trade-offs8 points
Trava Health attaches a named dose to every peptide price it publishes — 3 mg of sermorelin, 100 mg of NAD+ — which almost nothing else on this roster does, and it names its four fulfilling pharmacies.
Strengths
- Prints the dose beside the price on every peptide product page, so the figure describes a specific quantity
- Names its four fulfilling pharmacies and its laboratory partners in its terms of service
- Tells shoppers on the product page itself that the price moves with the dose, instead of leaving that to checkout
- Publishes a quarterly saving as a dollar figure rather than a percentage
Trade-offs
- A site-wide banner describes its medications as tested in FDA approved labs, wording that is easy to read as FDA approval of the product; a compounded preparation is not an approved drug
- The quarterly package is advertised as a saving without the resulting per-month figure being stated
- No state coverage list is published
- The peptide menu is three compounds, so a shopper comparing a wider protocol will need a second seller
38. Raeliva
$179/mo — the monthly plan; prepaid alternatives run $450, $750 and $1,400
Summary, strengths and trade-offs8 points
Raeliva publishes nine per-compound monthly prices, says its providers are licensed in every state, and warns its own readers that the effective rate on a prepaid plan is not a monthly payment.
Strengths
- Publishes a standing monthly price for nine separate products
- Warns readers that a multi-month plan's monthly figure is an effective rate, not a payment
- Prices microdose products separately from full-dose ones
- Says its trial evidence describes a different product from the compounded one it sells
Trade-offs
- Names no dispensing pharmacy anywhere
- Says lab work may be billed separately on top of the plan price
- Its fifty-state claim is a count with no list behind it
- Its corporate name reads like a research supplier, which it is not
39. Claya
$199/mo — the product page prints "As low as $199/mo" beneath the benefit list
Summary, strengths and trade-offs8 points
Claya lists its partner pharmacies by name and street address in the footer of every page, prices two compounds compared here on their own pages, and is one of the few sellers here whose terms commit the company itself to all fifty states.
Strengths
- Names two partner pharmacies in the footer, each with a street address, phone number and web address
- Commits the company itself to all fifty states plus the District of Columbia in its own terms
- Names its operating company and state of incorporation rather than trading anonymously
- States on the product page that no bloodwork is needed to get started
Trade-offs
- Both compounds carry the identical figure, so the page gives no sense of what separates them
- The figure is an "as low as" starting rate with no dose or strength attached
- Much of each peptide page is GLP-1 marketing, including a weight-loss calculator that has nothing to do with the compound
- Lab work is excluded rather than included, so any monitoring is a separate cost
40. GobyMeds
$199/mo — for 1 month, the only NAD+ format whose one-month figure is identical on both the NAD+ page and the pricing page
Summary, strengths and trade-offs12 points
GobyMeds names four dispensing pharmacies and its prescribing medical group outright, and prices sermorelin and NAD+ in several delivery formats — though its headline per-month figures are its multi-month totals divided down.
Strengths
- Names four dispensing pharmacies with a phone number, an email address and a domain for each
- Names the medical groups that furnish care rather than describing them generically
- Prints the whole one-month and three-month figures beside every divided badge, so the arithmetic is checkable
- Offers sermorelin in four delivery formats and NAD+ in two, each separately priced
- Says outright on its pricing page that lab work for its testosterone lines costs extra
- Publishes a street address and a phone number rather than a contact form only
Trade-offs
- Leads with per-month badges that are multi-month totals divided down, on both peptide pages and the pricing page
- Its own two pages disagree on the NAD+ injection's one-month figure
- Includes no lab work with either peptide line
- Its telemedicine statement qualifies the advertised fifty-state claim with the state a provider is licensed in
- States no dose or concentration on any peptide line
- Publishes no corporate entity name behind the brand
41. Ozari Health
$199/mo — per month, "Billed monthly"; a quarterly lane works out at $183 a month, billed $550 every three
Summary, strengths and trade-offs8 points
Ozari Health is the only seller in this batch that publishes a fifty-row table naming which of its two pharmacies fills in each state — and it dates its own prices.
Strengths
- Publishes a fifty-row table naming which pharmacy fills in each state
- Names both dispensing pharmacies, their cities and their accreditations
- Prints its own price-verification date on the treatment pages
- Gives the clearest statement of the compounded category on this roster
Trade-offs
- Its weight-loss figures are quarterly totals presented as monthly rates
- A second GLP-1 price ladder sits behind a JavaScript toggle and is not published as text
- Its "Save $268" and "Save $330" claims name no baseline, so the saving cannot be checked
- Requires a three-month minimum commitment on subscriptions
42. PepHaus
$199/mo — per month on the monthly plan, the only tier that is billed monthly; the same page prints $189/mo on a quarterly plan and $179/mo on a 6-month plan billed $1,074.60, and advertises the $179 as its "from" price
Summary, strengths and trade-offs8 points
PepHaus prints three plan lengths with a per-month figure and the prepaid total beside each, says on the product page itself that it is not a research-only website, and claims a certificate of analysis in every box — a certificate that is not reachable anywhere on the site.
Strengths
- Prints three plan lengths side by side with the per-month figure and the prepaid total for each, so the commitment behind the lowest rate is visible
- States its own position on research-labeled peptides on the product page, in its own words, rather than leaving the category to the reader
- Claims all fifty states in its own sentence on every peptide page, with the eligibility caveat stated rather than implied
- Lists what a box contains item by item, including the syringes, the swabs and the supply length
Trade-offs
- Claims a certificate of analysis three times per page and publishes no reachable certificate anywhere — no document, no image and no attribute wiring one into the page
- Its own comparison table characterizes the research-chemical market's prices, which is a seller describing its rivals and is not evidence
- The advertised "from" figure is the six-month rate, so the headline price always carries a prepayment
- Only the semaglutide page names its compounding pharmacy; the sermorelin and tirzepatide pages describe it by licensing class alone
43. Somira Health
$199.99/mo — Monthly Plan, per month; the seller also prints "$163.33 / month ($489.99 / quarter)" on a quarterly plan, which is its own division of the quarterly total
Summary, strengths and trade-offs8 points
Somira Health names VialsRX as the compounder for its whole longevity line, publishes monthly and quarterly figures for sermorelin and NAD+, and answers its state question with a licensure claim it then narrows in the next sentence.
Strengths
- Names VialsRX as the compounder for the whole longevity line, on the same page as the prices
- Publishes the quarterly total in brackets beside the quarterly per-month figure, so the arithmetic is visible
- States no membership fee and no hidden fees on the same block as the figures
- Publishes an operating company and a street address in the footer
Trade-offs
- Its state answer opens with a 50-state licensure claim about its providers and then withdraws it for the company
- Publishes no list of the states where fulfillment is actually available
- The quarterly per-month figures are divisions of a quarterly total, and sit in the same table as the billed monthly ones
- Only two of the compounds this site tracks are sold
44. Yucca Health
$215/mo — per month, billed monthly, no commitment
Summary, strengths and trade-offs5 points
Yucca Health pairs a 24-hour provider review with free expedited shipping, and lists NAD+ and sermorelin alongside its GLP-1 line, with coverage across all 50 states.
Strengths
- States a 24-hour provider-review turnaround up front
- Free expedited shipping is included rather than sold as an add-on
- Coverage is licensed across all 50 states
Trade-offs
- The compounding pharmacies it uses are described only generically, never named
- Program details beyond price and shipping are thin on the public site
45. OrderlyMeds
$224/mo — per month; a $448 lane exists but is gated to existing GLP-1 customers
Summary, strengths and trade-offs8 points
OrderlyMeds carries a June 2026 federal warning letter, names five dispensing pharmacies — one of which carries two federal letters of its own — and gives a different pharmacy roster on two of its pages.
Strengths
- Names five dispensing pharmacies rather than describing a class
- Publishes both the starter rate and the standing rate for each weight-loss molecule
- Says plainly that it does not require blood work before prescribing
- Prices the branded pens alongside the compounded products on one page
Trade-offs
- Carries a June 2026 federal warning letter naming its own website
- One of the pharmacies it names carries two federal letters of its own for adulterated drug products
- Its home page names three pharmacies and its FAQ names five
- Its treatment pages show branded-pen prices under bare molecule labels
46. Avono Health
$249/mo — the month-to-month rate, published twice on one page: as "NAD+ Injection | In stock | Starting at $249.00 per month" in the Wellness tab (which must be clicked to render), and again inside the bundle sentence "NAD+ Wellness Program (3 Month Bundle) $597.00 … Save $150 (compared to $249/mo with month-to-month pricing)". The bundle total was not divided; the monthly figure is the seller's own. The flex-dose tablet and nasal-spray forms carry the identical rate, so no separate rows are recorded for them
Summary, strengths and trade-offs10 points
Avono answers the two questions this roster asks most often and almost never gets answered: it names four dispensing pharmacies with their phone numbers and web addresses, and it names the medical group and two prescribers behind the platform by registry number.
Strengths
- Names four dispensing pharmacies outright, each with a phone number and a web address, in an answer on its own homepage
- Names the medical group and two individual prescribers by national provider identifier
- Publishes the same two monthly rates in two independent places on one page, so neither has to be taken on its own
- Prices three delivery forms of one compound at one rate instead of quoting a range
- Answers the state question and then says, in the same answer, that specific services may still vary
Trade-offs
- The peptide prices render only after a tab is clicked, so the page as delivered shows a GLP-1 catalog and no peptides at all
- The fifty-state answer qualifies itself in its own second sentence without naming which services vary
- A footer disclosure warns that a reader may be redirected to a third-party platform whose terms govern instead of this one
- No lab work is included in or priced beside either program
- The bundle blocks quote a three-month total beside a monthly rate, which invites a division the seller has already done
47. The Edit
$249/mo — per month, flat at every dose, provider visit and ongoing care included
Summary, strengths and trade-offs8 points
The Edit names its dispensing pharmacy, The Pharmacy Hub in Miami, up front, and prices NAD+, sermorelin, glutathione and GHK-Cu the same at every dose, with nothing charged until a clinician review is complete.
Strengths
- Names its dispensing pharmacy, The Pharmacy Hub in Miami, rather than describing it generically
- Charges one flat rate at every dose on its three injectable peptide lines
- Publishes prices on the treatment page itself, in both English and Spanish
- Runs no first-month teaser on its peptide lines, so the figure shown is the recurring one
- Carries a verifiable LegitScript seal
Trade-offs
- The GHK-Cu cream is quoted as a starting rate that moves with the strength prescribed, unlike the three flat injectable lines
- Longer plans are billed as one upfront charge rather than a lower recurring monthly rate
- Terms note that state availability is confirmed during consultation and may vary, despite advertising all 50 states
48. RxPepsDirect
$100 — pharmacy price for one injectable vial at wholesale, plus a separate $39 medical visit per order and $15 flat shipping; the seller publishes a separate nasal lane at $120, recorded as its own row below
Summary, strengths and trade-offs9 points
RxPepsDirect charges one $39 fee per order for the medical visit and then steps out of the transaction: Optimal Balance Pharmacy bills the patient directly at its own wholesale price, and that price is printed for every peptide on the site.
Strengths
- Names both the dispensing pharmacy (Optimal Balance Pharmacy, a Texas 503A) and the outside laboratory that tests each batch (Eagle Analytical Services), and publishes the batch reports
- Lists all 29 licensed states by name in its FAQ rather than only printing the count
- Separates its own fee from the medication entirely: $39 per order for the visit, with the pharmacy billing the drug at wholesale and adding $15 flat shipping
- Every peptide price is readable without an account, combination vials included
Trade-offs
- The figure is a per-vial pharmacy price, not a monthly one — the BPC-157 page itself says one vial lasts about five weeks
- KPV is not sold on its own; it is only available inside BPC-157 combination vials
- Semax is sold only as a Semax/Selank nasal spray, so its figure is a combination price
- Caps an order at three different peptides, so a wider protocol needs a second $39 visit
- Its FAQ says the company was founded in 2026, so there is very little independent history behind the pharmacy-at-cost claim
49. Breeze Meds
$169 — starting at; the card names no billing period and no supply length
Summary, strengths and trade-offs8 points
Breeze Meds claims all fifty states in its own unqualified words and names four filling pharmacies with phone numbers, though its one peptide figure is a floor with no period attached.
Strengths
- Claims all fifty states in its own words, without leaning on a pharmacy or physician license
- Names four filling pharmacies with phone numbers and websites
- Names its physician group and gives two prescribers with NPI numbers
- Puts the peptide figure on the home page rather than behind an intake
Trade-offs
- Publishes one tracked compound only, so the coverage claim carries most of the weight on this row
- Prints its figure as a floor with no billing period or supply length
- Serves no sitemap, so there is no product list to walk
- Puts both the coverage claim and the pharmacy names inside collapsed accordions
50. Polly
$183 — printed bare as '$183' on the NAD+ vial product page with no billing period stated; the card tags the line 'Injectable' and 'Weekly', which are dosing tags rather than a billing cycle
Summary, strengths and trade-offs10 points
Polly names two of its compounding pharmacies and gives NAD+ two priced product pages of its own, but attaches no billing period to any figure — its terms say the interval is disclosed inside checkout, behind an email gate.
Strengths
- Names two of its compounding pharmacies in a public FAQ answer rather than describing them generically
- Gives each NAD+ format its own product page with the figure printed on it
- Answers its own state-coverage question directly on the home page
- Says on each product page what the plan includes, item by item
- Publishes the operating entity behind the brand and a page explaining its rename
Trade-offs
- Attaches no billing period to any published figure, so none of its prices can be compared as a monthly rate
- Its terms disclose the billing interval only inside a checkout behind an email gate
- Publishes no sermorelin product page; that figure appears only on a home-page card
- Names its pharmacies as examples rather than as a complete list, and names none for a given order
- Includes no lab work and states no dose on any line
51. The Aesthetic Concierge
$189 — an add-on list price; the page names no billing period
Summary, strengths and trade-offs8 points
The Aesthetic Concierge prices its weight-loss medication in five-week blocks rather than months, includes basic blood work in its kick-off fee, and prints a states heading with nothing under it.
Strengths
- Includes basic weight-wellness blood work in the kick-off fee, which few sellers here do
- Prices a microdosing lane separately from a full-dose one on both molecules
- Prints the five-week block plainly instead of calling it a month
- Its discount arithmetic reconciles against every percentage it prints
Trade-offs
- Its list of states renders as nothing at all beneath its own heading
- Calls its supplier an "FDA 503A pharmacy", which is a category that does not exist
- Its brand-name management fee is billed every four weeks on one page and every five on another
- Its add-on peptide prices name no billing period
52. Pepti
$249 — vial price, an average four-week supply; the pen format is $319
Summary, strengths and trade-offs8 points
Pepti prints one all-in monthly figure for every treatment it sells, in two formats side by side, and it is the only roster row that publishes both a fifty-state footprint and a price for epitalon.
Strengths
- Prints an all-in monthly figure on every treatment card and states that no membership fee sits on top of it
- Names the unit each figure covers, so a four-week supply is never left to be guessed at
- Quotes a pen and a vial price side by side, which makes the format premium visible instead of buried in checkout
- States its own coverage as all 50 states and Washington, D.C. in its site footer
Trade-offs
- Bloodwork is a separate charge rather than part of the monthly figure, though recent labs can be uploaded instead
- The 503A/503B compounding pharmacy it uses is described but never named
- The PT-141 card gives no supply length, so its figure is the only one on the catalog that cannot be read as four weeks
- CJC-1295, ipamorelin and TB-500 are sold only inside combination vials
53. Big Easy Weightloss
$267 — starting at, for an eight-week plan; a combined sermorelin-and-NAD+ card carries the same figure for both
Summary, strengths and trade-offs8 points
Big Easy Weightloss names eleven pharmacies and publishes each one's shipping exclusions, then claims to serve all fifty states on the same site where it says its physicians are still applying for the rest.
Strengths
- Names eleven pharmacies and publishes six of their state-by-state shipping exclusions
- Warns in its own words that compounded drugs may vary in strength, quality and purity
- Refunds or credits the consultation fee if the reader is not a good fit
- Offers monthly installments on every eight to twelve-week package
Trade-offs
- Four of the pharmacies it names carry their own federal letters for adulterated or unapproved drug products
- Claims all fifty states on a site that elsewhere says its physicians are still applying for the rest
- Its pricing page and its product pages print different figures for the same package
- Its prices change with the pharmacy the reader picks, so the published figure is only a default
54. PeRx
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
PeRx, the trading name of Wellness MD Group PC, lists twenty-six compounds and blurs the price on every one of them, publishing a floor and a range on a separate pricing page instead.
Strengths
- Tied for the widest compound list on this roster, with each blend spelled out into its constituent peptides on its own page
- Publishes a floor and a range in ordinary body copy, so a reader can bound the cost without an account
- Names its operating company and its trading name in the first paragraph of its own terms
- Says in its terms that it ships to every state, and repeats the claim as a headline figure
Trade-offs
- Blurs the per-compound price on every product page and marks it hidden from screen readers, so no individual compound has a readable figure
- Its own pricing page contradicts itself on the consultation fee, listing "no separate consultation fee" among what every order includes and then answering twice that consultations are $50
- Says all sales are final once an approved prescription is charged
- Names no dispensing pharmacy, only the category
55. Renn
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Renn names four separate pharmacies, each with a telephone number and a web address, and says it serves all fifty states. Its published figures are floors rather than rates at a stated dose.
Strengths
- Names four dispensing pharmacies, each with a telephone number and a web address
- Answers the state question directly with all fifty rather than a count or a link
- Says there are no hidden fees or surprise charges
- Gives each medication its own page with its own figure
Trade-offs
- Its figures are floors, so the rate at a given dose is not published
- Prints its tirzepatide figure with an "as low as" on one page and without it on another
- Lists NAD+ with no price attached
- No certificate of analysis is reachable
56. Contour Health
$60/mo — printed as '$60 / month' directly beneath the words 'One price at every dose' — the seller's own statement that the figure does not climb with dose
Summary, strengths and trade-offs8 points
Contour Health says outright which of its prices is flat and which is a starting dose, and its NAD+ line is the one it calls one price at every dose.
Strengths
- States in its own words which figures are flat and which climb with dose
- Publishes a monthly unit against both peptide figures
- Sells medication by the vial with no subscription on its weight-loss line, and says so
- Publishes a hard error for a path that does not exist, with no body at all
Trade-offs
- Its brand name and its legal company name share no words, so the operator is hard to look up
- The sermorelin figure is a floor, and no page says what a higher dose costs
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
57. Gimme Care
$99/mo — per month when three months are bought at once
Summary, strengths and trade-offs8 points
Gimme Care puts a labeled "Billing cycle" control beside every product and shows the one-month and three-month rate together, which is rarer here than it should be.
Strengths
- Labels the billing cycle explicitly instead of leaving a reader to infer it
- Shows the one-month and three-month rate for the same product side by side
- Names Start Gimme LLC as the operating company
- States in its own words that it is "available in all 50 states"
Trade-offs
- Its cheapest figures require buying three months at once
- Publishes no named dispensing pharmacy
- No certificate of analysis is reachable
- Its blog quotes market-wide NAD+ cost ranges that are not its own prices
58. Coivas
$119/mo — per month after an $89 first month, on the quarterly plan; a monthly plan runs $129 after a $99 first month
Summary, strengths and trade-offs8 points
Coivas prints its own price-verification month on the page, publishes a comparison table whose first column is its own, and gives itself three different legal names across three pages.
Strengths
- Prints its own price-verification month directly on the treatment page
- Publishes both the intro and the standing rate for every product
- Names its clinical group and its address
- Its quarterly arithmetic reconciles exactly against every billed total it prints
Trade-offs
- Gives itself three different legal names across three of its own pages
- Its tirzepatide price renders only inside a comparison table, not as its own figure
- Its fifty-state claim is contradicted by its own terms
- Names no dispensing pharmacy and says the dispenser may vary
59. Maui MedSpa
$125/mo — "NAD+ pricing depends on the dose. For 100mg a week the price is $125 a month. For 200mg a week the price is $200 a month. For 300mg per week the price is $250 per month." The same page separately prints "Our Program Cost: $200 per month" for the peptide and hormone membership, which is a different charge that happens to equal the middle dose figure
Summary, strengths and trade-offs8 points
Maui MedSpa publishes a three-step dose ladder for one of the compounds compared here with a monthly figure against each step, and prints a membership fee on the same page that happens to equal one of those figures exactly.
Strengths
- Prints a three-step dose ladder with a separate monthly figure against each step
- States the weekly milligram dose that each figure buys
- Says what the membership covers and that lab work is discounted rather than free
- Puts its coverage question beyond doubt by naming a single physical location
Trade-offs
- Prints two unrelated charges of the same amount per month on one page
- Names five compounds and publishes a figure for one of them
- Prices its antioxidant add-on as one figure covering two additions, so neither can be read alone
- Names no compounding pharmacy
60. Ivím Health
$129/mo — the medication figure only, from "1 Month Price $129 + $75/mo Membership" — the membership is mandatory and printed in the same line, so the actual monthly outlay is $204. The same page offers "2 Month Price $74.50/mo billed as $149 upfront + $75/mo Membership", where the $74.50 is a division of a single $149 charge and the membership still applies
Summary, strengths and trade-offs8 points
Ivím Health prints the membership charge in the same line as the medication price on both peptide pages, so the advertised figure and the actual monthly outlay are never confused — and it runs a banner announcing peptide therapies as coming soon above a page selling one.
Strengths
- Prints the mandatory membership charge inside the price line on both peptide pages instead of revealing it later
- Labels its two-month option as a single upfront charge and shows the per-month division beside it, so the prepayment is visible
- Names the operating company, a suite address and a support contact in its own terms
- States plainly that the sublingual product is not an injection, which is a form distinction most sellers leave to the reader
Trade-offs
- Its sermorelin page attaches no billing period to the medication figure, while the same seller labels the identical figure a one-month price on its other peptide page
- A site-wide banner announces peptide therapies as coming soon with a waitlist, above a page already selling a peptide
- The membership roughly doubles the monthly outlay on both products, so neither advertised figure is the cost of therapy
- No state coverage list, no named pharmacy and no certificate of analysis in any page read
61. PlexusDx
$129/mo — per month on the seller's "Best value 6-month" tier — the figure its own page headline advertises as "from $129/mo"
Summary, strengths and trade-offs8 points
PlexusDx sells five of the six compounds this site ranks — sermorelin, NAD+, glutathione, GHK-Cu and PT-141 — each as an all-inclusive monthly program, and it is one of only seven sellers here that reaches the PT-141 board at all.
Strengths
- Reaches five of the six compounds this site ranks, one of seven sellers here to reach five or more
- States on every program page that the monthly price does not change as the dose changes
- Names the three commitment tiers and their per-month rates side by side instead of advertising only the cheapest
- Offers GHK-Cu as a topical cream and glutathione as a nasal spray or troche, so two of the five need no injection
Trade-offs
- Publishes its own corporate name two different ways — "PlexusDx, Inc." in one terms document and "PlexusDX LLC" in the other
- The glutathione page states both a 46-state and an all-50-state footprint without resolving which applies
- No compounding pharmacy is named on any of the five product pages
- Five states are said to require a scheduled video visit rather than the async intake, but the page never lists which five
62. Zera Health
$130/mo — Monthly plan, "$130/mo — 250mg vial — billed monthly"; the same block prints a quarterly column at "$110/mo — billed every 3 months", which is the seller’s own division of a quarterly total, and the hero prints a struck first-month offer, "From $99 $179 /first mo."
Summary, strengths and trade-offs8 points
Zera Health names Strive Pharmacy as its compounder in the footer of every treatment page, publishes a monthly and a quarterly plan side by side for three compounds compared here, and puts a fifty-state marquee above a FAQ that says something narrower.
Strengths
- Names Strive Pharmacy as the 503A compounder in the footer of every treatment page, with its web address
- Prints the monthly and the quarterly plan side by side with the billing cycle written into each, so the arithmetic is visible
- States the strength and the delivery form beside each figure rather than leaving the dose to an intake
- Says plainly on every plan block that there are no hidden fees and that shipping is included
Trade-offs
- A sitewide marquee reads fifty states while its own FAQ says the company operates in most of them
- Publishes no list of the states it actually serves
- One sitemap treatment path answers 200 and renders the homepage instead of the treatment
- Advertises third-party lab testing of the product in the same list as plan inclusions, where it reads like included lab work
63. Alternate Health Club
$140/mo — per month, printed as '$140.00 / month' on the product page for the line the seller calls NAD+ Injectable
Summary, strengths and trade-offs10 points
Alternate Health Club prices glutathione, NAD+ and sermorelin on three separate product pages of its own, each printing one figure with the month attached and no second, struck-through number beside it.
Strengths
- Gives each of its three tracked compounds its own product page with the figure and the period in the same line
- Prints one price per page with no struck-through second figure to read the wrong way round
- Says its medication pricing is flat at every dose rather than climbing as a dose is titrated up
- Answers its own question about state coverage instead of leaving the page silent
- Names its operating company and its state of registration in its terms
Trade-offs
- Names no dispensing pharmacy, describing it four different generic ways across four documents
- Publishes no state list and never prints the number of states it serves
- Its coverage answer sits inside a collapsed accordion rather than on the page
- Includes no lab work; its own terms treat laboratory tests as an extra cost
- States no dose or concentration on any of the three product pages
64. AgelessRx
$149/mo — per month after the first; the first month is $79 on a three-month plan billed in full
Summary, strengths and trade-offs9 points
AgelessRx publishes a short, deliberately curated peptide menu and names four compounds it has decided not to sell yet — but every headline figure on it is a first-month rate with a higher number behind it.
Strengths
- Names BPC-157, TB-500, MOTS-c and KPV on its own peptide page as compounds it has chosen not to sell yet, which is rare candor in this category
- Publishes the ongoing rate alongside the introductory one on three of its five peptide pages
- Sells PT-141 and sermorelin in both an injection and a nasal spray rather than a single format
- Says a plan can be paused or canceled at any time
Trade-offs
- Every headline figure on the site is a first-month rate, and the ongoing rate runs $50 to $70 higher
- The GHK-Cu cream page prints the same figure as both a first-month price and an ongoing one, so the two disagree on one page
- The glutathione page gives only the three-month-plan rate, leaving the plain monthly price unpublished
- The compounding pharmacy that fills prescriptions is not named, and no state list is published
- A competition ranking is quoted on the site as a credential; it is marketing, not an independent assessment of the products sold
65. Belle Health
$149/mo — from, per month on the 3-month supply; the same pricing page publishes $199/month on the 1-month supply
Summary, strengths and trade-offs9 points
Belle Health names the four compounding pharmacies it works with, prices sermorelin, NAD+ and glutathione as flat monthly rates on both a product page and a pricing page, and carries a February 2026 FDA warning letter about telehealth marketing claims.
Strengths
- Names four dispensing pharmacies outright instead of describing an unnamed licensed one
- Publishes every longevity figure twice — on the product page and again in a pricing table — and the two agree
- States that the price does not rise when the dose does, and that there is no consultation or setup fee
- Prices three tracked compounds, which most sellers publishing any peptide figure do not
Trade-offs
- Carries a February 2026 FDA warning letter over telehealth marketing claims
- Its FAQ pharmacy list and its pricing-page pharmacy tags do not name the same set
- Publishes no state list, so eligibility is settled inside the intake
- Its two GHK-Cu products carry prices but a "Coming Soon" control, so neither can be bought
- Lab work is described as ordered only when clinically necessary, never as included in the price
66. Peak Wellness
$149/mo — starting at, per month on the 6-month plan; the same table publishes $179/month on a 3-month plan and $199/month on a 1-month plan
Summary, strengths and trade-offs9 points
Peak Wellness sells one compound, NAD+, publishes a three-rung monthly ladder for it, and spends most of its own product page arguing that the human evidence for injectable NAD+ is early rather than settled.
Strengths
- Publishes all three rungs of its ladder with a month on each, so no figure has to be derived
- States plainly that human trial evidence for injectable NAD+ is early and still building
- Says no money is collected before a provider approves the order, and explains the card hold
- Answers its own state question directly, and separates its own coverage from its pharmacies’
Trade-offs
- Sells exactly one of the compounds this site tracks
- Describes "a licensed 503A pharmacy" throughout and never names one
- Prints per-day and per-administration divisions of its own figures beside them
- Publishes no operating company under a corporate suffix on any page read
- A different headline figure for its GLP-1 line sits on the same site and is easy to mistake for this one
67. Pomegranate Health
$149/mo — read as the product-page heading "Longevity | NAD+ Injection | $149/month | Boosts energy, mental clarity, longevity"; the same figure as this seller's sermorelin page, which is the seller's own pricing and not a transcription error
Summary, strengths and trade-offs9 points
Pomegranate gives each compound its own page with a single monthly figure in the heading, and its terms name the territory it serves rather than leaving availability to be discovered at intake — but the figure for its one non-longevity peptide carries no period at all.
Strengths
- Gives each compound its own product page with one figure in the heading instead of a range or a ladder
- Names the territory it serves in its terms, including two territories beyond the fifty states
- Answers the lab question in its own words rather than leaving it unaddressed
- Publishes the same product list in its navigation and its footer, so the range is visible from any page
Trade-offs
- The one product outside its longevity line carries no billing period at all, while its three siblings all print a monthly one
- No dispensing pharmacy is named — the site badge reads only "FDA-Regulated Pharmacies", which describes a category
- The lab answer says lab testing is often an important part of care, which is the opposite of saying it is included
- The fifty-state claim is immediately qualified by a sentence saying certain services and medications may not be available in certain jurisdictions
- The lab and treatment answers sit inside a collapsed accordion and are absent from the page until it is clicked open
68. SuperHealthy Rx
$149/mo — starting at, for a one-month supply
Summary, strengths and trade-offs8 points
SuperHealthy Rx publishes seven per-compound prices and renders two of them without a currency symbol at all — the GLP-1 cards read as bare numbers.
Strengths
- Prices seven separate products, including a microdosing lane for each weight-loss molecule
- Says in its own words that every dose costs the same and explains why
- Prices the injectable and nasal NAD+ forms separately
- Publishes medical-board complaint notices for three states
Trade-offs
- Two of its prices render with no currency symbol at all
- Its two microdosing products are priced but carry a coming-soon button rather than an order button
- Names no pharmacy and directs readers to contact it to find out which one will fill
- Publishes no availability list; the four states it names are about physician assignment
69. Try Ageless
$149/mo — hero reads "NAD+ 200mg Troche / $149 $199 / 1-month suplly" — the seller’s own spelling of the supply period; $149 current, $199 struck through
Summary, strengths and trade-offs8 points
Try Ageless runs a WooCommerce storefront where six preparations of the two compounds compared here each carry a figure, a strength and a supply period on their own product page, and it names a dispensing pharmacy in its terms rather than describing one.
Strengths
- Prices six separate preparations of two compounds, each on its own product page
- States the strength and the supply period beside every figure
- Names a dispensing pharmacy in its terms and again in its site footer
- Names its operating company and its street address in the same document
Trade-offs
- Prints the current figure before the struck-through one, the reverse of the order used elsewhere on the same page
- Attaches a dose caveat to every figure, so the published number is a starting point rather than a charge
- Makes no statement about which states it serves beyond a conditional in its terms
- Prices the nasal spray per bottle while pricing everything else per month, so the six figures are not directly comparable
70. Joi + Blokes
$150/mo — per month, no plan term stated
Summary, strengths and trade-offs8 points
Joi + Blokes names all seven pharmacies that may fill an order, with street addresses, and prices sermorelin and NAD+ as plain monthly figures with no plan term attached.
Strengths
- Names every pharmacy that may fill an order — seven of them — with a street address for each, in its own terms of service
- Quotes sermorelin and NAD+ as flat monthly figures with no prepayment tier to decode
- Warns New York and New Jersey shoppers up front that their pricing differs, rather than surfacing it at checkout
- Sells biomarker panels separately, so lab work is a stated purchase rather than a hidden condition
Trade-offs
- The storefront names no operating company, only the brand, so there is no registered entity a buyer can look up
- Only two of the compounds compared on this site are sold; the peptide menu is narrow
- A GHK-Cu skin cream appears in the navigation without a price on the shop pages
- Lab panels are billed on top of the monthly figure rather than included in it
71. RX Bella
$159/mo — printed as "NAD+ Injection · from $159/mo", a floor rather than a quoted rate
Summary, strengths and trade-offs9 points
RX Bella prints a monthly starting figure on every card of a twenty-protocol peptide menu and on its two GLP-1 injections. Nine of those protocols are stacks priced as one, and no card names a dose.
Strengths
- Prints a monthly floor on every one of twenty peptide protocols, grouped by goal, on an open page with no quiz or account in front of it
- Sells eight tracked peptides as single products, not only inside combinations, and prices semaglutide and tirzepatide on its home page
- Its terms say the subscription is one bundled charge covering the drug, the provider and the platform, with no separate membership fee
- Names its operating company, RX Web Meds LLC, with a mailing address, and lists the exact grounds on which it refunds
Trade-offs
- Every figure is a floor written as "from", and no card names a dose, a vial size or, apart from the NAD+ card, a delivery format
- Nine protocols are stacks priced as one, and some reuse a single peptide's description: the four-peptide BPC-157 blend is described as a copper peptide for skin and hair
- Its peptide menu repeats another telehealth brand's page, and every product the two share carries the identical figure, so the two are not independent prices
- Names no compounding pharmacy and no clinician, and its all-50-states claim is hedged by its program pages and terms, which publish no list
- Its program pages and its terms give different cancellation notice periods
72. HealthiCare
$159.99/mo — per month — the treatment page prints the figure with no period; the seller's own article states "NAD+ Cream ($159.99/month) - Topical application for daily maintenance and skin-level cellular repair."
Summary, strengths and trade-offs8 points
HealthiCare, run by Sunshine Health Studios Inc., prices sermorelin and NAD+ in two routes each, and names its dispensing pharmacy and the states it cannot ship sterile preparations to — in an article, not on the treatment page.
Strengths
- Names the dispensing pharmacy and the telehealth group that employs the prescribers
- Names ten states where it says sterile preparations cannot be dispensed, which is more than most sellers disclose about where they cannot ship
- Prices two routes for each compound, so the injection and the non-injection option can be compared directly
- Says the price does not change with dose and charges no membership fee
Trade-offs
- The treatment page attaches no billing period to any figure; the period appears only in a marketing article elsewhere on the site
- Its state claims do not reconcile — all fifty for consultations, forty-four licensed for dispensing, and ten states excluded, which leaves forty
- Its terms of service name two website addresses, neither of which is the site a reader is buying from, and hand off to a third company's platform terms
- No lab work is described as included
73. FormBlends
$161/mo — "1-month plan / Pay monthly · Ships monthly / $161 /month / $161 due today"; longer plans quote "$143 /month" against "$429 due today" (3 months), "$859" (6 months) and "$1717" (12 months)
Summary, strengths and trade-offs8 points
FormBlends names its three dispensing pharmacies with their cities and designations, prices seven of the compounds compared here on one-month plans, and publishes a state-by-state map it dates and sources to its own last hundred and sixty-five shipped orders.
Strengths
- Names three dispensing pharmacies with their cities, legal names and designations
- Publishes a dated state map and says the count comes from its own shipped orders rather than a marketing claim
- Prints a one-month plan whose per-month figure is also what is charged that month
- Says plainly that shipping is included and lab work is not
Trade-offs
- Quotes per-month figures on its longer plans that are divisions of the amount actually billed
- Buries seven product pages inside a sitemap of more than a hundred thousand article URLs
- Sells one of the compounds compared here only inside a two-compound blend
- Redirects one product address to a different one, so a cited URL and a read URL can differ
74. Heally
$165/mo — starting at, per month — the page reads "NAD+ Injection Program starting at / $165 / month" and "Free consultation included, billed only when you reorder"
Summary, strengths and trade-offs9 points
Heally, Inc. runs a marketplace that puts a free consultation in front of three priced peptide programs, and bills only when a patient reorders rather than on a standing subscription.
Strengths
- Charges nothing for the consultation and says so on every program page, so the price of finding out is zero
- Bills on reorder rather than on a standing subscription, and says so beside each peptide figure
- Sells lab panels as a separate, separately priced catalog instead of folding an unnamed lab fee into a program
- Names its operating company in its own privacy policy
Trade-offs
- The sermorelin page publishes a first-month figure and no ongoing rate at all
- Names no dispensing pharmacy, referring to it only as a partner pharmacy
- Lab work is a separate purchase, so a program price is not an all-in figure
- Its per-month figures are floors, and the peptide pages do not say what raises them
- Prints two different starting figures for Zepbound on two of its own pages
75. Cabana
$169/mo — per month
Summary, strengths and trade-offs8 points
Cabana names its pharmacy, publishes that pharmacy's ten-state licensing gap — and sells three injectable products after telling readers the same pharmacy does not dispense sterile compounds.
Strengths
- Names its dispensing pharmacy and publishes the ten states that pharmacy cannot ship to
- States in its own words that the FDA does not evaluate compounded products
- Says exactly what the NAD+ monthly fee covers, including the injection kit
- Says plainly that lab work and the diagnosis visit are not covered by the membership
Trade-offs
- Sells three injectable products while telling readers its named pharmacy does not dispense sterile compounds
- Its weight-loss floor covers three products at once, so neither molecule has a price
- Its four product pages publish no price at all
- Claims batch certificates of analysis without making one reachable
76. PharmaZee
$175/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $110.00
Summary, strengths and trade-offs8 points
PharmaZee prices five tracked peptides with a first-month figure and a recurring figure printed side by side, names its two filling pharmacies, and carries a 2026 federal warning letter.
Strengths
- Prints the first-month figure and the recurring figure together, so the introductory rate is not disguised
- Prices five products covering four tracked compounds, including two routes of the same one
- Names both filling pharmacies with street addresses in its FAQ
- States the concentration and bottle size on the products where those differ
Trade-offs
- Carries a federal warning letter that names this exact domain
- Hides the pharmacy names and the coverage answer inside collapsed accordions
- Publishes no state list and answers the coverage question with named prescribers instead
- Serves no sitemap, so the product list can only be found through the navigation
77. Zappy Health
$175/mo — monthly subscription: "$175/month", "Monthly Subscription", "All doses", "Billed monthly", with monthly virtual visits included. The product page headed "Injectable NAD +" labels the figure "Limited-time offer!", and the longevity page lists the same product as "AS LOW AS" and "from $175 / month"
Summary, strengths and trade-offs10 points
Zappy is one of the few sellers on this roster that answers the pharmacy question with a name and a web address rather than a category, and it sells its longevity compounds both in multi-compound bundles and one at a time, each with a monthly figure of its own.
Strengths
- Answers the pharmacy question with a named company and its web address on a dedicated page, instead of describing a regulatory category
- Links that page from the footer of every page on the site rather than burying it in the terms
- States plainly that it is not a compounding pharmacy and does not manufacture anything it sells
- Marks stock status beside each product, so an unavailable item is not priced as though it were on the shelf
Trade-offs
- Carries an FDA warning letter that names this company and this exact domain, over claims made about its compounded weight-loss line
- Leads its longevity range with multi-compound bundles, whose figures are not the price of any one compound in them
- The longevity page labels every single-compound figure "AS LOW AS" and "from" without printing a ceiling, and two product pages call their figure a "Limited-time offer!" without saying when it ends
- The terms name no state and make no coverage claim at all
- Two safety pages render under a page title naming an entirely different compound, so the title cannot be used to identify what a page is about
- No lab work is included in or priced beside any plan
78. Mondae
$179/mo — the same figure and the same two companion figures as its sermorelin and glutathione pages — recorded as read, not reconciled
Summary, strengths and trade-offs8 points
Mondae names the pharmacy that fills each order and states that shipping states differ by pharmacy — then prints the same three figures on all three of its peptide pages.
Strengths
- Names the dispensing pharmacy on the product page and warns that coverage varies by pharmacy
- States a per-month unit rather than leaving the period to be inferred
- Says in its own words that it charges no membership fee and the same price at every dose
- Names both its own company and the telehealth platform behind it
Trade-offs
- Three different molecules carry an identical set of figures, which no page explains
- Two of the three figures on each page carry no unit at all
- The plan-length selector's default is not visible in the page as served
- Publishes no state list of its own and describes no lab work as included
79. Effecty
$180/mo — read as the hero line "NAD+ Nasal Spray — Starting at $180 /month" — the only Effecty longevity page whose headline figure carries no asterisk and no prepayment footnote; there is no cost table on this page, so no plan ladder is published for the nasal form
Summary, strengths and trade-offs10 points
Effecty prints a three- or four-rung cost table under the heading "How much does treatment cost?" on its injectable pages, with the billing cycle spelled out beside every rung — and then prices the same compound differently on its own index page than on the product page it links to.
Strengths
- Names the billing cycle beside every rung of its injectable cost tables, so no rung has to be interpreted
- Footnotes its own headline figures with the prepayment they require, on the same page, rather than leaving the asterisk unexplained
- Prices five distinct longevity products including two delivery forms of one compound
- Splits the shipping answer between its weight-loss line and its longevity line instead of giving one blanket claim
Trade-offs
- Prices one product differently on its index page than on the product page that index links to, and only the index says which figure requires prepayment
- The oral-dissolving page has no cost table at all, so its single hero figure carries no billing period
- No dispensing pharmacy is named — the answer is "state-licensed compounding pharmacies" and, elsewhere, "our trusted pharmacy partner"
- The availability claim is "all states nationwide" and never counts them, so it cannot be checked against a list
- A nonsense path on this host lands on the homepage rather than returning a document, so a URL cannot be verified by status alone
- No lab work appears in any plan description
80. Amble
$199/mo — the month-to-month rate, read under the column header "Plan | Per Month" as "1 Month $199", beside "3 Month $183", "6 Month $167" and "12 Month $125"; the sitewide banner on the same page reads "Limited Offer: GLP $150 + NAD $100" with no period attached and no product page repeats it, so this seller shows two NAD+ figures at once
Summary, strengths and trade-offs10 points
Amble puts a plan ladder under a column it labels "Per Month", so every rung on it is already a monthly rate and nothing has to be divided — and then contradicts its own cheapest rung with a sitewide banner offer that no product page repeats.
Strengths
- Labels its price column "Per Month", so every rung of the plan ladder is already a monthly rate and a reader never has to divide anything
- Publishes the full ladder for all three priced compounds on the product pages themselves rather than behind an intake
- Names the five states where a live video or audio visit is required instead of leaving that to be discovered at checkout
- Answers the state-availability question about the company separately from the question about its prescribers, which most sellers on this roster conflate
Trade-offs
- A sitewide banner advertises a NAD+ figure that no product page repeats and that carries no billing period, so the seller shows two different NAD+ numbers at once
- No dispensing pharmacy is named — the FAQ answers only that 503A and 503B facilities are regulated, which describes a category and not a supplier
- The fifty-state claim carries the seller's own parenthetical "exclusions apply" and no exclusion is named anywhere on the site
- Twenty-two peptide URLs read as a catalog and are signed editorial articles with no price and no cart, which is easy to mistake for a product range
- Names a fourth compound as an available treatment in its FAQ and publishes no page or price for it
- No lab work is named as part of any plan, and the "what you get" list stops at supplies, shipping and monitoring
81. Concierge MD
$199/mo — starting at, per month on a monthly subscription; the order form on the same page prices the same 500 mg vial at $249.00 as a one-time purchase, and offers a 1000 mg vial as a separate selection
Summary, strengths and trade-offs8 points
Concierge MD prices NAD+ and sermorelin on the pages that sell them, publishes a table of about two dozen per-state professional corporations in place of one operating company, and runs Drip Hydration under the same structure.
Strengths
- Names the strength of the vial a subscription buys, and offers a second strength as a separate selection, on the page itself
- Publishes a table of the medical entities that provide services in each region, rather than describing them as unnamed third parties
- Names California as the governing law in its own terms
- Prices a subscription lane and a single-month lane separately on both compound pages, so the cost of not committing is visible
Trade-offs
- No single operating company is named for the brand; the footer carries only a trading name and the entity table is a list of about two dozen professional corporations
- Its NAD+ page attaches a sermorelin figure to a monthly subscription that the sermorelin page itself prices differently
- Its coverage claim and its entity table do not reconcile into a list of states a reader can check
- Four more compounds are sold here than are compared on this site, because their pages could not be read on the day this row was written
82. Eviora MD
$199/mo — the "NAD+ Injection" card prints "from $199/mo" — a starting floor; the card states no dose or vial size
Summary, strengths and trade-offs12 points
Eviora MD prints a monthly starting figure on every card of an open twenty-card peptide menu, sells eight tracked peptides on their own, and publishes no price for its GLP-1 programs.
Strengths
- Prints a monthly starting figure on every card of a twenty-card peptide page, with no quiz, account or email gate in front of it
- Sells eight tracked peptides as single products, so those figures can be set against other sellers
- Bills each subscription as one total, which its terms split between the pharmacy, the medical group and the platform
- States fifty-state service in its FAQ and on its About page
- Lists the five cases in which it refunds, one of them a provider declining to prescribe
Trade-offs
- Every figure is a floor written as "from", and only the NAD+ card names a form; no card states a dose
- CJC-1295, ipamorelin, TB-500, KPV and Semax appear only inside stacks, so none has a price of its own
- Several stack cards reuse a single peptide’s description — the four-peptide BPC-157 stack is described only as a copper peptide
- Its semaglutide, tirzepatide and microdose programs publish no price on their own pages
- Its homepage, program pages and terms give three different cancellation terms
- The pharmacy, the medical group and the prescriber all go unnamed
- Its peptide page follows the same template, card list and most of the same figures as other storefronts on this site, so it is not an independent reading of the market
83. Form by GBY
$199/mo — per month; one figure covers three routes, which the page names together
Summary, strengths and trade-offs8 points
Form by GBY prices GHK-Cu by the unit and NAD+ and glutathione by the month on single-compound pages, and sells its weight-loss medicines only inside a three-component formula.
Strengths
- Gives GHK-Cu, glutathione, NAD+ and sermorelin their own pages instead of one combined menu
- Answers "Is compounded GHK-Cu FDA-approved?" with "No" in its own FAQ, on each product page
- Prints the unit its GHK-Cu price is charged against rather than implying a month
- Says plainly that the FDA does not review compounded products for safety, effectiveness or quality
Trade-offs
- Sells its weight-loss medicines only inside a three-component formula, so neither drug has a scoped price
- Its bundle page prints a figure for glutathione that its own product page contradicts
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
84. MadeMed
$199/mo — 6-month plan, billed $1194 every 6 months; the quarterly tab was not opened on this page
Summary, strengths and trade-offs8 points
MadeMed publishes a plan rate for four peptide products, names the pharmacy behind its nasal line, and states its coverage as a count of states with the excluded ones listed by name.
Strengths
- Prints a per-month plan rate and the full prepayment beside it on the same tile, so the billing cycle is not hidden
- Names the pharmacy behind its nasal line rather than saying only that a US pharmacy is used
- Answers its state question with a count and then lists the states it does not serve
- Publishes both an injectable and a sublingual route for the same compound at separately stated rates
Trade-offs
- The nasal spray page prints one figure in its hero and a different one on the plan tile
- The state list differs by product, so there is no single coverage answer for the company
- Requires a blood test the buyer arranges and pays for at an outside lab
- Publishes no corporate entity, so there is no registered company a reader can look up
85. New Wave Health
$199/mo — from, per month, for the product the menu calls "NAD+ Injection"
Summary, strengths and trade-offs14 points
New Wave Health prints a monthly starting figure beside every product on a twenty-item peptide menu, and sells compounded semaglutide and tirzepatide with no price on either.
Strengths
- Puts a monthly starting figure beside every product on its peptide menu, with nothing advertised without one
- Names its operating company in its terms and prints a street address, a phone number and a support email for it
- Its terms promise an electronic notice 5 to 7 days before every recurring charge, and let a subscriber switch off auto-refill in the portal
- Lists the grounds on which it refunds, including a provider who declines to prescribe
- States under the menu that compounded medications are not FDA-approved
- Checked against FDA's warning-letter record in September 2026: no letter found under its name
Trade-offs
- Every figure is a floor written as "from", and nothing says what moves a program above it
- TB-500, KPV, CJC-1295, ipamorelin and semax are sold only inside combination products, so none has a price of its own
- Seven of its nine combination products carry the description of their first ingredient alone
- Its menu lists the same twenty products at the same figures as another storefront in this comparison that trades under a different company name
- Sells compounded semaglutide and tirzepatide with no price on either drug page
- Names no pharmacy and no prescriber, and its terms call the company a technology platform that does not practice medicine
- Its homepage says all 50 states while its program pages say Virginia and the states where its providers are licensed, without naming them
- Its FAQ says it never sells or shares data; its California privacy notice says it may have sold or shared identifiers and browsing data with advertising networks
86. Options Medical Weight Loss
$199/mo — per month, printed on the product page directly beneath the compounding disclaimer
Summary, strengths and trade-offs8 points
Options Medical Weight Loss prices NAD+ and glutathione on their own product pages by the month, says its weight-loss injections are made in 503B outsourcing facilities, and prints an FDA compounding disclaimer under each figure.
Strengths
- Gives NAD+ and glutathione their own product pages with a monthly figure on each
- Says the FDA does not review or approve compounded medications for safety or effectiveness, on every product page
- Names the facility category its weight-loss injections come from rather than saying only "licensed"
- Names the two manufacturers of the approved versions of the drugs it prescribes
Trade-offs
- Its semaglutide figure requires paying for twelve months upfront, and its tirzepatide figure is a program starting rate that the homepage prints higher
- Publishes no state list and names no dispensing pharmacy
- Sells no other tracked peptide
- No certificate of analysis is reachable
87. NEUVÉ
$217/mo — "starting at" per month, and the seller's own pricing answer says "Medication, labs, and treatment supplies are billed separately" — so the drug is not in this figure
Summary, strengths and trade-offs8 points
NEUVÉ publishes a starting monthly figure on six peptide protocols, then answers its own pricing question by saying medication, labs and supplies are billed separately — so the figure beside each protocol is not what the therapy costs.
Strengths
- Names the laboratories it draws through, Quest and LabCorp, which most sellers here leave unstated
- Answers its own question about what the monthly price covers instead of leaving the exclusions unwritten
- Publishes a starting figure for six separate peptide protocols rather than one blended program rate
- States the governing law and the county where a dispute would be heard
Trade-offs
- The figure beside each protocol excludes the medication, which is the largest part of what the therapy costs
- Every one of its six figures is a "starting at" floor with no plan term and no ceiling published
- Two of the six protocols price a two-peptide stack, so neither peptide in either pair has a price of its own
- No compounding pharmacy is named, only the category of facility that compounds the medication
88. JRNYS
$219/mo — from, per month; read off the /longevity index because the product's own page prints only its neighbor's price
Summary, strengths and trade-offs8 points
JRNYS prints each longevity product's price only on the other product's page — read either one alone and the NAD+ and glutathione figures come out reversed.
Strengths
- Prices NAD+, glutathione and a tirzepatide microdose separately rather than behind the membership floor
- Names its microdose product as a microdose rather than as a full dose
- Says plainly in its terms that prescriptions may move between pharmacies
- Publishes a longevity index that lists every product and figure in one place
Trade-offs
- Each longevity product page prints its neighbor's price and none of its own
- Its FAQ says pricing is confirmed after consultation while its pages publish fixed figures
- Names no dispensing pharmacy, and says the dispenser can change without notice
- Makes no state-coverage claim on the pages read
89. Rylo
$219/mo — month-to-month plan: "$219 a month", "One price, every month. No contract, cancel any month." The same page's quarterly plan, selected by default, reads "$183 a month" and "Billed $549 every 3 months"
Summary, strengths and trade-offs8 points
Rylo Health LLC names its dispensing pharmacy and its clinical group by name, prices six compounds at a flat rate that does not move with dose, and sells each on a quarterly plan or month to month, with the quarterly rate the lower of the two.
Strengths
- Names the dispensing pharmacy with its street address and phone number, and names the clinical group that writes the prescriptions
- Prints the three-month total beside every quarterly rate, and offers a month-to-month plan with no contract on the same page
- Says the price does not change with dose or refill, and charges no membership fee on top
- States that no lab work is required before starting, rather than leaving a lab fee to appear later
Trade-offs
- The lower rate needs a plan billed every three months; buying month to month costs more on every product
- The home page table shows only the quarterly rate, so the month-to-month price appears only on each product page
- Says formulations and fulfillment vary by state without saying which ones, so the fifty-state claim is qualified in a way a reader cannot check
- No lab work is included, which is the flip side of not requiring any
90. Heros Health
$249/mo — per month; a banner offers $75 off a first month
Summary, strengths and trade-offs8 points
Heros Health names four pharmacies while telling readers it uses one, publishes three different entry prices for the same weight-loss program, and ships an NAD+ page whose unfilled template sections render as text.
Strengths
- Names four dispensing pharmacies with their cities
- Publishes a standing monthly figure for its NAD+ injection
- Says which sterility standard its dispensing pharmacy meets
- States plainly that compounded medicines cannot be returned or resold
Trade-offs
- Says it uses one pharmacy exclusively directly above a list of four
- Its weight-loss program covers both molecules under one fee, so neither drug has a price
- Three different entry prices for that program appear on a single page
- Its NAD+ page ships with unfilled template sections rendering as visible text, and a dead tirzepatide page is linked from every footer
91. Vita Bella
$7 — per shot, footnoted "with Membership"; the membership fee is not stated on the same page
Summary, strengths and trade-offs8 points
Vita Bella prices NAD+ against IV clinics in a two-column table, and both of its own figures are conditioned by a footnote most readers will skip.
Strengths
- Names Vita Bella Health LLC as the operating company
- States the vial size and the number of injections it contains
- Publishes its footnote conditions on the same screen as the figures
- Sells four tracked compounds rather than one
Trade-offs
- Its headline per-shot figure requires a membership whose price is not on the page
- Prices only NAD+ — its sermorelin, tesamorelin and PT-141 carry no published figure
- Describes a "US FDA-Inspected Pharmacy" without naming one
- Its comparison column is a competitor category, which is easy to misread as its own price
92. Good Life Meds
$124 — the page names no supply period; the product carries a coming-soon badge and a $99 first-order promotion
Summary, strengths and trade-offs8 points
Good Life Meds names its pharmacies and prints four green "Passed" test badges on every product page, with no document behind any of them.
Strengths
- Names both dispensing pharmacies and its medical group
- Charges one semaglutide price at every dose level
- Prints the milligram content and the vial volume on its peptide pages
- Says plainly that its published prices exclude promotional offers
Trade-offs
- Prints four green test-passed badges with no certificate behind any of them
- Publishes no statement that its compounded products are not FDA-approved
- Its three peptide products carry coming-soon badges and no supply period
- Its fifty-state operation is a count with no list
93. HealthHub
$129 — "NAD⁺ Injection Kit – $129 / A 4-week injection kit with clear instructions and all supplies included"; the FAQ repeats "The NAD+ injection kit is $129 for 4 weeks"
Summary, strengths and trade-offs8 points
HealthHub answers the pharmacy question with six named facilities and their street addresses, and prices three of the compounds compared here in five preparations, every one of them on a four-week supply rather than a calendar month.
Strengths
- Names six compounding pharmacies with their street addresses on the product pages themselves
- Says exactly what each figure covers — consult, medication, supplies and shipping
- Prices three preparations of one compound separately rather than quoting one rate for all
- Answers the lab-work question plainly instead of leaving it to the intake
Trade-offs
- Renders a long price table of unrelated medications on every product page, none of it the product being read
- Quotes four-week supplies while most sellers quote months, so its figures need converting before they compare
- Publishes no statement at all about which states it serves
- Prices its on-demand compound from a floor rather than at a rate
94. Solas Health & Wellness
$140 — For four INJECTIONS, not one and not a month — read as "NAD+ Injection 4 for $140", which works out at $35 an injection with no frequency stated. The clinic separately prices "NAD+ IV Infusion 250 mL · energy, focus & longevity $200" per infusion
Summary, strengths and trade-offs8 points
Solas publishes no corporate entity and instead puts one named, licensed clinician on every page — and prices peptides per cycle rather than per month, which is a unit almost nothing else here uses.
Strengths
- Publishes a per-cycle range as well as a starting figure, so the spread a buyer faces is visible
- Puts one named, licensed clinician on the pages and states the two states she is licensed in
- Says the consultation fee is credited toward the first cycle rather than charged on top
- States plainly that no membership, enrollment or hidden fees apply
Trade-offs
- Publishes no corporate entity anywhere on the pages read
- The peptide price is per cycle, and the only cycle length it publishes is a four-to-twelve-week range on its blog, so it cannot be compared with a monthly rate
- Names no dispensing pharmacy, describing them only as licensed compounding pharmacies
- Its NAD+ figures use two different units — four injections for one price, and a single infusion for another
95. REMEVi
$145 — per four weeks, not per month — "One number. Any delivery form.... NAD+ · 4-week subscription · $145 / 4 wks", labeled "Founder's pricing"; the same figure applies to the injection, the nasal spray and the oral dropper, so choosing a route costs nothing extra here
Summary, strengths and trade-offs9 points
REMEVi charges one flat figure for a four-week subscription, the same figure for every compound and every delivery form it sells, and it says four weeks rather than a month — a distinction worth thirteen charges a year instead of twelve.
Strengths
- Names its billing unit as four weeks rather than calling it a month, which almost no seller on this roster does
- Charges one flat figure across both compounds and, for one of them, across all three delivery routes, so the route costs nothing extra
- States on both product pages that what it sells is a non-approved compounded preparation, not a generic of any approved drug, and has not been studied as a finished product
- Claims coverage as fifty states plus the District of Columbia and prints the count itself
- Runs its intake and its follow-up care in English and Spanish, stated on the page rather than buried in a settings menu
Trade-offs
- The figure is labeled founder's pricing, which is a seller telling you the rate is introductory without saying when it ends
- Four-week billing produces thirteen charges a year, and nothing on the page converts that into an annual figure for the reader
- The compounding pharmacy is described by licensing class and never named
- No certificate of analysis appears on any page read; the quality claim rests on a pharmacy certification badge instead
96. Body Good Studio
$149 — from; the card names no billing period
Summary, strengths and trade-offs8 points
Body Good Studio carries a 2025 federal warning letter, prices five tracked compounds openly, and publishes a line on its own home page conceding that its brand names and final copy are still pending clinical and legal review.
Strengths
- Prices five tracked compounds on one open page with no intake in the way
- Prints the vial sizes behind each range rather than only the floor
- Charges one semaglutide price at every dose
- States in its own words that its compounded products are not FDA-approved
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Its own page says the brand names and final copy are pending clinical and legal review
- Its fifty-state claim is hedged in the following sentence and no list is published
- Three of its five figures name no billing period at all
97. CLYR Health
$159 — one vial, "try it first · no auto-renew"; three vials are $299 and six are $499
Summary, strengths and trade-offs8 points
CLYR Health prices seven tracked compounds by weekly dose with the whole ladder visible before any intake, names its pharmacy, and puts a competitor's cream price in the same table as its own.
Strengths
- Prices seven tracked compounds with the full ladder visible before any intake
- Prints the vial size, concentration and weekly dose beside each figure
- Names its dispensing pharmacy and its medical group
- Its savings arithmetic reconciles against every multi-vial total it prints
Trade-offs
- Puts a competitor's cream price in the same table as its own
- Its tirzepatide hero quotes a cycle rate the ladder below contradicts
- Its LegitScript badge links to its own article rather than to a listing
- Says only that the service is available in certain states, without naming any
98. NativeMed
$159 — a first-month rate, not a recurring one: the product page prints "Regular price $159.00 From … Sale price $159.00 first month then $186/mo*". The standing figure is $186. The same page also carries a plan grid reading "$189/mo 3-MONTH PLAN" and "$479 $159/mo", and the all-products collection shows "$159.00 Starting at / $199.00 / $159.00" — four figures for one product, none of them reconciled by the seller
Summary, strengths and trade-offs7 points
NativeMed prints the word "Passed" beside four named laboratory tests on its coenzyme page, and publishes no certificate, no PDF and no link a reader could use to see any of them.
Strengths
- Labels its promotional figure "first month then" on the product page rather than leaving the reader to discover the standing rate later
- Names the operating company, the clinical practice and a street address in its own terms
- Describes the four laboratory tests it says each lot undergoes, and how often the potency test is run
Trade-offs
- Prints test results as "Passed" while publishing no certificate, no PDF and no link — the claim cannot be checked by anyone reading the page
- Four different figures for the one product across its own product page and collection page, none reconciled
- Carries an FDA warning letter for false and misleading claims that names this website by address
- No dispensing pharmacy, no state coverage list
99. VitaFusions IV
$159 — a per-session price for one mobile infusion, read as "NAD+ - $159 $195 — Our most popular anti-aging treatment to support brain health and mental clarity" where the second figure is struck through and the first is not; the page is headed "Mobile IV Packages & Pricing" and every card ends in "Book Now", so no billing period exists and nothing recurs. A separate package, "NaD+ Boost - $299 $350", combines this compound with a vitamin blend and is a combination rather than this compound on its own's price
Summary, strengths and trade-offs11 points
VitaFusions is a mobile infusion service, not a shipped program, and it answers the question this roster asks hardest: it names the pharmacy that makes its medication, with a phone number, in its own FAQ.
Strengths
- Names the pharmacy that makes its medication, with a telephone number, in a plain FAQ answer
- Prints a full package price list on one page rather than behind a booking flow
- States that travel fees and taxes are already inside the quoted price
- Says what qualification the person administering the infusion holds
- Says plainly that infusion therapy is not a substitute for medical treatment
Trade-offs
- Every package price is printed as an undated pair with the dead figure unlabeled, so a text-only reading can pick the wrong one
- A regional mobile service with one booking telephone number and no coverage claim anywhere
- A shop section on the same domain is headed for research compounds and marked not for human or veterinary consumption, though it lists no product
- The compound is also sold as a combination package whose higher figure buys a vitamin blend as well, which invites a false comparison
- No lab work is included in or priced beside any package
- An age interstitial covers every page before any content is reachable
100. Vitalex Health
$159 — from, per month — a floor rather than a quoted bill
Summary, strengths and trade-offs8 points
Vitalex Health publishes the broadest open peptide price list read in this pass — twenty priced protocols across six goal areas, singles and stacks alike — on a page that ships the same template, the same headline and two identical figures as another seller entering this roster the same day.
Strengths
- Prices seventeen distinct protocols in visible text on one open page, with no quiz, account or gate in front of any of them
- Groups the catalog by goal rather than by compound, and names the exact combination in every stack
- Prices the stacks as well as the singles, so a reader can see what adding a peptide actually costs
- Claims fifty-state service for itself with a number on its own About page
Trade-offs
- Its peptide page is the same template, headline and disclaimer as another seller on this roster, with two figures identical to the dollar — the two are not independent readings of the market
- Every figure is a "from" floor, so none is a quoted monthly charge
- CJC-1295, ipamorelin, TB-500, KPV and Semax are sold only inside stacks and are never priced alone
- No compounding pharmacy is named anywhere, and the disclaimer places prescribing entirely with independent third parties
101. Always Wellness and Recovery
$179 — the "From" figure on the catalog card; the same card offers a bundle at $399, and no billing period is named for either
Summary, strengths and trade-offs8 points
Always Wellness and Recovery prints a single-vial price and a three-month bundle total on the same card for each of its injectable peptides, and then divides the bundle itself — its own product copy restates a $529 three-month supply as "about $176 per month".
Strengths
- Prints the single-vial price and the multi-month bundle total on the same card, so a reader can see what the longer commitment actually costs
- Says in its own words that there is no membership fee, no subscription and no automatic billing
- Lists what ships in the box — vial, bacteriostatic water, syringes, dosing guide and sharps container — rather than leaving supplies unstated
- Names both compounding categories it sources from, 503A and 503B, and claims fifty-state service in three separate places
Trade-offs
- Its own product copy divides a three-month total into a per-month figure that is never billed
- The compounding pharmacies are described only by their regulatory category and are never named
- The nasal-spray bundles are priced only on the catalog card, with no product page of their own read
- No lab work is included, and labs are not mentioned in any program description
102. HealthSource
$179 — printed as "NAD+ Nasal Spray — Wellness — $179.00 every 4 weeks". A nasal spray, not an injection; the injectable is a separate SKU at a higher figure
Summary, strengths and trade-offs8 points
HealthSource prices every peptide "every 4 weeks" — thirteen charges a year, not twelve — on a page that also carries "every 30 days" and "/ month" against other products.
Strengths
- States the billing period on every single line rather than leaving it to be assumed
- Prices four peptide SKUs across three routes on one browsable catalog
- Distinguishes fixed-price SKUs from variant SKUs and says which is which on the card
- Tags every prescription item on the catalog rather than only at checkout
Trade-offs
- Its peptides bill every four weeks, which is thirteen charges a year and will read as twelve in any monthly column
- Three different billing periods appear on the same catalog page against different products
- No operating company was found on the pages read
- No pharmacy named, no certificate of analysis, no state coverage list
103. ZYP Medical
$179 — one-time, for a six-week titration; maintenance is then $249 every six weeks
Summary, strengths and trade-offs8 points
ZYP Medical prices peptides as four-week stacks rather than by the month, lists the seven states it serves by name, and states in its own words that its compounded GLP-1 medicines are not FDA-approved.
Strengths
- Names the seven states it serves rather than printing a count
- States plainly that its compounded semaglutide, tirzepatide and NAD+ are not FDA-approved
- Prints the unit beside almost every figure — four weeks, six weeks, one-time, per month
- Says its consult fee buys clinical time and does not guarantee a prescription
Trade-offs
- Prices most of its peptide catalog as multi-compound stacks, so no single peptide has its own figure
- Names no dispensing pharmacy and publishes no certificate of analysis
- Serves seven states, so most of the country cannot buy from it
- Its testosterone line reaches only three of those seven states, which the page states separately
104. Clover Meds
$198 — for a four-week supply, "First and Every Month", struck through from a $247 list price
Summary, strengths and trade-offs8 points
Clover Meds carries a June 2026 federal warning letter, names its pharmacy with a street address, lists the four states it operates in, and every rung of its plan ladder reconciles.
Strengths
- Names its pharmacy with a street address, under a heading saying patients should know where their medicine comes from
- Lists the four states it operates in rather than claiming a footprint it does not have
- Every rung of both plan ladders reconciles against its printed total
- Charges one price at every dose on both weight-loss molecules
Trade-offs
- Carries a June 2026 federal warning letter naming its own website
- Operates in four states, so most readers cannot buy from it
- Its governing law, its venue and its operating states are three different places
- Its NAD+ price buys four weeks, which its own copy calls a month
105. CoraDoc
$199 — for four weeks, struck through from $349
Summary, strengths and trade-offs8 points
CoraDoc prices its peptides in four and ten-week blocks rather than months, and runs a countdown sale whose banner figures contradict the program cards on the same page.
Strengths
- Prices three peptides individually rather than behind its own category floor
- Prints the block length — four weeks, ten weeks — beside each peptide figure
- States in its own words that its compounded weight-loss drugs are not FDA-approved
- Disclaims the similarly named company its brand could be confused with
Trade-offs
- Its sale banner and its program cards give different prices for both weight-loss molecules
- The sale carries a hard end date, so every figure here is perishable
- Names no dispensing pharmacy and publishes no certificate of analysis
- Its nationwide claim is prose with no state list behind it
106. DadVantage Men’s Health
$200 — for 500 mg lyophilized; the page also prints $350 for 1,000 mg and no billing period for either
Summary, strengths and trade-offs8 points
DadVantage prices sermorelin at three vial strengths and NAD+ at two, and every figure it publishes is a quantity price rather than a monthly one.
Strengths
- Names the vial strength beside every figure, so a reader can compare cost per milligram
- Prices three sermorelin strengths instead of one headline number
- States plainly that telehealth visits work anywhere in Florida and in-home visits are local
- Puts its peptide and injection prices on one open page with no intake
Trade-offs
- No figure on the page carries a billing period of any kind
- Publishes no operating company on any page read
- Serves one state, so most readers here cannot use it
- Names no dispensing pharmacy and publishes no certificate of analysis
107. Enough! Wellness
$249 — Per four weeks, and it buys the whole stack — NAD+, sermorelin and glutathione together, not the coenzyme alone. The seller publishes a full commitment ladder beside it and prints the total and the derived rate on each rung: "4-week subscription $249/4-week · 12-week commitment charged as $627 → $209/month · 24-week commitment charged as $1,134 → $189/month · 52-week commitment charged as $2,327 → $179/month". The lowest figure on the page, $179/month, is a division of a $2,327 charge taken up front
Summary, strengths and trade-offs8 points
Enough! publishes a commitment ladder that prints the total charge and the derived monthly rate on the same line — so the cheapest number on the page is attached to a two-thousand-dollar up-front payment, in writing.
Strengths
- Prints the total charge and the derived monthly rate on every rung of its commitment ladder
- States the billing period as four weeks rather than calling it a month
- Says plainly what is in the stack and that a clinician adjusts it
- Publishes an unqualified fifty-state claim in its own trust bar
Trade-offs
- The best-value figure requires a $2,327 payment up front, which only the same line discloses
- No compound in the stack has a price of its own
- Publishes no corporate entity and no copyright line on the page read
- Prints "No $5,000 clinic" as marketing copy, which is a competitor figure and not its own
108. Team Wellcore
$250 — the only NAD+ figure the page actually prints — "Starting at $250" in its body copy, with no billing period; its structured data carries a lower figure that appears nowhere on screen, and a separate "$34 for consult" is charged before any medication is priced
Summary, strengths and trade-offs8 points
Team Wellcore names its dispensing pharmacy with an address, a phone number and the ten states that pharmacy cannot ship sterile compounds into — and then charges for a consult before it will quote the price of any medication.
Strengths
- Names the dispensing pharmacy with a street address and a phone number rather than describing a class of facility
- Names the ten states that pharmacy cannot ship sterile compounds into, which is a checkable exclusion list rather than a coverage claim
- States the consult charge up front and says the medication is billed only after a provider approves
- Describes its compounded products as patient-specific and not FDA-approved in its own FAQ rather than burying the point
Trade-offs
- Four of its six tracked products publish a price only inside structured data, where no reader ever sees it
- Where a visible figure and a structured-data figure both exist they disagree, and the visible one is the higher
- Its own state arithmetic is wrong — it claims licensure in forty-four states while naming ten it is excluded from
- No visible figure carries a billing period, so nothing it publishes can be read as a monthly rate
109. Fridays
$259 — the product page prints the figure with no billing period, supply length or cycle stated
Summary, strengths and trade-offs8 points
Fridays lists four partner pharmacies with street addresses in its own terms, prices three longevity products at one flat figure each, and trades under two different corporate names.
Strengths
- Publishes four partner pharmacies by name with street addresses and phone numbers
- Prints one figure per product with no ladder that climbs as the dose rises
- Says in its own terms that labs and pharmacies are not operated by the company
- Offers the same compound in both an injectable and an oral route at a stated strength range
Trade-offs
- Publishes two different corporate names for itself, one in the footer and one in the terms
- Prints its figures with no billing period, supply length or cycle attached
- Publishes no state list, so eligibility is settled inside the intake
- Places lab work outside the program the figures cover
110. Rejuvia Wellness
$260 — per vial, printed as $260 in the table's "VIAL" column beside a course of "3 vials / 5 months"; the page says vials start at $240 and most protocols need one to six vials, so the figure is the price of one vial, not of the course
Summary, strengths and trade-offs8 points
Rejuvia prices its peptides by the vial and prints beside each figure how many vials a course takes and how long it runs. The cost of a full course is mapped out at the consultation, not printed.
Strengths
- States the vial count, the milligram strength and the course length beside every vial price
- Publishes a figure for eight separate tracked compounds
- Charges nothing for the initial consultation and says so
- Marks each course as a standard or premium tier rather than blending them
Trade-offs
- Each figure is the price of one vial, and most courses take more than one, so no figure on the table is the cost of a multi-vial course
- Publishes no corporate entity on any page read
- Charges separately for the initiation visit on top of every course
- Publishes no state list and names no dispensing pharmacy
111. Cosmetic Laser Professionals
$269 — The SUBSCRIPTION RATE for A 1,000 MG unit — "NAD+ 1000mg- $369, $269 with monthly subscription". The seller separately sells in-office injections in EXPIRING PACKAGES, a unit nothing else here uses: "(15) NAD+ injections $299 exp. after 12 months · (30) $399 exp. after 24 months · (50) $499 exp. after 36 months"
Summary, strengths and trade-offs8 points
This seller names its compounding pharmacy and its accreditation, then prices one product three different ways on one page — per vial, per troche, and in injection packages that expire on a stated date.
Strengths
- Names its compounding pharmacy and that pharmacy's accreditation body
- Publishes beyond-use dates by storage class, which nothing else on this roster does
- Prints the dose the 30-day supply assumes, so the window can be checked against a different dose
- Names the operating company and its trading name in the same footer line
Trade-offs
- Uses three incompatible units for one product — per vial, per troche, and expiring injection packages
- The injection packages carry an expiry, so unused doses can lapse
- Publishes no state coverage
- Its compounding disclaimer sits at the bottom of a long page rather than beside the price
112. DrBrainRx
$275 — per vial, described by the seller as a "10mL vial (1 month supply)" — and a separate $25/month care tier is required: "Care access is required for all prescriptions."
Summary, strengths and trade-offs8 points
DrBrainRx sells a single tracked peptide — an NAD+ vial with a stated one-month supply — and its product page makes a paid care membership mandatory, then publishes what that membership costs on a page of its own.
Strengths
- Publishes the price of the care membership its own product page makes mandatory, on a page a shopper can read first
- Prints the vial volume and the sterile-compounding standard the vial is made to beside the figure
- Says the injection supplies come with the vial rather than leaving them to be bought separately
- Separates its compounded tier from its brand-name tier and prices each, so a buyer knows which one applies
Trade-offs
- Publishes no state list at all, so eligibility cannot be checked before starting an intake
- Sells one tracked compound, and a GHK-Cu address on its own domain answers with the homepage while appearing in no sitemap
- Its footer sends "Memberships" to a third-party booking widget off the domain rather than to the priced page on its own site
- Calls the vial a one-month supply and then says a vial "may last multiple weeks depending on dose and frequency"
113. SynergyRx
$275 — starting at, the bottom of a range; the catalog names no billing period
Summary, strengths and trade-offs8 points
SynergyRx prices four tracked peptides at exactly the same figure and its two GLP-1s separately, prints that figure before the product name rather than after it, and runs terms of service naming a different company as the operator.
Strengths
- Puts a figure beside four separate tracked peptides rather than behind one category floor
- Says plainly that it neither manufactures nor dispenses what it sells
- Prices PT-141, which few sellers on this roster price at all
- Publishes its catalog without an intake in the way
Trade-offs
- Prices four different peptides at exactly the same number, with no dose or vial size to separate them
- Its terms of service name a different company as the operator throughout
- Publishes no price for either weight-loss molecule
- Will not publish its state list, directing readers to customer service instead
114. Rehydra+ Wellness
$279 — starting at
Summary, strengths and trade-offs7 points
Rehydra+ Wellness grew out of a mobile IV-therapy business and now sells a broad peptide catalog — BPC-157, KPV, MOTS-C, tesamorelin, sermorelin and GHK-Cu — with prices posted openly on its storefront, though it names neither a legal entity nor the pharmacy that fills its orders.
Strengths
- Publishes a phone and text line plus a named staff email, unusual for this category
- Its catalog spans six named peptides beyond a GLP-1 and testosterone line
- Consultations are free and financed payment plans are offered
Trade-offs
- No legal entity is named anywhere on the site; the terms identify only the brand
- Says it serves 20 states but never lists which ones, so coverage cannot be confirmed before intake
- Its LegitScript badge is a self-hosted image linking to a generic checker page rather than a confirmable certification record
- The compounding pharmacy is not named, and no page says which of its named clinicians prescribes
115. PeptidesRx
$296 — "NAD+ / Energy that lasts past three in the afternoon / from $296 per vial / $802 for 3 months \u00b7 $1,462 for 6 months / One vial typically lasts four to six weeks". The WooCommerce catalog prices NAD+ at "$ 189.00".com/product/nad/
Summary, strengths and trade-offs8 points
PeptidesRx prices ten of the compounds compared here, names the pharmacy that fills the orders and gives its address, and runs two live catalogs on one domain whose figures do not agree with each other on a single compound.
Strengths
- Prices ten of the compounds compared here, more than any other seller on this roster
- Names its dispensing pharmacy, its street address and its telephone number
- States the vial strength and the expected duration of a vial beside most figures
- Publishes the states its pharmacy is not licensed in rather than only the count
Trade-offs
- Runs two live catalogs whose figures disagree on every compound they share
- Prints a third, templated figure on every product page that belongs to no product
- Gives two coverage numbers in one paragraph that cannot both be right
- Prices a third figure for one compound on a marketing page separate from both catalogs
116. MD Total Wellness
$300 — per 1000mg vial; the seller describes one vial as typically a one to two month supply, depending on the dosing protocol
Summary, strengths and trade-offs8 points
MD Total Wellness prices its peptides and NAD+ by the vial with the vial size printed, on a price list of its own that its main service pages do not link to.
Strengths
- Prices its peptides and NAD+ by the vial with the vial size printed
- Includes in-office lab testing inside its published weight-loss price
- States plainly that its compounded weight-loss medicines are not FDA-approved
- Says where it dispenses from and where it can ship, in one sentence
Trade-offs
- Its per-vial price list is on a page its main service pages do not link to
- Serves one state, so most readers cannot buy from it
- Names no dispensing pharmacy and publishes no certificate of analysis
- Its terms name Florida law for a California clinic
117. Better Med Spa
$325 — printed as 'Starting at $325' for the in-clinic NAD+ IV infusion, with no billing period stated. A separate new-patient special on the same page prints a struck-through 385 against a lower 199 for its at-home and in-office shot plans
Summary, strengths and trade-offs8 points
Better Med Spa sells epithalon and GHK-Cu only as one combined protocol at one price, and attaches no billing period to any figure it publishes.
Strengths
- Names thirteen tracked compounds, one of the deepest menus on this roster
- Publishes a figure on each individual treatment page rather than gating them
- Gives epithalon and GHK-Cu a dedicated page rather than burying them in a list
- Separates its NAD+ IV from its at-home and in-office shot plans
Trade-offs
- Attaches no billing period to any peptide figure, so none can be compared
- Sells epithalon only bundled with GHK-Cu, so neither has a price of its own
- Its legal company name shares no words with its brand
- Publishes no state list and names no dispensing pharmacy
118. LaSara Medical Group
$350 — The seller's own arithmetic contradicts its own label: the page prints "$350 — $5.83 per day" for both the subscription and the one-time option, and the shop label reads "$350 - Monthly Subscription". But $350 ÷ $5.83 = 60.0 days, not 30 — while the same seller's growth-hormone page divides by exactly 30. Recorded as not a monthly rate because the page's own division says sixty days. A NASAL SPRAY, not an injection
Summary, strengths and trade-offs8 points
LaSara sells both its peptides as nasal sprays, prints a per-day figure beside each price, and one of those divisions only works if the supply is sixty days rather than the month its shop label claims.
Strengths
- Prints a per-day division beside every figure, which is what made the sixty-day discrepancy visible at all
- Names the route in the product URL and the product title, so a nasal spray is never mistaken for an injection
- Publishes the subscription tier and the one-time price side by side with the discount stated as a percentage
- Publishes a street address and a phone number in the footer of every page
Trade-offs
- The coenzyme's own per-day figure implies a sixty-day supply while its shop label calls it a monthly subscription
- The only corporate name on its terms belongs to its website platform vendor
- Its weight-loss pages carry a figure that does not match the one on its about page, so cross-page consistency is not a habit here
- No pharmacy named, no certificate of analysis, no state coverage list
119. Healthy Resolutions
$400 — per vial; the page names no billing period and no supply length
Summary, strengths and trade-offs8 points
Healthy Resolutions names three partner pharmacies with full addresses and prices sermorelin at two strengths, but its "States We Cover" page publishes no states at all.
Strengths
- Names three partner pharmacies with street addresses, phone numbers and one facility class
- Prices two sermorelin strengths separately instead of publishing a single range
- Publishes its registered company name rather than trading under a bare brand
- States its coverage explicitly, however small, rather than leaving it to the intake
Trade-offs
- Its "States We Cover" page publishes no states, so the only list is a footer sentence
- Serves four states, so most readers are ineligible before anything else matters
- Attaches no billing period to either priced compound
- Makes no statement about lab work on either priced page
120. Invigorate Advanced Aesthetics
$500 — No unit is published — "NAD+ | Supports cellular energy, mental clarity, and anti-aging | $500", the dearest line on the table. A separate "NAD+ SM" line is $250
Summary, strengths and trade-offs8 points
Invigorate publishes a per-compound price for eleven peptides and attaches no unit to any of them — not a vial, not a month, not a dose — on a page that prints the same list twice in two different orders.
Strengths
- Publishes a per-compound figure for eleven peptides rather than one starting rate
- Prints the catalog as a proper table as well as a card grid
- Prices blends as their own lines instead of implying them from the singles
- The price list sits on the service page itself, not behind an intake
Trade-offs
- Not one figure carries a unit — no vial size, no dose, no billing period
- The card grid prints prices before the names they belong to on about half the rows
- Publishes no corporate entity; the only company named on the legal page is its web agency
- Names no dispensing pharmacy and publishes no state coverage
121. Oasis Medical Clinic & Spa
$549.95 — the online shop lists "NAD+ IV Therapy" at this figure with a quantity selector; no dose, session length or period is stated
Summary, strengths and trade-offs8 points
Oasis splits its consultation charge into a deposit and a balance, so the first figure on its peptide page understates even the visit. Of the compounds on that page, it prices only NAD+, as an IV therapy in its online shop with no dose stated.
Strengths
- States the full cost of the first appointment in one sentence, in two parts
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Prices NAD+ only as an IV therapy with no dose stated, and the two consultation figures are easily read as one
- Prices no peptide; its online shop says its peptide products are unavailable
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
122. AHBARx
$699 — charged every 6 months for a 6-month supply, medication delivered every 3 months
Summary, strengths and trade-offs8 points
AHBARx sells sermorelin by the vial with a monthly delivery, and sells its NAD+ and glutathione only as six-month prepaid supplies.
Strengths
- States the delivery cadence beside every figure, not just the amount
- Says in its own words that services are available "within all 50 states of the United States"
- Publishes the vial strength — 9mg — beside the sermorelin price
- Says its medications are sourced through "U.S.-based, FDA-registered compounding pharmacies"
Trade-offs
- Publishes no operating company on any page read
- Two of its three tracked compounds are sold only as six-month prepaid supplies
- Charges every six months while shipping every three, so the money runs ahead of the medicine
- Names no dispensing pharmacy and publishes no certificate of analysis
123. TrufaMED
$1000 — printed as '$1,000 per session' for a single in-clinic infusion, under the seller's own heading 'One protocol, one price. No mg-tiered upsells and no surprise add-ons.' A mobile session delivered to the patient is priced higher on the same page
Summary, strengths and trade-offs8 points
TrufaMED charges one flat figure per NAD+ session with no milligram tiers, and says on the same page that the therapy is not FDA-approved for anti-aging.
Strengths
- States a flat per-session price with no milligram tiers, and says so explicitly
- Prices its in-clinic and mobile sessions separately and openly
- States in its own words that the therapy is not FDA-approved for anti-aging
- Describes what each session includes rather than only what it costs
Trade-offs
- Prices per session, a unit nothing on a monthly comparison can absorb
- Sells one tracked compound only, so there is nothing to compare within the seller
- Publishes no corporate entity on any page read
- Publishes no state list and names no dispensing pharmacy
124. Balanced Healthcare
$1500 — the standard (non-member) price for a loading course the page describes as '4 doses over 8 days (500mg each)' — eight days, not a month. A member price of 1,350 is published beside it, and the page says the loading course is recommended but not required
Summary, strengths and trade-offs8 points
Balanced Healthcare publishes two prices for everything — one for members, one for everyone else — and prices its peptide programs by tier rather than by compound.
Strengths
- Publishes both the member and the non-member figure instead of only the discounted one
- States the dose count and the number of days its NAD+ loading course covers
- Says the loading course is recommended rather than required
- Runs a full published pricing page rather than quoting only at consult
Trade-offs
- Its peptide tiers do not name the compounds they cover, so no figure is compound-scoped
- Every figure has two values, and which one applies depends on a membership sold separately
- Its NAD+ course covers eight days, which no monthly comparison can absorb
- Publishes no corporate entity, no state list and names no dispensing pharmacy
125. Bayan Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Bayan Health is one of the few sellers anywhere on this roster that publishes a KPV price, and it bills that price monthly across a fixed three-month protocol.
Strengths
- Publishes a KPV price, which almost nothing else on this roster does
- States both the monthly charge and the three-month commitment on the same line
- Says the physician consultation fee is included in the monthly price
- Describes its supply in its own words as "U.S. 503A pharmacy partners"
Trade-offs
- Publishes no operating company on any page read
- Sells five more tracked compounds without publishing a figure for any of them
- Ships the whole three-month protocol at once while billing across three months
- Publishes no state list, names no pharmacy and posts no certificate of analysis
126. Bridgeside Telehealth
Does not publish a NAD+ price.
Summary, strengths and trade-offs9 points
Bridgeside Telehealth prices every peptide identically, at $99 for the consultation and $300 for the medication if it is prescribed, and charges nothing for the visit when therapy is judged inappropriate.
Strengths
- One published figure covers any peptide it prescribes, so the price does not move with the compound chosen
- States that there is no charge for the visit at all if peptide therapy is not clinically appropriate
- Names its operating entity, Bridgeside Telehealth LLC, in its own Terms of Use rather than trading under a bare brand
- Says plainly that additional peptides are only considered after the first month, instead of selling a stack up front
Trade-offs
- Publishes two incompatible price structures on one site: the home page says "The total cost is $300" including the consultation, while every peptide page says the consultation is $99 and the medication $300 on top of it
- Its own FAQ asks "Is the $300 a subscription?" and the answer field still reads "Tab Item Content"
- Says it is licensed in 44 states and publishes no list of which ones
- Names no compounding pharmacy, only "a licensed U.S. compounding pharmacy"
- The category pages name only GHK-Cu and NAD+ outright; the rest of the menu appears as categories and disclaimer text rather than a catalog with strengths
127. Chronos Body, Health & Wellness
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Chronos Body, Health & Wellness is a Louisiana clinic that prices weight-loss medication by the injection in its office and by the two-to-three-month package by post, and it says openly it is not a national platform.
Strengths
- Prices weight-loss medication per injection in its office, which almost nothing else on this roster does
- Says how long each package lasts rather than calling it a month
- Names the two states it treats in and says it is not a national service
- Cites the compounding sections by number in its own disclaimer
Trade-offs
- Serves two states, so most readers cannot buy from it
- Its consultation fee differs across three of its own pathways
- Its NAD+ and microdosing pages publish no price
- Names no dispensing pharmacy and links no certificate behind its certification badge
128. Next Vial
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Next Vial names its pharmacy with a street address and lists the forty-nine states it serves, and then hides every price but one behind a plan selector.
Strengths
- Names its dispensing pharmacy with a street address and a telephone number
- Lists the forty-nine states it serves rather than printing a count
- Names the clinician network that reviews the intake
- States plainly that compounded medicines are not FDA-reviewed
Trade-offs
- Four of its five peptide products show a plan selector where a price should be
- Its weight-loss floor covers two different drugs behind one figure
- The one published figure names no billing period
- Alaska is absent from its own state list, so the coverage is not nationwide
129. Rixa Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Rixa Health prices its weight-loss ladders in four- and five-week blocks rather than months, prints the weekly milligram at every rung, and says the figure is a pass-through of what the compounding pharmacy charges.
Strengths
- Prints the weekly milligram beside every rung of both ladders
- States the block each figure buys — four weeks, five weeks or thirty days — instead of implying a month
- Says its price is a pass-through of what the preparing compounding pharmacy charges, shipped separately
- Says it offers no contracts or long-term commitments
Trade-offs
- Nothing it prices is priced by the month, so nothing compares cleanly to a monthly rate
- Its oral semaglutide is a two-ingredient tablet, so that route carries no scoped price
- Names no dispensing pharmacy and publishes no state list
- Several rungs of its own ladder still carry the placeholder text "Your description goes here"
130. Thrivelab
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Thrivelab names 503A compounding as its source and condemns the research-peptide gray market by name — then publishes no price for any peptide it lists, only for its two weight-loss molecules.
Strengths
- Warns readers away from research-labeled peptides sold without medical oversight
- Names 503A compounding as the source for everything it sells
- Prints an intro month and a following-month figure rather than one number
- Publishes a consultation price alongside the medication price
Trade-offs
- Its peptide page names ten tracked compounds and prices none of them
- Its following-month figures are ranges, so the standing price is not a number
- Its most eye-catching figure belongs to a competitor column, not to itself
- Names no dispensing pharmacy and makes no state-coverage claim
131. Valhalla Vitality
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Valhalla Vitality lets the patient choose which pharmacy fills the prescription and says the price does not change either way.
Strengths
- Lets the patient pick which verified pharmacy fills the prescription
- Says the price is the same whichever pharmacy is chosen
- States that compounded drug products are not approved or evaluated by the FDA
- Says it serves 50 states nationwide
Trade-offs
- Publishes a figure for only one of the four compounds it sells
- Publishes no operating company on any page read
- Names none of the pharmacies it invites patients to choose between
- No certificate of analysis is reachable
132. Vigormeds
$59/mo — from, per month, for a topical cream rather than a dose of the peptide
Summary, strengths and trade-offs8 points
Vigormeds publishes two different monthly figures for its NAD+ injection and two more for its NAD+ nasal spray, with identical descriptions and nothing distinguishing them, and one product card whose price is printed with no number in it.
Strengths
- Prices NAD+ and glutathione across injection, nasal spray, oral and topical routes
- States in its own terms that it is not licensed to practice medicine and provides no healthcare service
- Says a prescription may be filled by and transferred between several pharmacies, which most sellers leave unsaid
- Marks products that are not yet available as coming soon rather than selling them
Trade-offs
- Publishes two different monthly figures for its NAD+ injection and two more for its nasal spray, unreconciled
- One product card prints a price with no number in it at all
- Its weight-loss figures carry no billing period beside them
- Publishes no state list; its terms point at a link instead of naming states
133. Stealth Health
$88/mo — from, per month, as prescribed by your clinician
Summary, strengths and trade-offs8 points
Stealth Health prices to the cent and attaches a month to every figure, and it is the only seller in this batch whose glutathione comes in two separately priced formulations.
Strengths
- Attaches "/mo" to every figure across every product page
- Prices two glutathione formulations separately instead of quoting one number
- Names Stealth Health Inc as the operating company
- Says no payment is taken upfront — only when a prescription is approved
Trade-offs
- Publishes no state list, and its shipping claim spans two countries
- Names no dispensing pharmacy
- Its GHK-Cu price buys a combination topical, not the copper peptide alone
- No certificate of analysis is reachable
134. Green Cap Health
$89/mo — per month as an add-on, which the pricing page lists as "Available on top of any tier" of its weight-loss plans; prepay tiers of $249 for three months and $449 for six sit beside it
Summary, strengths and trade-offs9 points
Green Cap Health sells compounded semaglutide and tirzepatide at one monthly price at any dose, and prices NAD+ and sermorelin injections as add-ons to those plans. It publishes two different monthly figures for the same GHK-Cu foam on two of its own pages.
Strengths
- Puts the per-month figure and the prepay total side by side for each injection
- Prices each weight-loss drug the same at any dose, with no separate membership charge
- States in its own words that its compounded products are not FDA-approved
- Says it requires third-party batch testing from its pharmacy partners and reviews the reports
- Prices NAD+ and sermorelin separately rather than behind one longevity floor
Trade-offs
- Publishes two different monthly prices for the same copper-peptide foam on two of its own pages
- Names no dispensing pharmacy and publishes no certificate of analysis
- Names Texas as where its people hold licenses without saying where it can ship
- Sells NAD+ mainly as a cream and a foam, so the injection is the only tracked form with a clean figure
135. Harbor
$99/mo — a flat monthly program rate, read as "NAD+ program | Most chosen | $99 /mo | Flat monthly price — no increases as your dose changes"; the page also advertises "Save up to $600 on multi-month prepaid plans vs monthly" without publishing any prepaid rung, so the discounted price is asserted and never shown
Summary, strengths and trade-offs10 points
Harbor publishes one flat figure per compound with "no increases as your dose changes" written beside it, names its partner medical group in a footer disclosure, and then tells you in its own terms that it makes no promise the service reaches your state.
Strengths
- Prints one flat figure per compound with an explicit promise that it does not rise as the dose is titrated
- States what the figure covers — medication, clinician care and check-ins — on the same line as the figure
- Names its operating company, its state of incorporation and its registered address in the first paragraph of its terms
- Names the partner medical group that provides consultations, separately from the platform company
- Says plainly that it is not a pharmacy and does not dispense, rather than implying it fills its own prescriptions
Trade-offs
- The terms decline to say where the service is available, so no state coverage can be recorded at all
- Advertises a large saving on multi-month prepaid plans without publishing a single prepaid rung to check it against
- No dispensing pharmacy is named — prescriptions go to an unnamed pharmacy "within a pharmacy network"
- The claim that a prescriber is licensed in your state is a fact about the prescriber and reads, in context, like a coverage promise the terms explicitly refuse to make
- No lab work is included in or priced beside the program rate
136. HeliMeds
$99/mo — per month, and the page footnotes it: "price with the first order of 12-month package"
Summary, strengths and trade-offs8 points
HeliMeds names its pharmacy and prints specific batch-testing tolerances, and sells its flagship weight-loss product on a page that never says which drug it is.
Strengths
- Names its dispensing pharmacy and says plainly that it is not one itself
- States its potency tolerance as a number and names the sterility chapter
- Prints the vial size and volume beside its sermorelin figure
- Says its compounded medicine is not FDA-approved, in those words
Trade-offs
- Its weight-loss product page never names the drug it sells, so no price could be filed for it
- Its own terms give two incompatible answers about which states it serves
- Its NAD+ headline price is footnoted as the twelve-month first-order rate
- Its terms carry another brand's pharmacy network in an unedited clause
137. Tonik Wellness
$104/mo — printed as "NAD+ — As low as $104.00 / month". The same page states "This product is out of stock. Product is not available in this quantity."
Summary, strengths and trade-offs8 points
Tonik Wellness gives each peptide its own page with one clean figure and one clean unit, and then prints, under each of them, that the product cannot be bought.
Strengths
- One product, one page, one figure, one stated unit — the plainest price disclosure in this batch
- States its own limits in writing: the operating company "does not provide medical or pharmacy services"
- Names the operating company in its footer and again in its trademark notice
- Marks stock status on the product page itself rather than at checkout
Trade-offs
- Both peptide products were out of stock on the date read
- The figure is an "as low as", and the page does not say what raises it
- No dispensing pharmacy named, no certificate of analysis, no state coverage list
- A narrow catalog beside sellers on this roster carrying a dozen compounds
138. Villas Health
$107.99/mo — subscription rate, struck through from $119.99
Summary, strengths and trade-offs8 points
Villas Health carries a 2025 federal warning letter naming its own website, and prints a one-time price and a subscription price side by side on every product, several of them marked down from a struck-through figure.
Strengths
- Prices the injection and the nasal form of each peptide separately rather than as one product
- Prints the one-time price and the subscription price on the same line
- Publishes its site in Spanish as well as English from the same navigation
- Says its GLP-1 products are compounded rather than implying they are the branded drug
Trade-offs
- Carries a 2025 federal warning letter naming its own website address
- Every listing shows a struck-through figure beside the live one, and a related-products strip whose prices run into the same text
- Names no dispensing pharmacy and publishes no certificate of analysis
- Makes no state-coverage claim on the pages read
139. Jently
$119/mo — as low as, per month; the nasal spray is listed at the same figure
Summary, strengths and trade-offs8 points
Jently names the compounding pharmacy that fills its prescriptions, with its street address and its 503A status, and prices five tracked compounds at the same monthly floor.
Strengths
- Names Precision Compounding Pharmacy, with its street address and its 503A status
- Says compounded drugs are not FDA-approved for safety, efficacy or quality, in its own words
- States that it is a telehealth platform and not a pharmacy or a manufacturer
- Prices five tracked compounds openly rather than behind an intake
Trade-offs
- Its host answers a success code for a page that does not exist, so no absence can be proven by status
- Publishes no state list, saying only that notices are on a partner’s page
- Every headline figure is an "as low as" floor rather than the rate at a stated dose
- No certificate of analysis is reachable
140. PreventiveMD
$119/mo — "As low as $119/mo per month, all-in" — the seller's own wording, a floor rather than a quoted rate, on a page that separates its all-in lane from its branded lane where the membership fee and the medication are billed as two named lines
Summary, strengths and trade-offs8 points
PreventiveMD prints an all-in monthly figure for each compounded protocol and, on the same page, breaks its branded lane into a membership fee plus a medication rate as two named lines — and it publishes a list of the peptides it will not sell yet, with the review dates it is waiting on.
Strengths
- Prints an all-in monthly figure per compounded protocol and, on the same page, breaks the branded lane into a membership fee and a medication rate as two separate named lines
- Publishes a list of eleven peptides it does NOT offer because they are under regulatory review, with the anticipated review dates, instead of quietly not selling them
- Says in its own FAQ that its compounded medications are not FDA-approved and describes the pharmacy category and the standard they work under
- Distinguishes the topical form of its copper peptide from the injectable form and states plainly that it does not sell the injectable
Trade-offs
- Every peptide figure is an "as low as" floor rather than a quoted rate, so no page states what a given patient would pay
- No state coverage list appears anywhere, on any page read
- The compounding pharmacies are described as a class it works with and are never named
- Its participating medical group is named as the current one, which is a disclosure that the arrangement can change
141. Rebody Health
$119/mo — per month after the first month, which is $59.50 — the page reads "$59.50 due today. Then $119 monthly."
Summary, strengths and trade-offs8 points
Rebody Health, operated by Compound Technologies, Inc., prices five compounds across injection, nasal spray, troche and cream, and prints the ongoing rate beside the first-month rate on every product page instead of only the discounted one.
Strengths
- Prints the recurring rate beside the discounted first month on every product page, so the ongoing cost is readable before checkout
- Enumerates its jurisdictions state by state in its terms, District of Columbia included, rather than asserting a count
- Sells one compound in more than one route — sermorelin, NAD+ and PT-141 each have an alternative to the needle, priced separately
- States in its terms that the consultation fee sits inside the plan price and names the amount
Trade-offs
- Names no compounding pharmacy — its terms say only that orders are dispensed by independent licensed pharmacies
- The injectable NAD+ line bills in two-month blocks, so its advertised per-month figure is a division rather than a charge
- Every headline figure on the site is an introductory one, and the ongoing rate is roughly double it on most products
- No lab work is described as included at any tier
142. PepScribe
$129/mo — from
Summary, strengths and trade-offs8 points
PepScribe prices six tracked compounds individually from one catalog and says in its own FAQ which pharmacy class fills them — 503A — while declining to name the pharmacy itself, because the one that fills your order depends on your state.
Strengths
- Prices six tracked compounds individually rather than behind one category floor
- Says which pharmacy class fills its orders and which sterile-compounding standards apply
- Publishes the same sermorelin figure on the catalog and on the product page
- Says the online visit costs nothing and that there is no membership fee
Trade-offs
- Names the clinician network but not the dispensing pharmacy, because it varies by state
- Makes no state-coverage claim of any kind on the pages read
- Publishes no certificate of analysis
- Its catalog prints each price between one product and the next, which is easy to misread
143. TeleClinic
$129/mo — the pay-as-you-go monthly rate; the introductory first month is $99
Summary, strengths and trade-offs8 points
TeleClinic names Rush Pharmacy as its 503A compounder and prices NAD+ as an introductory rate with the regular figure struck through beside it.
Strengths
- Names Rush Pharmacy as one of the 503A pharmacies that compound its medication
- Shows the introductory and standing rate together instead of only the discount
- Names Teleclinic Holdings LLC as the operating company
- Says pricing may vary by dosage and clinical evaluation rather than implying a fixed rate
Trade-offs
- Sells only one tracked compound
- Its headline figure is introductory, and the standing rate is 30 percent higher
- Publishes no state list
- No certificate of analysis is reachable
144. TrueMe
$129/mo — per month on the month-to-month cadence; the same product is $79 a month on the three-month cadence, which the page labels "Most Popular"
Summary, strengths and trade-offs8 points
TrueMe publishes an actual list of the states it serves, prices NAD+ and sermorelin on a one-month and a three-month cadence, and prints two different versions of that state list on its own site.
Strengths
- Publishes an itemised list of the states it serves rather than a count
- Prints the month-to-month and the three-month rate side by side on every product
- Says compounded medications are not FDA-approved and have not been evaluated for safety, effectiveness or quality
- States that it is not a state-licensed pharmacy nor a drug manufacturer
Trade-offs
- Publishes two different versions of its own state list, one with five states and one with six
- Sells its weight-loss products under drug-class names without naming the drug
- Lists glutathione with no price attached
- Names no dispensing pharmacy and no certificate of analysis is reachable
145. Bodi Envi
$130/mo — the seller prints this as a flat rate per month for the single longevity product, with no dose tier attached to it, on the same page where its weight-loss products carry countdown intro rates
Summary, strengths and trade-offs7 points
Bodi Envi prices its one tracked compound at a flat monthly rate with no dose tier, and names the professional corporation behind the brand — a form very little else here publishes.
Strengths
- Names a professional corporation rather than only a trading name
- Names the company on the other side of the transaction rather than only a trading name
- Publishes a figure on its own site with the unit recorded beside it
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Offers a single tracked compound, and its other products run countdown timers against their rates
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
146. Magnolia Regenerative Medicine
$135/mo — starting at, per month; the homepage table prints the same figure in this seller’s own column
Summary, strengths and trade-offs8 points
Magnolia Regenerative Medicine publishes a flat per-compound rate for twelve of the peptides this site tracks, on one catalog page, with the billing cadence printed beside each figure.
Strengths
- Prices twelve tracked compounds individually on one catalog page instead of behind an intake
- Prints the billing cadence beside each figure, so a quarterly item is visible as one
- Names Magnolia Regenerative Medicine Health LLC as the operating company in its own footer
- Separates single-compound products from its blends by name, which makes a scoped price readable
Trade-offs
- Publishes no list of states it serves
- Names no dispensing pharmacy; its comparison table says only "US FDA-Inspected Pharmacy"
- Sells five of the compounds it stocks only inside blends, so those carry no scoped price
- No certificate of analysis is reachable
147. PrescribedRX
$137/mo — the seller’s own per-month equivalent of a $412 three-month plan, listed against $462
Summary, strengths and trade-offs8 points
PrescribedRX publishes a monthly rate and a three-month equivalent for every peptide it sells, and shows the arithmetic on the same tile.
Strengths
- Publishes the prepaid total and the per-month equivalent for every plan
- Gives each compound and each route its own priced page
- Names PrescribedRX LLC as the operating company
- Prices the nasal glutathione separately from the injection instead of quoting one figure
Trade-offs
- Publishes no state list
- Names no dispensing pharmacy
- No certificate of analysis is reachable
- Its struck-through comparison prices are never explained
148. Rewinding RX
$139/mo — printed as "ONGOING VITALITY PROTOCOL — Monthly NAD+ subscription — $139/month — 1,000mg NAD+ (Monthly Cellular Support) — Ongoing Physician Oversight — Automatic Delivery". The same page also offers a non-recurring alternative: "30-DAY RESET — One month of NAD+ — $149 one-time"
Summary, strengths and trade-offs8 points
Rewinding RX publishes a flat monthly subscription with the dose printed beside it, and names itself as an LLC and a Ltd. in two places on the same page.
Strengths
- Prints the milligram strength and the volume beside the coenzyme figure, which almost nothing else on this roster does
- Offers a one-time thirty-day option beside the subscription and labels which is which
- States a flat price with no dose ladder and says so in its own words
- Names the clinical practice separately from the brand
Trade-offs
- Names itself as an LLC in one paragraph and a Ltd. in the footer of the same page
- The growth-hormone figure carries no period at all while the coenzyme figure does
- Claims third-party testing in its own copy with no certificate reachable anywhere
- The shop path redirects, so a cited shop URL is not a URL this seller serves
149. Mavés Health
$149/mo — printed on the homepage card as "Energy + Longevity — NAD+ — Starting at $149/month". The seller's sibling card on the same homepage strips a first-month condition off a figure, so this card being unqualified is not evidence that the figure is unconditioned — it is evidence that this homepage does not carry conditions
Summary, strengths and trade-offs8 points
Mavés Health labels its growth-hormone figure a first-month rate on the product page and strips that condition off the same number on its homepage, and its terms of service name a company operating a different website entirely.
Strengths
- The product page states both the first-month rate and the standing rate in one line
- Prints the vial volume and the milligram strength beside the figure and says a home kit is included
- Discloses an unusually complete vendor stack — platform, two clinical entities and a named pharmacy — in its own terms
- Marks stock status on the product page
Trade-offs
- The homepage advertises the promotional figure without the condition that makes it promotional
- Its terms of service name a company operating a different domain than the one serving them
- The testing language on this site sits on the weight-loss pages, never on either peptide page
- No state coverage list and no certificate of analysis
150. Nucore Health
$149/mo — per month, any dose
Summary, strengths and trade-offs8 points
Nucore Health charges one monthly figure at any dose for each of its three NAD+ and glutathione products and says it serves all fifty states.
Strengths
- Prints "Any Dose" beside every figure, so titration does not change the price
- Says in its own words that services are "available nationwide in all 50 states"
- States that prescription treatment is not guaranteed and clinical review is required
- Marks its products FSA/HSA eligible on the product page
Trade-offs
- Charges more for the nasal spray than for the injection with no stated reason
- Publishes no operating company on any page read
- Names no dispensing pharmacy
- No certificate of analysis is reachable
151. FWD
$149.99/mo — the member cell for the smaller of two sizes, read as "Vial (300mg/ml) | 15mL | 30ml | Member Price $149.99 $199.99 | Non-Members $249.99 $299.99" — the two columns here are SIZES, not billing terms, unlike the injection page whose columns are Monthly and Quarterly; the seller reuses one grid for two different meanings and only the column headers say which
Summary, strengths and trade-offs11 points
FWD publishes a two-column price grid on every product page — one column for members, one for everyone else — so the difference a membership makes is visible before anyone signs up, which almost nothing else on this roster shows.
Strengths
- Publishes a member rate and a non-member rate side by side, so the cost of not joining is visible before signup
- Prints the strength of every product beside its price, which most of this roster leaves out entirely
- Prices three separate delivery forms of one compound rather than a single headline product
- Labels its quarterly columns as quarterly, so a prepaid total is not mistaken for a monthly rate
Trade-offs
- Carries an FDA warning letter that names this company and this exact domain
- Reuses one grid layout for two different meanings — billing terms on some pages, container sizes on others — with only the column header to tell them apart
- The terms state that services are available only in certain states and no state is ever listed
- No dispensing pharmacy is named — the answer is "our state-licensed compound pharmacies around the country"
- One page advertises a percentage saving against an unnamed comparison price that is not this seller's own
- The FAQ page footer carries a copyright year two years behind the about page on the same site
- No lab work appears anywhere in the program description
152. Measured
$159/mo — catalog card prints "FROM" above "$159/mo", with "No insurance required" and "Medication included"
Summary, strengths and trade-offs8 points
Measured prices three of the compounds compared here in one catalog table, marks each as medication-included, and is the rare seller that publishes its service area as a named list of states rather than a claim.
Strengths
- Publishes its service area as a named list of twenty-six states rather than a nationwide claim
- Prices three of the compounds compared here in one catalog table, so they can be compared without three intakes
- Marks every peptide card medication-included and no-insurance-required beside the figure
- Answers its own lab-work question plainly instead of leaving it to an intake
Trade-offs
- Carries a federal warning letter over false and misleading telehealth claims
- Names no dispensing pharmacy — only "independent, state-licensed pharmacies"
- The sitemap advertises per-compound URLs that all serve the same catalog page
- The catalog states no form for any peptide, so injection, oral and nasal are not distinguished
153. Mirabel Meds
$159/mo — printed as "NAD+ Injection · from $159/mo" — a floor rather than a quoted rate
Summary, strengths and trade-offs7 points
Mirabel Meds publishes a wide peptide menu with a monthly figure on every product, and prices five of them as multi-peptide stacks rather than as single compounds.
Strengths
- Puts a monthly figure on every product in a wide menu, with the period printed beside each one
- Sells eight tracked compounds as single products rather than only inside combinations
- Names its corporate entity plainly in its own terms
Trade-offs
- Every figure is a floor written as "from", so no product has a quoted rate a buyer can hold it to
- Five products price a multi-peptide stack at one figure, which cannot be compared against a single-compound price
- No pharmacy is named — the site refers to partner pharmacies as a category
- No service area is published anywhere on the site, including in its terms
154. EdgeRx
$175/mo — per month; the sublingual route is priced identically on the same site
Summary, strengths and trade-offs8 points
EdgeRx sells the same compound in two needle-free formats at the same monthly price, and says in its own words that it is "not the peptide gray-market".
Strengths
- Charges the same monthly figure for the nasal and sublingual route of a compound
- Groups its catalog by goal and prints a protocol count beside each group
- Says its GHK-Cu topical is "pharmacy-compounded, not the OTC version"
- Attaches the month to every protocol figure it publishes
Trade-offs
- Publishes no operating company on any page read
- Its PT-141 and glutathione lines are sold inside multi-protocol categories with no single figure
- Publishes no state list and names no dispensing pharmacy
- Says its compounds are "tested for purity" but publishes no certificate of analysis
155. Neo Soma Healthcare
$175/mo — the sale figure on a running countdown, printed beside a struck-through regular figure of 219; the page labels it 'Monthly Refills'
Summary, strengths and trade-offs8 points
Neo Soma states a dose schedule next to each monthly refill price, which is rarer here than the price itself — but both figures are sale figures running against a countdown clock.
Strengths
- States the dose and weekly frequency beside the price, not just a product name
- Labels both peptide figures as monthly refills rather than leaving the period unstated
- Names its operating company on two separate legal pages
- Keeps its two peptide products on separate pages with separate figures
Trade-offs
- Both published figures are promotional and sit beside a struck-through regular figure
- A running countdown means the figure a reader sees may not be the figure they are charged
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
156. Ambiante Health and Wellness
$179/mo — the catalog's own "from" figure for the single-compound NAD+ tile, under the Cognitive & Neurological category
Summary, strengths and trade-offs8 points
Ambiante Health and Wellness is the fourth seller found serving a byte-identical peptide menu under a different company and a different price list, and it prices seven tracked compounds on its own.
Strengths
- Prices seven tracked compounds individually rather than only as blends
- States that its medications are compounded in a United States pharmacy on every product card
- Says a licensed provider reviews each case before a prescription is written
- Publishes its menu without an intake wall, so the figures can be compared before signing up
Trade-offs
- Serves the same peptide menu as three other sellers on this roster under a different company
- Its own template misfiles some descriptions, so a blend can carry a single compound’s sentence
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
157. LVNG RX
$179/mo — printed as "NAD+ Injection · from $179/mo" — a floor rather than a quoted rate
Summary, strengths and trade-offs7 points
LVNG RX puts a monthly starting figure on each single-peptide program and on both weight-loss injections. The weight-loss figures sit on its home page; the program pages that advertise flat, transparent pricing print none.
Strengths
- Puts a monthly figure on each of its single-peptide programs, with the period printed beside it
- Names its corporate entity plainly in its own terms
- States that its programs carry no consultation charge and no dose-change surcharge
Trade-offs
- Its semaglutide and tirzepatide pages advertise flat, transparent pricing and print no figure; the only weight-loss figures are starting prices on the home page, under a banner quoting a lower figure that names no medication
- Every figure, peptide or weight-loss, is a floor written as "from", so none is a rate the seller has committed to
- Two products price a pair of peptides at one figure, which is not a price for either compound
- No pharmacy is named and no service area is published anywhere, including in its terms
158. Vyora Wellness
$189/mo — per month, read from a related-products listing on an open page; the product page itself is password-gated
Summary, strengths and trade-offs8 points
Vyora Wellness describes independent third-party potency and purity testing in its own FAQ, and publishes one peptide price behind a shop that hides most of the rest.
Strengths
- Describes what its third-party testing checks — strength, match to prescription, contaminants
- Names Vyora Wellness LLC and publishes an informed-consent addendum
- Says it partners with "U.S.-based 503A certified pharmacies"
- Attaches a month to the one peptide figure it shows publicly
Trade-offs
- Publishes no certificate of analysis despite describing third-party testing
- Gates most product pages behind a password, so most prices cannot be read
- Publishes no state list and names no dispensing pharmacy
- Its one readable NAD+ figure appears only in a related-products strip
159. Elevated Health
$196/mo — per month; a three-month plan is $188 a month, and a product strip on the same page calls $188 the starting monthly figure
Summary, strengths and trade-offs8 points
Elevated Health carries a 2025 federal warning letter, publishes a four-rung ladder for both weight-loss molecules, and runs terms of service that govern a different website entirely.
Strengths
- Publishes a four-rung ladder for both weight-loss molecules with every rate printed
- Prices NAD+ and sermorelin on monthly and quarterly lanes
- States its potency tolerance as a number rather than as an adjective
- Says what the treatment price includes, down to the supplies and the shipping
Trade-offs
- Its terms of service govern a different website and never name this one
- Its cross-sell chip prices tirzepatide at a figure its own tirzepatide page contradicts
- Its NAD+ page calls the same number both the monthly and the three-month rate
- Carries a 2025 federal warning letter naming its own website, and publishes no statement that its compounded products are not FDA-approved
160. Believe Health
$199/mo — from, per month, read from the homepage
Summary, strengths and trade-offs8 points
Believe Health runs the same peptide menu as two other sellers on this roster under a different company, and it is the dearer of the three on every compound they share.
Strengths
- Publishes a monthly figure for seven separate compounds
- Names Believe Health LLC as the operating company in its own terms
- Prices its NAD+ line on the homepage rather than behind an intake
- Says its peptides are "reviewed individually by a licensed provider and compounded in a U.S. pharmacy"
Trade-offs
- Runs a peptide menu identical to two other sellers here under a different company
- Carries the misfiled compound descriptions that template ships with
- Publishes no state list, no named pharmacy and no certificate of analysis
- Its homepage and menu price different subsets, so no single page shows the whole catalog
161. BluefitMD
$199/mo — the monthly membership with no commitment; its energy-and-mood page prints a $119 floor for the same product
Summary, strengths and trade-offs8 points
BluefitMD prices sermorelin and NAD+ with a full package ladder, publishes two different per-month figures for the same six-month sermorelin package, and links a weight-loss page from every page that returns not-found.
Strengths
- Prints the vial size, the milligrams and the weekly injection count beside each NAD+ tier
- Publishes a package ladder from one month to twelve with the total on each rung
- States its potency tolerance as a number and cites the sterility chapters by name
- Sells two NAD+ strengths as separate products rather than as one range
Trade-offs
- Its own six-month sermorelin package carries two different per-month figures, one of which the total contradicts
- Its NAD+ starting price differs between two of its own pages
- Three pages linked from every navigation return not-found, so no weight-loss price is reachable
- Names no dispensing pharmacy and makes no state-coverage claim
162. Get Thin MD
$199/mo — the month-to-month rate, in the seller's own sentence: "For the month-to-month package, the price is $199 per month. If you select a larger package, the monthly price continues to go down." The same page advertises "(Get Started For As Little as $129/Month)" at the top — $129 is the floor of a longer package, not a month
Summary, strengths and trade-offs8 points
Get Thin MD trades under a legal name most readers would never guess, publishes a month-to-month figure well above its advertised one, and runs a growth-hormone product page carrying no price at all.
Strengths
- States the month-to-month price in a plain sentence, which most sellers on this roster never do
- Names its operating company in the first person in its own privacy policy
- Its growth-hormone page states plainly that the compound "is not currently available as an FDA-approved drug product"
- Tags every prescription item in the navigation with a prescription marker
Trade-offs
- The advertised figure and the month-to-month figure differ by seventy dollars on the same page
- The growth-hormone product page carries no price at all — the only figure for it sits in a navigation rail on a different product's page
- The privacy policy and the terms name different corporate forms for the one brand
- No certificate of analysis, no named pharmacy, no state coverage list
163. Longevixx
$199/mo — starting rate, per month
Summary, strengths and trade-offs7 points
Longevixx runs one of the wider peptide menus on this roster — twenty programs, each quoted as a monthly figure — including PT-141, epitalon and semax, which few sellers price.
Strengths
- Publishes a monthly figure beside every one of its twenty peptide programs, not a starting price for the catalog as a whole
- Prices PT-141, epitalon and semax, three compounds most sellers on this roster do not list at all
- Charges nothing when a request is turned down
Trade-offs
- Semax, KPV, TB-500 and CJC-1295 are sold only inside combination vials, so the figure beside each is the price of a pairing rather than of that peptide alone
- Its terms limit service to the states where the company operates without naming them, so coverage cannot be checked before signup
- The compounding pharmacy that fills prescriptions is not named on the site
- Every figure is a starting rate, and the catalog does not say what moves a program above it
164. Luma Meds
$199/mo — per month
Summary, strengths and trade-offs8 points
Luma Meds says it is available in all fifty states on its product page and only in certain states in its terms, and its compounded tirzepatide plan card renders no price at all.
Strengths
- States in its own words that compounded medicines are not FDA-reviewed
- Prices the oral and injectable forms of the weight-loss molecules separately
- Publishes a standing monthly figure for NAD+, sermorelin and glutathione
- Names its medical group in its terms
Trade-offs
- Its terms contradict its own fifty-state claim
- Its injectable tirzepatide card renders no price, leaving one navigation entry as the only figure
- Semaglutide carries three different prices across one page
- Its three-month anchor price does not match three times its own monthly rate
165. Whoosh Wellness
$199/mo — starting at, per month; a second block on the same page prints $499/mo for the same compound
Summary, strengths and trade-offs8 points
Whoosh Wellness says every batch it ships is third-party tested and publishes two sermorelin ladders on one page whose lower rungs differ by three hundred dollars.
Strengths
- Says in visible text that every batch is third-party tested for potency and purity
- Prices GHK-Cu at two named strengths rather than one blended figure
- States it compounds only at licensed 503A/503B pharmacies
- Attaches a month to almost every figure on its pricing page
Trade-offs
- Prints two sermorelin ladders on one page, $300 apart, with no stated difference
- Publishes no certificate of analysis despite claiming batch testing
- Publishes no operating company on any page read
- Its product page for GHK-Cu drops the period its pricing page states
166. Meto
$210/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
Summary, strengths and trade-offs8 points
Meto puts a $149 blood panel in front of the prescription and bills in two published lines: a $29 monthly membership charged $320 a year, and the medication itself at a monthly rate that starts at $85 for BPC-157.
Strengths
- Splits the bill into two published lines, membership and medication, and says so plainly instead of quoting one blended figure
- Publishes a monthly figure for each single peptide as well as for the stacks, so a one-peptide protocol can be costed before signing up
- Marks its MOTS-c and tesamorelin stack "Not currently available while awaiting FDA regulatory action" rather than quietly delisting it
- Requires a blood panel before prescribing and prices it openly at $149 instead of burying it in an intake
Trade-offs
- The $149 panel and the $29 monthly membership both sit on top of every medication price, so no single figure on the site is the cost of therapy
- Says medication is billed "at your member rate - typically 15-25% below a la carte" without publishing what that member rate actually is
- Publishes a headline of 50 states covered by its clinician network but no state-by-state list
- Describes its pharmacies only as FDA-registered and 503A; none is named anywhere on the site
167. Loop Health
$229/mo — starting at, per month, on both the men’s and the women’s shop pages
Summary, strengths and trade-offs8 points
Loop Health sells peptides inside a membership, prices four tracked compounds at a flat monthly rate that does not climb with dose, and states a state count rather than publishing a list.
Strengths
- Charges the same monthly figure at every GLP-1 dose, so titrating up does not raise the bill
- Prices four tracked peptides on the same page as its weight-loss medicines
- Cites named trials by name and journal beside its GLP-1 claims
- Describes itself as an independent health research collective rather than a pharmacy
Trade-offs
- States a count of forty-four states but publishes no list of them
- Its host answers a success code for a page that does not exist, so nothing can be shown absent by status alone
- Names no dispensing pharmacy
- Sells peptides only inside a membership, so the peptide figure is not the whole cost
168. Coby Health
$239/mo — per month, billed monthly — the page reads "Monthly Plan: $329 $239 / month" and "(One 1000mg vial/month - monthly subscription - save $70 per month!)"
Summary, strengths and trade-offs8 points
Coby Health LLC sells sermorelin and NAD+ on stacked subscription lanes, and its sermorelin page carries two different price tables that disagree about what the monthly lane costs.
Strengths
- Puts the billing period beside every peptide figure — billed monthly, billed quarterly, billed biannually — rather than printing a bare per-month rate
- States the vial count on its peptide lanes, so the quantity behind the figure is readable
- Says plainly in its own footer that it is a marketplace and does not itself provide medical or pharmacy services
- Names the cancellation fee it keeps if an order is stopped before it reaches a pharmacy
Trade-offs
- The sermorelin page prints two price tables that disagree about which figure is the monthly rate
- Its six-month sermorelin lane repeats the quarterly lane's description word for word, so what that lane actually ships is unclear
- Publishes no service-state list for its peptide lines; the only coverage sentence on the site is scoped to its GLP-1 programs
- Names no dispensing pharmacy, and says the patient does not choose one
169. Alinwell
$249/mo — from, per month, read from the homepage rather than the peptide menu
Summary, strengths and trade-offs8 points
Alinwell prices eight peptides per month on one page and prices sermorelin twice — its homepage and its peptide menu carry different sermorelin figures on the same day.
Strengths
- Prices eight separate peptides on a single readable menu page
- States a monthly period on every peptide figure it publishes
- Names its operating company in its own terms rather than only a brand
- Says in its own words that its peptides are compounded in a U.S. pharmacy
Trade-offs
- Publishes two different sermorelin figures on two of its own pages
- Its peptide descriptions are misfiled — a copper-peptide sentence sits under a four-compound blend
- Publishes no list of states it serves
- Names no dispensing pharmacy and publishes no certificate of analysis
170. Apex MD
$249/mo — per month, injectable
Summary, strengths and trade-offs8 points
Apex MD charges one figure — $249 a month — for NAD+ injectable, NAD+ nasal spray and sermorelin alike, and discounts only the first month on a separate funnel page.
Strengths
- Prints the monthly period beside every figure on its peptide page
- Charges the same figure for the nasal and injectable routes rather than upselling one
- Says in its own terms that fulfillment runs through "compounded pharmacies" licensed in the states it serves
- Publishes its prices without an account or an intake
Trade-offs
- Publishes no operating company anywhere on the pages read
- A separate funnel page prices sermorelin differently from the peptide page
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
171. Layla
$249/mo — per month after a $199 first month; a quarterly plan is $199 a month
Summary, strengths and trade-offs8 points
Layla publishes three different tirzepatide prices on one page, two mutually exclusive discount labels on another, and a savings total that does not match its own arithmetic.
Strengths
- Publishes a monthly and a quarterly lane for each of its three peptides
- Names its provider entity in its terms
- Prices NAD+ and glutathione separately rather than as one longevity product
- Prints the standing rate beside the first-month rate rather than only the discount
Trade-offs
- Carries three different tirzepatide prices on a single page
- Its sermorelin card prints two first-month discounts that cannot both be true
- Two of its savings totals do not match its own arithmetic
- Publishes no statement that its compounded products are not FDA-approved
172. LunaRx
$249/mo — from, per month
Summary, strengths and trade-offs8 points
LunaRx is the only seller on the shared peptide template that prices semax, and it is the cheapest of the three on sermorelin, MOTS-C and epitalon.
Strengths
- Prices eight compounds per month, including semax, which few sellers here price at all
- Says on its own homepage that its protocols are "503A compounded — no reconstitution required"
- Names LunaRx LLC on the site itself, not only in a buried terms page
- Undercuts both of its template siblings on sermorelin, MOTS-C and epitalon
Trade-offs
- Its peptide menu is identical to two other sellers here, under a different company
- Prices semax only as a two-compound "Semax / Selank" line
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable anywhere on the site
173. Pause Rx
$249/mo — starting at, per month
Summary, strengths and trade-offs8 points
Pause Rx prices eight peptide products at a monthly rate, names Rush Pharmacy as its filler, and says on every page that it is not a pharmacy itself.
Strengths
- Names Rush Pharmacy as the pharmacy that fills its prescriptions
- Repeats on every product page that it is "not a state-licensed pharmacy nor a drug manufacturer"
- Prices five tracked compounds across eight products, injection and needle-free alike
- Charges less for the sermorelin troche than for the injection
Trade-offs
- Its GHK-Cu cream is the one product with no stated billing period
- Publishes no operating company on any page read
- Publishes no state list
- No certificate of analysis is reachable
174. Remote Pharmacy
$249/mo — "30-Day Supply / 1000mg / $249 / per month", with "First month: $149" in the same card; the card beside it prints "90-Day Supply / 3000mg total / $629", which the seller labels "Just $209/month" — its own division of the 90-day total, not a charge
Summary, strengths and trade-offs8 points
Remote Pharmacy sells one compound compared here and prints its whole ladder — a 30-day rate, a first-month rate and a 90-day total — beside a per-month figure it computed itself from the 90-day total.
Strengths
- Prints the 90-day total and the 30-day charge as figures rather than only as a per-month rate
- States the milligram strength for both supply sizes beside their prices
- Says plainly that it accepts no insurance, HSA, HRA or FSA rather than leaving that to checkout
- Answers its pharmacy and compliance questions in an accordion on the product page itself
Trade-offs
- Leads with a per-month figure it computed from the 90-day total rather than with a charge
- The entire product page renders inside a third-party frame, so nothing is published in the page itself
- Names no dispensing pharmacy despite trading under a name that says pharmacy
- Makes no statement at all about which states it serves
175. RxION Health
$249/mo — printed as "Select your plan: Monthly Supply — $249 / month", with no anchor figure, no promotional strike-through and no plan term. The line directly below it is the seller's own disclaimer that compounded NAD+ is not FDA-approved for the indications it is sold for
Summary, strengths and trade-offs8 points
RxION Health prints a plain monthly figure and, directly underneath it, its own sentence saying the compounded product is not FDA-approved for any of the uses it is being sold for.
Strengths
- Prints its own approval-status disclaimer directly under the price rather than in a footer
- One figure, one unit, no strike-through and no plan term to unpick
- Names the operating company in the first line of its own terms
- Names the clinical practice separately from the brand
Trade-offs
- The named clinical partner is the same white-label practice standing behind a long list of unrelated brands, so naming it distinguishes very little
- No dispensing pharmacy named and no certificate of analysis anywhere
- No state coverage list published
- Only one of its peptides carries a published figure on the pages read
176. Vytora Health
$249/mo — per month on a month-to-month plan, in the page's own FAQ answer; the same answer gives $200/month on a 3-month plan billed $600 every 3 months, and states the figure includes medication, physician consultation, supplies, shipping and support, with the same price at every dose
Summary, strengths and trade-offs8 points
Vytora Health answers the cost question in a sentence on each product page, giving the month-to-month rate and the prepaid rate together with the actual charge beside each — and on the sermorelin page that sentence contradicts the price block at the top of the same page.
Strengths
- Answers the cost question in one sentence per product page, giving the month-to-month rate, the prepaid rate and the actual prepaid charge together
- States what the figure covers — medication, consultation, supplies, shipping and support — instead of leaving a reader to discover the extras
- Says the price is the same at every dose, so titrating up does not change the bill
- Separates the marketing company from the clinical practice in its own terms, and says the brand is not a medical provider or a pharmacy
Trade-offs
- Its sermorelin page prints one figure at the top and a different month-to-month figure in its own FAQ, with nothing reconciling them
- The clinical practice is named with two different corporate suffixes — one form in the body of the terms, another in the footer of every page
- No state list is published; the terms say only that some services are available in certain states
- The compounding pharmacies are described as a network and never named, and no certificate of analysis appears on any page read
177. WePeptideRx
$250/mo — per month supply, subcutaneous, consultation included
Summary, strengths and trade-offs8 points
WePeptideRx prices three peptides per month supply on one page and prices PT-141 only as a fixed-milligram bundle, so its cheapest and dearest figures are not comparable.
Strengths
- Prints "per month supply" beside its three main figures rather than a bare number
- States the milligram total behind every bundle price
- Says the provider consultation, medication and shipping are included with no separate fees
- Describes itself as LegitScript-certified telehealth in its own words
Trade-offs
- Publishes no operating company on any page read
- Its PT-141 and NAD+ bundles carry no period, so they cannot be compared to its monthly rows
- Answers 200 at a nonsense path, so absence cannot be proven from status alone
- Publishes no state list, no named pharmacy and no certificate of analysis
178. Bioverse
$259/mo — read from "Starting at $339 $259/mo" with the higher figure struck through, and confirmed lower on the same page by "Best value for NAD+ — Starts at $259/month. Lower than 12 leading brands.*" No plan term is attached to either sentence, and the page adds "Only pay if prescribed — You'll only be charged if a provider determines" the treatment is appropriate
Summary, strengths and trade-offs8 points
Bioverse publishes downloadable certificates of analysis — and the page holds exactly two of them, both for its weight-loss drugs, neither for the injectable coenzyme or antioxidant this site compares.
Strengths
- Publishes downloadable certificates of analysis at a named URL, and both files resolve to real PDFs rather than dead links
- States both the anchor figure and the charged figure in the same line on each product page
- Prints "Only pay if prescribed" beside the price rather than after checkout
- Names the operating company in its own footer and the clinical practice in its terms
Trade-offs
- The certificate page lists exactly two documents and neither covers a compound this site compares — the testing disclosure and the peptide catalog do not overlap
- Carries an FDA warning letter over online sale of unapproved and misbranded drugs
- Publishes no dispensing pharmacy and no state coverage list
- The "lower than 12 leading brands" comparison names none of the twelve
179. ElitePhysiqMD
$267.30/mo — the catalog rate of $267.30/mo.; every figure on this catalog is the member price under a $99.00/month membership, and on the two product pages opened in full the member figure was exactly 10% below the struck-through list price ($225.00 against $250.00, $267.30 against $297.00). The list price for this item was not read on its own page and is not stated here.
Summary, strengths and trade-offs8 points
ElitePhysiqMD publishes the widest prescription peptide catalog on this roster — fifteen of the sixteen compounds this site tracks, each with a figure in visible text — and every one of those figures is a member rate that sits on top of a separate monthly membership charge.
Strengths
- The widest prescription peptide catalog on this roster, with a figure in visible text on every item
- Its product pages state that compounded preparations are not FDA-approved and that human evidence for peptides is limited, on the page taking the order
- Calls one of its weight-loss compounds investigational, which is accurate and rare
- Publishes the one-time-purchase total, the visit fee and the shipping charge as separate named lines rather than one blended figure
Trade-offs
- Every catalog figure is a member rate, and the catalog page itself never mentions the monthly membership those rates depend on
- Two of the compounds it lists are sold only inside a two-peptide stack, so neither has a price of its own
- The compounding pharmacy is described by licensing class on every page and is never named
- No state coverage list and no certificate of analysis appear anywhere in the pages read
180. Hartwater Wellness
$285/mo — the seller's flat per-peptide monthly figure, "$285 per month for a single peptide … regardless of which peptide you are prescribed" — NAD+ (injectable) is listed inside this seller's peptide menu although it is a coenzyme, so this is the seller's own classification and not this site's
Summary, strengths and trade-offs8 points
Hartwater charges the same figure for every peptide it prescribes and says so in one sentence — so its price column has one number in it, and any table that gives this seller eleven different figures has invented the variance.
Strengths
- States one price for every peptide and says so explicitly, which removes the whole per-compound guessing game
- Publishes the bundle rates as well as the single rate
- Describes its pharmacies by license class and locates them in its own metro
- Draws the line against research-chemical vendors in its own words rather than by implication
Trade-offs
- Publishes no corporate entity
- Lists NAD+ and glutathione inside a peptide menu, which blurs a category the flat pricing then covers
- Names no dispensing pharmacy
- Publishes no state coverage; it is a single Texas clinic
181. Factor Health MD
$349/mo — per month
Summary, strengths and trade-offs8 points
Factor Health MD publishes the deepest plan ladder in this batch — four terms plus a pay-as-you-go rung priced by milligrams — and names two different states as its governing law in one contract.
Strengths
- Publishes four subscription terms and a pay-as-you-go rung for both weight-loss molecules
- Prices the pay-as-you-go rung by vial strength, so a reader can see what milligrams cost
- Every stated monthly-times-term total reconciles exactly
- Prices NAD+, sermorelin and glutathione individually as well as inside bundles
Trade-offs
- Its own terms name Florida law in one section and Delaware in another
- Calls its suppliers FDA-approved compounding pharmacies, a category that does not exist
- Points readers to a state list that is not on the site
- Both weight-loss products are vitamin blends by default rather than the bare active
182. Mochi Health
$54 — starting at, plus a separate Mochi Health membership; the page states no billing period for the medication figure
Summary, strengths and trade-offs8 points
Mochi Health prices NAD+ in three formats and sermorelin in one, and states under every figure that the medication cost sits on top of a separate membership fee rather than inside it.
Strengths
- Prices NAD+ in three delivery formats, so the injection is not the only option with a figure attached
- States on every product page that the medication figure excludes the membership, rather than burying that in terms
- Names the dosage each figure corresponds to, and says additional dosages exist
- Runs a pharmacy marketplace and says so openly, rather than implying a single in-house facility
Trade-offs
- No medication figure carries a billing period, so none is comparable to a monthly rate without arithmetic
- Every figure requires a separate membership the product page does not add in
- Names no dispensing pharmacy; its pharmacy page is a recruitment page for pharmacies, not a disclosure
- Publishes no state list — its FAQ describes the program as virtual and available "anywhere in the United States", which is a format claim rather than a licensure list
183. Onus IV
$60 — per shot at the 100 mg dose, with no billing period stated; the members' rate on the same rung is $49, and the published ladder runs 200 mg at $120 ($87.50 for members), 250 mg at $150 ($105), 300 mg at $180 ($122) and 350 mg at $210 ($130) — so the member discount rises from 18 percent at the smallest dose to 38 percent at the largest rather than being one percentage
Summary, strengths and trade-offs9 points
Onus IV is a Colorado clinic chain that publishes a dose-by-dose NAD+ ladder with a member price beside every rung — and the member discount widens from 18 percent at the smallest dose to 38 percent at the largest.
Strengths
- Publishes a dose-by-dose NAD+ ladder with a stated milligram amount and a figure on every rung, which almost nothing else compared here does
- Prints the member price beside the standard price on every rung rather than advertising a discount in the abstract
- Names its operating company and a privacy officer by name in its own policy
- Names the clinics and the mobile service it operates, so a reader can tell where the treatment happens
Trade-offs
- Colorado only, so most readers of a national comparison cannot buy here at all
- No governing-law clause exists: the site publishes a privacy policy and a disclaimer and has no terms-of-service page at all
- Its sermorelin listing is a range with no strength and no protocol, and its GHK-Cu listing is a bare figure with no quantity
- The published address omits the city, giving only a street, a state and a ZIP code
- No compounding pharmacy is named and no lab work is described as included
184. iThriveMD
$79 — the member add-on price, unlocked with any hormone or weight-loss plan; the page states no billing period
Summary, strengths and trade-offs8 points
iThriveMD prints a non-member and a member price for every peptide it sells, and the member price is between a half and a fifth of the other.
Strengths
- Prints the member and non-member figure together instead of only the discounted one
- Says its compounding happens "under Section 503A in a USP <797>-compliant sterile cleanroom"
- Operates in-person clinics as well as telehealth and says so
- States that compounded drugs "have not been reviewed or approved by the FDA"
Trade-offs
- None of its figures carries a billing period
- Its cheapest prices require buying a separate hormone or weight-loss plan first
- Answers 200 at every path, so nothing about the site can be proven absent
- Publishes no operating company, no state list and no named pharmacy
185. Nuform Health
$90 — the per-month figure printed beside a prepaid two-month oral kit — "$90/mo oral kit · $180 (2 month plan) · Billed in 2 month increments · INCLUDES SUPPLIES"
Summary, strengths and trade-offs8 points
Nuform Health, Inc. sells prescription peptide kits that are prepaid in multi-month blocks, and it says in its own copy that it does not offer monthly prescriptions or subscription plans — so the per-month figure printed beside each kit is arithmetic, not a bill.
Strengths
- States its own position on research-labeled peptides in plain words on its product pages, rather than leaving the category question to the reader
- Prints the prepaid total and the plan length beside every per-month figure, so the arithmetic is visible
- Says outright that it does not sell monthly prescriptions or subscriptions, which is the fact most sellers with prepaid kits leave out
- Names its operating company in its own footer and again in its terms
Trade-offs
- Every peptide price is a division of a prepaid block, so the advertised per-month figure is never what is charged
- Two entities appear across the site and the terms, and neither document explains which one a buyer contracts with
- The compounding pharmacy is described only as a 503A/503B facility and is never named
- No state coverage list, and no certificate of analysis or third-party testing anywhere in the pages read
186. Healthon
$110 — the catalog figure, printed as "NAD+ Nasal Spray. Original price:. Final price: $110 Out of Stock". No billing period is stated anywhere on the catalog row
Summary, strengths and trade-offs8 points
Healthon publishes four peptide SKUs, three different figures for the injectable coenzyme across its own pages, and an out-of-stock notice on every single one of them.
Strengths
- Publishes a browsable catalog with a figure against every SKU rather than gating prices behind an intake
- Sells the growth-hormone peptide in two routes and the coenzyme in two routes, each priced separately
- Marks stock status honestly on the catalog rather than letting a reader discover it at checkout
- Names the operating company and the clinical group in its own pages
Trade-offs
- All four peptide SKUs were out of stock on the date read
- Three different figures for the injectable coenzyme across the catalog, the product page and the site-wide rail
- Carries an FDA warning letter over online sale of unapproved and misbranded drugs
- The product page prints a period fragment — "first month /mo after Billed every 3 months" — with the numbers missing
187. Heva Health
$115 — for a 30 mL topical cream; the shop page states no billing period
Summary, strengths and trade-offs8 points
Heva Health sells peptides by the vial from an open shop page, and its PT-141 figure is one of the lowest anywhere on this roster.
Strengths
- Publishes the volume of every vial beside its price
- Runs an open shop page rather than quoting only after an intake
- Names Heva Health LLC as the operating company
- Says its medications are "FDA-approved or compounded at FDA-registered, state-licensed pharmacies"
Trade-offs
- No figure on the shop page carries a billing period
- Its "licensed in all 50 states" line describes the clinician, not the service area
- Publishes no state list of its own and names no dispensing pharmacy
- No certificate of analysis is reachable
188. Take10Rx
$115.97 — printed "per month" under a "QUARTERLY PLAN" heading billing $347.91 today, exactly three times this figure
Summary, strengths and trade-offs8 points
Take10Rx prices sermorelin, glutathione and two forms of NAD+ per month on a quarterly plan, and its own product page asks whether a buyer can pay monthly instead — which is the clearest sign that the per-month figure is not a monthly charge.
Strengths
- Prints the amount actually charged today beside the per-month figure
- Puts the plan heading directly above the price rather than in a footnote
- Answers on its own page whether monthly billing is possible instead of quarterly
- Gives sermorelin, glutathione and both NAD+ routes their own product pages
Trade-offs
- Prints "per month" for a charge its own heading says is quarterly
- Carries a second billed figure on two pages with nothing saying what it buys
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
189. OurView Health
$120 — the product-page figure and the with-membership figure; neither states a billing period
Summary, strengths and trade-offs8 points
OurView Health says its parent company is the pharmacy, and publishes a membership table that halves its NAD+ figure without naming a billing period on either side.
Strengths
- Publishes a with- and without-membership comparison instead of only the member rate
- Says it compounds and ships "across all 50 states"
- States that completing an assessment does not guarantee a prescription
- Prices products on open pages rather than behind an intake
Trade-offs
- No figure anywhere on the site carries a billing period
- Describes its parent pharmacy without naming it
- Publishes no operating company on any page read
- Its own savings table prints a malformed annual figure
190. VIV RX
$124 — from — the shop grid and the product page both print this as a floor per month
Summary, strengths and trade-offs8 points
VIV RX prices three tracked peptides as floors on one shop page, itemises what each plan includes, and carries a 2026 federal warning letter naming its own domain.
Strengths
- Lists what each plan includes as an itemised set rather than as a promise of value
- States the administration route and frequency for each compound on its own page
- Says plainly that FDA registration is not FDA approval, on the same line as the claim
- Prices three tracked compounds on one page a reader can compare at a glance
Trade-offs
- Carries a federal warning letter that names this exact domain
- Every figure is a floor, so the price a buyer actually pays is not published
- Names no dispensing pharmacy, only a license held by an unnamed one
- Publishes no state list and settles eligibility inside the intake
191. modMD
$125 — Per 125 MG — the menu prices NAD+ strictly by dose, at exactly a dollar a milligram across four strengths: "NAD+ 125mg $125 · NAD+ 250mg $250 · NAD+ 500mg $500 · NAD+ 750mg $750", plus a separate "NAD+ 125 Sub Q $125" shot line
Summary, strengths and trade-offs8 points
modMD publishes one long price menu on which some peptides are sold by the milligram and others by the month, with the unit printed on each line — the clearest single example of this market's unit problem.
Strengths
- Prints the unit on every peptide line, so a milligram price and a monthly price are never confused with each other
- Prices the telehealth consultation on the same menu as the medication instead of leaving it implied
- Publishes four NAD+ strengths and four glutathione strengths rather than one starting figure
- The whole catalog sits on one page a reader can scan end to end
Trade-offs
- Publishes no corporate entity across a 973 KB menu and an 832 KB terms page
- Sells TB-500 only inside blends, so no price for that peptide alone exists
- Its glutathione pricing does not scale with dose, which makes the cheapest line the most expensive per milligram
- Names no dispensing pharmacy and publishes no state coverage
192. Peaks Curative
$129.99 — the category listing names no billing period
Summary, strengths and trade-offs8 points
Peaks Curative carries a February 2026 federal warning letter, names its pharmacy, and tells readers in one place that its treatments are FDA-approved and in another that compounded products are not.
Strengths
- Names its dispensing pharmacy as a legal entity
- Lists the nine states its doctors and pharmacy are licensed in
- Prints the vial size, the concentration and the sprays per bottle beside each figure
- Offers PT-141 as a nasal spray with a one-time price beside the subscription
Trade-offs
- Carries a February 2026 federal warning letter naming its own website
- Says its treatments are FDA-approved on one page and that compounded products are not on another
- Three of its four prices appear only on a category listing, not on the product page
- Its checkout offers a fifty-state dropdown while it names nine licensed states
193. StackMD
$140 — starts at; the homepage states no billing period for this figure
Summary, strengths and trade-offs8 points
StackMD prices NAD+, sermorelin and glutathione from one homepage list and settles every product page at a single "plans starting at" figure.
Strengths
- Says explicitly there are "no membership fees or hidden charges"
- Explains in its own words what compounding is and why a pharmacy may do it
- Prices three tracked compounds on one homepage list
- Gives each compound and each route its own product page
Trade-offs
- Its per-compound figures carry no billing period
- Publishes no complete operating company name
- Its product pages quote a plan floor that is lower than any compound figure it names
- Publishes no state list, no named pharmacy and no certificate of analysis
194. YourHealthRx
$150 — printed as 'NAD+ · As low as $150/mo' inside a goal panel; the page conditions its advertised rates on a promotional code or a six-month supply and prints a dated expiry, so the figure is a conditional floor rather than a month-to-month rate
Summary, strengths and trade-offs8 points
YourHealthRx prints a rate against five separate peptides and conditions every one of them on a promotional code or a six-month commitment that expires on a stated date.
Strengths
- Publishes a rate for five distinct peptides rather than one blended protocol
- States the condition attached to its rates instead of hiding it after intake
- Prints an expiry date on the promotion rather than running it indefinitely
- Groups its catalog by goal so a reader can find the compound for their purpose
Trade-offs
- Not one advertised rate is a plain month-to-month price
- Every figure requires a promotional code or a six-month supply, or both
- Its own page says it does not prescribe and routes to partner workflows, leaving unclear whether it is the seller
- Publishes no state list and names no dispensing pharmacy
195. Regenics
$159 — member price on the 1,000 mg option ($299 non-member), revealed only after selecting a potency; the purchase-plan control offers one-time or every ten weeks, so no month is named
Summary, strengths and trade-offs9 points
Regenics prints two figures for every peptide it sells — a list price and a lower member price — and the member price is the only one a buyer can reach, because the catalog itself says ten further peptides are visible only after a $39-a-month membership.
Strengths
- Prints the non-member figure beside the member figure on every peptide page, so the discount is visible rather than implied
- Says on the NAD+ page that the compound is "Not FDA-approved for weight loss or athletic performance", which is a scoping most sellers leave out
- Its sermorelin page states plainly that adult wellness use is off-label and that the evidence for it is limited
- Sells GHK-Cu as a prescribed compounded cream and says so, rather than as a cosmetic jar
Trade-offs
- The full peptide catalog is behind a paid membership — the site says ten further peptides are member-only and names none of them
- Every published figure is a member rate that sits on top of a $39-a-month membership charge
- Its NAD+ page shows no price at all until a potency is selected, so the page reads as priceless on arrival
- Two of its own pages describe the same sermorelin item at two different strengths
- The 503A compounding pharmacy is never named, and no service-state list is published anywhere
196. Midi Health
$165 — per 30-day supply (15 mL); the page names a supply, not a billing period
Summary, strengths and trade-offs8 points
Midi Health, a midlife and menopause telehealth practice, sells sermorelin and an NAD+ nasal spray from its own formulary and publishes a figure for each, one as a monthly rate and one as a 30-day supply.
Strengths
- Prints the unit beside each figure, and the two units genuinely differ rather than being flattened into one
- Attributes the NAD+ explainer on that page to a named person at the company rather than to an anonymous team
- Frames both compounds around midlife symptoms rather than generic longevity copy
- Puts the FDA-status disclaimer directly under the product claim rather than in a footer
Trade-offs
- Describes "our trusted compounding pharmacy" without naming it
- Publishes no state list, and its insurance-and-pricing path returns a 404
- Only two of the compounds this site tracks are sold, so anything else means a second seller
- The NAD+ figure is a supply price, which is easy to misread as a monthly rate beside the sermorelin row
197. Sky Health Wellness Clinic
$175 — Per INJECTION, and the only NAD+ line on the chart with no "From" in front of it — "NAD+ Injection $175". The other two routes are floors: "NAD+ Nasal Spray From $165" and "NAD+ IV Drip From $349"
Summary, strengths and trade-offs8 points
Sky Health publishes a single alphabetical price chart covering seventy-one services, prices the peptide visit separately from the medication, and puts a "From" in front of the figures that are floors.
Strengths
- Publishes one chart covering its entire service list, alphabetically, on a single page
- Prices the peptide appointment as its own line rather than folding it into the medication
- Marks which figures are floors with an explicit "From" and which are not
- Names its operating company in the terms
Trade-offs
- No peptide figure on the chart states a unit — not a vial, not a dose, not a month
- The peptide menu page publishes only the $99 visit fee, so a reader landing there sees no medication price
- Its terms decline to say where the service is available
- Names no dispensing pharmacy
198. BioGlow Health
$179 — the price beside "~1 month supply"; the listing's own description calls this nasal product injectable
Summary, strengths and trade-offs8 points
BioGlow Health puts every peptide figure in visible text on an open shop page with no account gate, and then describes two of its three nasal sprays with the word "Injectable" — the injection copy pasted onto the nasal listing.
Strengths
- Every product figure sits in visible text on an open shop page — no account, no quiz and no blur between a reader and the price
- Publishes a dose ladder for its GLP-1 line rather than one headline figure, which is the same transparency applied to a different lane
- Runs the whole site in English and Spanish from a header toggle
- Claims fifty-state service for itself in its own footer
Trade-offs
- Two of its three nasal-spray listings — NAD+ and glutathione — describe themselves as injectable, so the delivery copy contradicts the product name
- Every price is labeled "~1 month supply" with a tilde and no billing cycle, so no figure is a quoted monthly charge
- The compounding pharmacies are described only as licensed and are never named
- Lab panels are required by its own process description but are not stated to be included in any price
199. Invyncible
$192 — the current price against a struck-through $240.00 anchor, with a quantity selector and no billing period or supply length stated anywhere on the page
Summary, strengths and trade-offs9 points
Invyncible names six compounding pharmacies with street addresses and phone numbers, says the patient chooses which one fills the prescription, and prints a two-state exclusion at the top of every product page — three disclosures almost nobody else on this roster makes.
Strengths
- Names six compounding pharmacies in a table with street addresses, phone numbers and websites, rather than describing a category
- States that the patient chooses which of those pharmacies fills the prescription, and may nominate one outside the network
- Prints its two-state exclusion in visible text at the top of every product page rather than revealing it at checkout
- Names the operating company, its brand relationship and a street address in the footer of every page
- Warns on the glutathione page that the product needs refrigeration and overnight shipping, before the order is placed
Trade-offs
- No product page states a billing period or a supply length, so none of its figures can be read as a monthly cost
- Every figure is a discount against a struck-through anchor, which is a promotional shape rather than a settled price
- The glutathione page offers two vial sizes under a single displayed figure without saying which it applies to
- No certificate of analysis or third-party testing claim appears on any page read
200. Fidelity Medical Clinic
$198 — a three-month supply as an initial order; the same $198 buys eight doses over two months as maintenance
Summary, strengths and trade-offs8 points
Fidelity Medical Clinic advertises "$99 a Month" for a figure its own pricing box says buys two months, and charges one tirzepatide price for eight doses, seven doses and four doses.
Strengths
- Prints the dose count, the vial size and the concentration inside every price box
- Publishes an initial, a step-up and a maintenance rung for each product
- Prices the oral forms of both weight-loss molecules identically and separately
- Says what the package includes, down to the supplies and the shipping
Trade-offs
- Its headline calls a two-month price a monthly one
- Charges the same tirzepatide price for eight, seven and four doses
- Its NAD+ price buys three months as an initial order and two as maintenance
- Its comparison figures for branded drugs are unsourced and its step-up unit is left indeterminate
201. Bowery Clinic
$199 — flat product-page price; the page prints a strength and a supply length beside it that this figure does not reflect
Summary, strengths and trade-offs9 points
Bowery Clinic puts one flat sticker price on each peptide with the strength and the supply length printed beside it, and tells shoppers on the product page that nothing further is added at checkout.
Strengths
- Prints the strength, the format and the words "Lasts approximately 4 weeks" beside each sticker price, so the figure describes a stated quantity instead of a billing cycle
- Offers a dissolvable troche as well as a vial on several peptides, so most of the catalog is usable without injecting
- One of the widest published peptide menus on this roster: KPV, Semax, Epithalon and MOTS-c each carry their own visible price
- Answers the price question head-on in its FAQ, explaining why its peptides cost more than research-grade material
Trade-offs
- Its own Terms say charges "may include" consultation fees, laboratory or diagnostic services and membership or administrative fees, which contradicts the product pages saying there are no additional fees
- Section 32 of the same Terms states the products "are not intended for human or animal consumption of any kind" and are "Not medical treatments", wording that sits oddly on a site selling prescribed therapy
- Describes its pharmacies only as "503A FDA-Registered Pharmacies" and never names one
- Publishes no state list at all, so a shopper cannot tell before signing up whether care is available where they live
- Prices Semax, MOTS-c and Epithalon against a five-week supply, so those three figures are not monthly costs
202. Mevo Health
$199 — as low as; the product card prints the figure with no period, while the page hero separately says plans start as low as $199/month
Summary, strengths and trade-offs8 points
Mevo Health prices compounded NAD+ injections on the same product row as its two GLP-1 lines and names three prescribing physicians, but publishes no pharmacy and no coverage.
Strengths
- Names three prescribing physicians and the network one of them heads
- Prices its NAD+ line on the same row as its weight-loss lines, in the same unit
- Cites published research for each of its three claims about weight regulation
- Publishes a phone number and a support address rather than a form only
Trade-offs
- Publishes no product page at all; the only NAD+ detail is a card and an email gate
- Prints the card figure with no period, next to a hero figure that carries one
- Names no dispensing pharmacy and publishes no state list
- Its sitemap holds seven URLs, six of them policy pages
203. Harmony Wellness Clinic
$200 — for a 5 week supply — five weeks is not a month
Summary, strengths and trade-offs8 points
Harmony Wellness Clinic prices its peptides by supply length rather than by month, and three of its four supply lengths are not a month.
Strengths
- Attaches a supply length to almost every figure instead of printing a bare number
- Prices eleven tracked compounds on one open services page
- Says its prescriptions "may include FDA-approved medications or compounded formulas, which are not reviewed by the FDA"
- Names the regulatory class of its suppliers — 503A pharmacies licensed by state boards
Trade-offs
- Charges the same $200 for a five-week supply and a one-month supply of different compounds
- Its PT-141 price names no supply length at all
- Publishes no operating company, no state list and no named pharmacy
- No certificate of analysis is reachable
204. The NP 2 Go
$200 — per vial for home delivery; the same block prices an in-office NAD+ treatment at $50, also with no period
Summary, strengths and trade-offs8 points
The NP 2 Go publishes a full dose ladder for its two weight-loss drugs under two different programs, prices sermorelin and NAD+ by the vial, and prints three different state counts on its own site.
Strengths
- Publishes a complete dose ladder for both weight-loss drugs rather than a single starting figure
- Prices the same dose under two different programs side by side, so the trade-off is visible
- Says in its own words that compounded semaglutide and tirzepatide are not FDA approved
- Prints the unit its peptide figures are charged against — a vial, or a single in-office treatment
Trade-offs
- Prints three different counts of the states it serves on its own site, unreconciled
- Publishes no list of states, only counts
- Names no dispensing pharmacy, saying only "reputable pharmacy partners"
- No certificate of analysis is reachable
205. Unique Physique
$200 — sold as a one-month supply, but the ten syringes shipped cover five or ten weeks depending on which of its two dosing schedules is prescribed
Summary, strengths and trade-offs8 points
Unique Physique markets a prescription NAD+ injection as a supplement, publishes two incompatible lists of the states it cannot serve, and sells a one-month supply whose own dosing instructions do not fit a month.
Strengths
- Publishes its dosing schedule, its syringe count and its beyond-use date beside the price
- Says plainly that it is a medical practice and not a retail pharmacy
- Names the states it cannot serve rather than only the ones it can
- Concedes in writing what happens if a patient uses the vial past its date
Trade-offs
- Its pricing page and its terms name two different, incompatible lists of excluded states
- Its one-month supply ships enough syringes for five or ten weeks, past its own beyond-use date
- Neither weight-loss molecule is named anywhere on its pricing pages, so neither has a price
- Markets a prescription injection under the word supplement
206. LifespanningRx
$225 — one-time purchase of a 1 month supply; the same page prices the identical supply at $191.25 on a lane it labels "1-month subscription SAVE 15%"
Summary, strengths and trade-offs6 points
LifespanningRx names its operating company and its state of incorporation in its own terms, and puts a supply-duration control on each product page so a reader can see what one month and what three months cost before starting an intake.
Strengths
- Names its operating company, its state of incorporation and a street address in its own terms, and names Florida as the governing law
- A supply-duration control sits on each product page, so the one-month and three-month figures can both be read before an intake starts
- States beside the price that a prescription follows a telehealth consultation and that the preparation is dispensed by a licensed compounding pharmacy
Trade-offs
- No state coverage list appears anywhere on the site, so eligibility can only be settled by starting an intake
- The compounding pharmacy that fills an order is described by category and never named
- The home page carries a patient-count claim and a clinician-credential claim that a reader has no way to check from outside
207. Levers Health
$247 — the floor of a published range, printed as "NAD+ Injection — Metabolism & Energy — Regular price From $247" with no billing period attached. This is the figure an earlier sweep attributed to this seller's antioxidant; it belongs to the coenzyme
Summary, strengths and trade-offs8 points
Levers Health sells its antioxidant in one-, two- and four-month supplies at three stated figures, while a banner on the same site advertises the same injection at barely half the one-month price.
Strengths
- Publishes three supply lengths at three stated figures, so the multi-month discount is calculable rather than implied
- One of the best-documented operating companies in this batch — named across several pages with a street address and a copyright line
- Carries a copper-peptide topical alongside the injectables, which few sellers here do
- Shows a customer review count on the product card rather than an unsourced rating alone
Trade-offs
- A banner figure and a product-page figure for the same injection differ by seventy-eight dollars
- The banner discount is date-stamped, so any comparison built on it decays on a known day
- Claims third-party testing in its terms and a purity test on the product page, with no certificate reachable
- No pharmacy named and no state coverage list
208. Avara Rx
$249 — starting at; the page states no billing period
Summary, strengths and trade-offs8 points
Avara Rx prints "Starting at" and a number on each of its three peptide pages and states no period on any of them, while its GLP-1 copy on the same site says "per month".
Strengths
- Publishes a figure for all three of its tracked compounds without an intake
- Describes itself in its own words as "a LegitScript-certified telehealth pharmacy"
- Gives each compound its own page rather than burying them in one menu
- States a review cadence — "1:1 doctor-led care, every quarter" — beside each price
Trade-offs
- None of its three peptide figures carries a stated billing period
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- Its GLP-1 copy states a period its peptide pages do not
209. ClickSlim
$249 — per four-week package, charged as "$249 every 4 weeks" at checkout, where the package text calls it "$249/month or $199 with GLP1"; the homepage card headed NAD+ prints the lower figure, which the checkout ties to a GLP-1 program
Summary, strengths and trade-offs8 points
ClickSlim prices the same weight-loss program at two different monthly figures on one page. Its homepage NAD+ card prints the rate its own checkout gives for patients also on a GLP-1 program, not the standalone price.
Strengths
- States that it is not a state-licensed pharmacy nor a drug manufacturer
- Says compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality
- Footnotes which of its products contain a weight-loss drug rather than leaving it to the intake
- Shows the NAD+ package price at checkout before any personal details are entered
Trade-offs
- Prices the same program at two different monthly figures on one page
- Its homepage NAD+ card shows the rate for patients also on a GLP-1 program, not the standalone price
- Bills NAD+ every four weeks while its package text calls the price monthly
- Its NAD+ state list appears only at checkout, not on the product page
210. Nip & Tuck Wellness Institute
$249 — printed as 'NAD+ Ampule (30-Day) - Starting at $249+'. The same page prices an in-clinic NAD+ drip separately at a different figure; the two are recorded as two products, not merged
Summary, strengths and trade-offs8 points
Nip & Tuck publishes a figure against each of eight compounds and its own overall range in words — and prints two different sermorelin prices on the same page.
Strengths
- Publishes a figure for eight separate tracked compounds on one page
- States its own overall price range in plain words rather than leaving it to be inferred
- Prices oral and injectable forms of the same compound separately
- Prices multi-peptide stacks separately from the single compounds inside them
Trade-offs
- Publishes two different sermorelin figures on one page with no explanation
- Almost every figure is a floor marked with a plus sign rather than a settled rate
- Publishes no corporate entity, only a named physician
- Publishes no state list and names no dispensing pharmacy
211. WeightCare
$249 — per 30 doses; the page names a dose count rather than a billing period, and prints its own "$8.30 / DOSE" division of this figure
Summary, strengths and trade-offs9 points
WeightCare publishes the ten states it will not serve, prices sermorelin as a flat monthly program and NAD+ by the dose, and carries a February 2026 FDA warning letter over telehealth marketing claims.
Strengths
- Names the ten states it cannot serve instead of leaving coverage to the intake
- States the sermorelin figure as a monthly rate with no commitment and no separate membership
- Lists the telehealth visit, the medication and unlimited prescriber messaging as included in the published figure
- Puts the compounding disclaimer above the price rather than below the fold
Trade-offs
- Carries a February 2026 FDA warning letter over telehealth marketing claims
- Prints per-day and per-dose divisions of its own figures beside them, which is how a comparison ends up quoting an invented rate
- Its NAD+ figure is priced by dose count, not by month, so it is not comparable to the sermorelin row as printed
- Sends prescriptions to "an accredited pharmacy" and never names one
- Publishes no operating company anywhere on the site
212. TeleWellnessMD
$249.95 — per vial as listed — "NAD+ / General Therapy / 1000mg / x1 Vial"; the seller publishes no billing period for it
Summary, strengths and trade-offs8 points
TeleWellnessMD prices by the vial rather than by the month, printing the strength and the vial volume beside every figure, and it folds the consultation fee into the price of the therapy instead of billing it separately.
Strengths
- Prints the strength and the vial volume beside every figure, so a reader can see what the money buys
- Folds the consultation fee into the therapy price rather than charging for the visit separately
- Offers glutathione in two vial sizes at two published figures instead of one blended rate
- States that further consultations are scheduled at no additional cost
Trade-offs
- Publishes no billing period at all, so none of its figures can be compared against a monthly rate
- Ships its whole formulary inside a hidden block of the catalog page, where the prices render for nobody
- Names its own corporate entity two ways — "TeleWellnessMD®, LLC" in the Terms of Use, "TeleWellnessMD™ Inc." in the footer
- Describes its pharmacies as LegitScript certified without naming any of them
213. Garcia Weight Loss
$250 — Per INFUSION: printed as "250mg of IV NAD+: $250.00 per infusion". The same list prints five further units for the same compound — "500mg of IV NAD+: $500.00 per infusion", "Intramuscular (IM): $50.00 per injection", "Intramuscular (IM): $300 per vial (At Home Use)", "Package of 3 IV NAD+ 250mg: $700.00" and "Package of 12 Intermuscular (IM) Injections: $500.00" (the misspelling is the seller's)
Summary, strengths and trade-offs8 points
Garcia Weight Loss publishes six different units for one compound on a single page — per infusion, per milligram tier, per injection, per vial, per package of three and per package of twelve.
Strengths
- The most itemised price list in this batch — six units for one compound, each labeled
- Separates the in-clinic infusion from the at-home vial and prices both
- States the minimum term for the growth-hormone program separately from the monthly figure
- Publishes package pricing beside single-unit pricing so the discount is calculable
Trade-offs
- Six units for one compound means no single figure represents what the compound costs here
- Its legal name contains neither brand it trades under, so a company search on the brand finds nothing
- A regional clinic model, so the infusion figures assume travel a shipped program does not
- No dispensing pharmacy named, no certificate of analysis, no state coverage list
214. Lyfe Rx
$250 — a bare storefront figure; a separate "NAD+ Optimization Protocol" is listed at $240.00 on the same page
Summary, strengths and trade-offs8 points
Lyfe Rx carries a 2025 federal warning letter naming its own website, and today publishes a flat storefront price for bremelanotide and for two glutathione products with no billing period stated anywhere on the listing.
Strengths
- Puts a figure beside every product in an open storefront rather than behind an intake
- States in its own words that compounded drugs are not reviewed by the FDA and are not generic equivalents
- Says plainly that it is a telehealth platform and not a pharmacy
- Sells bremelanotide under its molecule name rather than a brand alias
Trade-offs
- Carries a 2025 federal warning letter that names its own website address
- Prints no billing period beside any storefront figure, so no price here is a monthly one
- Lists a nasal spray and a "protocol" at different prices for the same compound without saying what separates them
- Names no dispensing pharmacy and publishes no certificate of analysis
215. Pure Hydration
$250 — per single infusion given at the seller's spa, with "4-6 Recommended" printed beside it; there is no subscription and no billing period, and a package of six 500mg treatments is priced separately
Summary, strengths and trade-offs8 points
The only two dollar figures on Pure Hydration's copper-peptide page are the seller describing what the market charges, in an answer that never says what it charges.
Strengths
- Names its operating company in the footer of every page read
- Publishes per-compound pages rather than one undifferentiated peptide menu
- Publishes patient injection guides as documents a reader can actually open
- Answers a cost question at all, which several sellers in this batch do not
Trade-offs
- Prices only its in-person NAD+ infusions; the figures on its GHK-Cu page describe the market, not its own peptide programs
- Serves its own patient PDFs over plain HTTP from an HTTPS page
- Names no dispensing pharmacy and publishes no state coverage
- Its cost answer reads like a quote and is not one, which is the easiest error on this host to make
216. Nex Gen Health Rx
$299 — from; the product page states no billing period
Summary, strengths and trade-offs8 points
Nex Gen Health Rx names its dispensing pharmacy, prices four tracked compounds, and states a period for none of them.
Strengths
- Names Manifest Pharmacy rather than describing an unnamed accredited one
- Publishes a PT-141 figure, which most of this roster does not
- Prices glutathione to the cent instead of rounding to a marketing number
- Cross-links each product to the others from within the product page
Trade-offs
- None of its four figures carries a billing period
- Publishes no operating company on any page read
- Its sermorelin price is published on a testosterone product page rather than a sermorelin one
- Publishes no state list and no certificate of analysis
217. Arc-1
$299.99 — listed on the storefront with no billing period stated
Summary, strengths and trade-offs8 points
Arc-1 publishes a list price and a lower subscription price for each injection, and the subscription figure is the only one on the page that carries a month.
Strengths
- Shows the list price and the subscription price side by side rather than only the lower one
- Prices three separate injections on an open storefront with no intake first
- Attaches the month explicitly to the subscription figure
- Publishes a glutathione injection price, which most sellers here do not
Trade-offs
- Publishes no operating company on any page read
- Its regular prices carry no billing period at all
- Publishes no state list and names no dispensing pharmacy
- A product page URL says "one-time-purchase" while the page sells a monthly subscription
218. Nava Health
$300 — per infusion at 250mg for a non-member; the same row shows $200 for a member. 500mg is $500 non-member and 1000mg is $800
Summary, strengths and trade-offs8 points
Nava Health publishes a full price list with a member and a non-member column for every line, prices NAD+ and glutathione by the infusion at three strengths each, and adds a third column for two membership tiers on its packages.
Strengths
- Publishes a full itemised service price list rather than a headline figure
- Prints the member and non-member price on the same row, so the discount is visible
- Prices NAD+ and glutathione at three strengths each rather than one
- Warns readers in its own words against buying research chemicals online
Trade-offs
- Its host answers a success code for a page that does not exist, so no absence here can be proven by status
- Prices infusions per session, so nothing here is a monthly cost
- Publishes no state list and names no dispensing pharmacy
- Sells seven other tracked peptides that carry no published figure at all
219. InVigorate Med Spa
$350 — "250mg infusion $350. 500mg infusion $600." — a per-visit charge with no billing period stated; the menu adds "IV Infusions are usually about 30 minutes to an hour in length. NAD infusion may take longer."
Summary, strengths and trade-offs8 points
InVigorate Med Spa publishes a full intravenous menu with a figure against every drip, and is one of the few sellers here whose figure for the compound compared is a charge for a single visit rather than a monthly rate.
Strengths
- Publishes a figure against every item on its intravenous menu, not a selection
- States the milligram strength for both of the priced options
- Charges per visit and says so, rather than quoting a rate nobody is billed
- Names its street address and telephone number on every page
Trade-offs
- Carries a federal warning letter that names its own domain
- Puts its prices on a menu page while its page named for peptides carries none
- Sells the antioxidant compared here only inside blended drips priced as a whole
- Names no compounding pharmacy anywhere on the menu
220. Miami Bariatric & Plastic Surgery
$350 — printed as 'From $350' against '1-Month (20 injections)'; a two-month course of forty injections is priced separately, and a consult fee is charged on top
Summary, strengths and trade-offs8 points
Miami Bariatric prices six peptides on one table and gives almost every one a different term — four to eight weeks, six weeks, nine to twelve weeks — while calling four weeks a month.
Strengths
- Publishes a figure for six separate compounds on a single readable table
- States the program length beside every figure rather than leaving the term unstated
- States the injection count for its NAD+ courses rather than only a duration
- Publishes its consultation fees separately and says when they are credited back
Trade-offs
- Six compounds carry six different terms, so no two figures on its own table are comparable
- Calls a four-week program one month, which is thirteen payments a year rather than twelve
- Every figure is a floor, and no page says what the ceiling is
- Publishes no corporate entity, no state list and names no dispensing pharmacy
221. Endocrinology Associates
$500 — Per TREATMENT, and a floor — "NAD+ Therapy Starting at $500 per treatment". No course length and no frequency are published, so the figure cannot be turned into a month
Summary, strengths and trade-offs8 points
A named Ohio endocrinology practice that publishes a dedicated peptide pricing page — per vial for the peptides, per treatment for the coenzyme — and also runs a retail storefront it links from the same site.
Strengths
- Publishes a dedicated peptide pricing page on a named medical practice's own domain
- States the unit on every line — per vial for the peptides, per treatment for the coenzyme
- Names the operating company in the sentence that describes who runs the site
- Publishes a street address and a contact route in the same document
Trade-offs
- Every figure is a "starting at", and no vial size sits beside any of them
- Publishes no state coverage and names no dispensing pharmacy
- Runs a consumer retail arm it links from its own clinical site, which is a commercial surface a reader should know about
- The only PDFs it links are intake and records-release forms, not testing documents
222. AquaVita NextGen
$599 — the whole price of a ten-injection kit — "Peptides · NAD + · $599 · NAD+ 10 ML (10 injections) · 10 week program". This is a per-kit charge covering ten weeks, not a monthly rate, and the seller states the program length itself
Summary, strengths and trade-offs8 points
AquaVita NextGen prices its two peptide products as ten-injection kits covering a ten-week program, not as monthly subscriptions — and files them, along with a lipotropic vitamin injection, under a heading it wrote itself: Peptides.
Strengths
- States the program length and the number of injections beside each peptide price, so the unit behind the figure is visible
- Prices its weight-loss lane in both a one-month and a three-month supply with both totals shown
- Names the operating company in the opening sentence of its terms and says it owns and operates the site
- Carries a disclaimer stating the products are compounded and advising a licensed clinician be consulted first
Trade-offs
- Its peptide prices cover ten weeks while its weight-loss prices cover a month, on the same page and with no note that the units differ
- It files a lipotropic vitamin injection under the heading "Peptides" alongside the two peptide products
- The disclaimer under its product grid is the dietary-supplement formula — that statements have not been evaluated and the product is not intended to diagnose, treat, cure or prevent any disease — printed beneath compounded prescription products
- No state coverage list, no named pharmacy and no certificate of analysis anywhere in the pages read
223. Modern Age
$750 — Per SESSION, not per month: printed as "IV Drip Therapy: NAD+ — $750/session — NAD+ IV in our NYC Clinic — Approximately 3 hours", with an option table beneath it beginning "1 session $750". An in-person infusion in a named city, not a shipped subscription
Summary, strengths and trade-offs8 points
Modern Age sells its peptides by the session and by the injection in a physical New York clinic, and the only corporate name in its terms belongs to its payment processor.
Strengths
- States its unit explicitly on every figure — per session, per injection — instead of leaving a period to be assumed
- Prints how long the infusion takes beside the price, which no shipped-subscription seller can offer
- Publishes an option table with multi-session pricing rather than one headline figure
- Says where the service happens and that walk-ins are accepted
Trade-offs
- The only corporate name in its terms is its payment processor's
- A single physical clinic, so its figures are not comparable to a nationwide shipped program
- No dispensing pharmacy named and no certificate of analysis
- Its per-session figure is many times any subscription figure on this roster, and the units are not interchangeable
224. AgeRejuvenation
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
AgeRejuvenation names fourteen tracked compounds on one peptide page, the deepest single menu in this batch, and does not price a single one of them.
Strengths
- Names fourteen tracked compounds on one page, the deepest single menu here
- Names its operating company on two separate legal pages
- Runs separate NAD+ and glutathione pages beneath the main peptide menu
- Covers KPV, semax, epitalon and MOTS-c, which most rosters miss entirely
Trade-offs
- Carries no figure on its peptide menu or on any compound page
- Its legal name is tied to one location while the brand is presented as regional
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
225. Alpha MD
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Alpha MD prices one product under three peptide names and publishes a second, higher figure for buyers in California — and neither figure is a monthly rate, because both buy a supply the page measures in weeks.
Strengths
- Publishes a separate figure for California buyers rather than surfacing the difference at checkout
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Both published figures buy a supply window whose width the page says depends on the dose prescribed
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
226. Beverly Hills Rejuvenation Center
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Beverly Hills Rejuvenation Center sells three tracked compounds as one blended product and organizes its peptide catalog by goal rather than by compound.
Strengths
- Publishes a peptide hub organized by goal, with the blend reachable as a linked product page
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- The three compounds cannot be bought separately, and no price is published for the blend
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
227. the biostation
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
the biostation links per-compound fact sheets from its peptide page, and one of the two, fetched directly, answers successfully with an empty file.
Strengths
- Publishes per-compound reading material of its own, which most sellers here do not
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- One of the two linked documents answers with an empty file, and neither is a certificate
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
228. Compass Human Performance
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Compass Human Performance runs a page called peptide therapy that names no peptide; the one compound recorded here is on its service list, as an infusion.
Strengths
- Describes its services clearly enough that the one compound recorded here is unambiguous
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its peptide page names no compound at all, which makes the page itself uninformative
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
229. Della Bellezza Med Spa
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Della Bellezza names sixteen compounds on one service page, eleven of them ones this site tracks, and its own storefront — open to the public — sells skincare rather than any of them.
Strengths
- One of the widest single-page compound lists on this roster
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own storefront is open and sells skincare, so the breadth is a menu with nothing priced behind it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
230. Eden Health Club
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Eden Health Club runs a separate page for each of thirteen compounds tied to one Colorado location, and the only number on any of them is the same one repeated sitewide.
Strengths
- Publishes a page per compound rather than one combined peptide menu
- Names thirteen tracked compounds, among the deepest menus here
- Names its operating company on the pages it serves
- Ties each compound page to a named location rather than a vague service area
Trade-offs
- Carries no compound-specific figure on any of its per-compound pages
- The only figure sitewide repeats identically on every page, so it prices nothing
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
231. Immortals
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Immortals quotes its headline offer per day over a catalog priced per item, and only one of the four tracked compounds it names carries a figure at all.
Strengths
- Names four tracked compounds as products in its own navigation
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its headline figure is quoted per day, a unit nothing else here can be compared against
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
232. InjectCo
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
InjectCo publishes two different monthly prices for the same compounded semaglutide program on two of its own pages, and prints "We Only Use FDA-Approved, Trusted Products" above copy describing compounded drugs.
Strengths
- Itemises what the monthly subscription buys, down to the injection supplies and the training
- Prices a sublingual form separately from the injection
- Names the pharmacy class — 503B — rather than leaving it unstated
- Publishes street addresses for two physical clinics
Trade-offs
- Publishes two different monthly figures for the same compounded semaglutide program
- Prints an FDA-approval headline above compounded product copy
- Its five dedicated peptide pages carry no price for any peptide
- Serves one state, so most readers cannot buy from it
233. Invigorate Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Three unrelated businesses connected to this comparison trade under names built from the same word, and this is one of them; its peptide page names no peptide.
Strengths
- Publishes a detailed infusion menu that names both compounds recorded here
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its peptide page names no compound, and its brand collides with two unrelated sellers
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
234. Ivologist
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Ivologist publishes no price on any product page. The only figure it attaches to itself is a range inside its own blog comparison table, which is where this record’s single price comes from and why it is recorded as a range.
Strengths
- Says plainly that compounded medications, if prescribed, are not FDA-approved
- Names the pharmacy categories it works with — 503A and 503B — rather than saying only "licensed"
- Puts its own price range beside branded, commercial-program and surgical costs in one table
- Says eligibility is determined by licensed providers through a medical evaluation
Trade-offs
- Publishes no price on any product or program page
- Its only self-scoped figure is a range in a blog post, and the top of that range is three-quarters higher than the bottom
- Publishes no state list and names no dispensing pharmacy
- Sells sermorelin and NAD+ with no figure attached to either
235. Just Wellness
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Just Wellness prices nine things on its home page and not one of them is a peptide; its peptide page, the one document that should carry a figure, carries none.
Strengths
- Publishes detailed prices for its other services in clearly stated units
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its peptide page is the only page on the site with no figure on it at all
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
236. Kina Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Kina Health publishes three different corporate names across three of its own pages and no figure for any of the three peptides it sells.
Strengths
- One of the three company names in its terms reads as a pharmacy business, though no page says which facility fills a given order
- Lists NAD+, glutathione and GHK-Cu as distinct treatments rather than one bundle
- States a flat consult fee up front rather than revealing it at checkout
- Publishes both a terms page and a separate privacy policy
Trade-offs
- Three different company names appear across its own pages with no explanation of the relationship
- Publishes no figure for any peptide it sells
- Publishes no state list
- Describes no lab work as included in what it charges
237. Lovely Meds
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Lovely Meds carries a 2025 federal warning letter, names seven dispensing pharmacies outright, and prints weight-loss body copy on a sermorelin product page.
Strengths
- Names seven dispensing pharmacies with their cities, which almost no seller here does
- Charges one price at every dose on both weight-loss molecules
- Publishes the full plan ladder from one month to twelve
- Says in its own words that its compounded medicines are not FDA-evaluated
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Its sermorelin page carries a weight-loss product's body copy word for word
- Its home page prints an FDA-approval claim beside compounded product cards
- Admits it is available in many but not all states without saying which
238. Modern Wellness Clinic
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Modern Wellness Clinic names eight tracked compounds on one service page and tells readers, in its own words, that many of its patients arrive after buying peptides from research chemical companies with no medical oversight.
Strengths
- States plainly, on the page selling the treatment, what it thinks of the unsupervised market
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own linked storefront serves a page with no products, so nothing is priced anywhere
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
239. Nolu
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Nolu prices three weight-loss options at the same figure regardless of dose, and every one of those figures is quoted on a twelve-month plan. It says it serves all fifty states and, two lines later, that some services may not be available in all of them.
Strengths
- Charges the same figure at every dose and says so on the page
- Names Nolu LLC as the operating company in its footer
- Says compounded medications are not FDA-approved and have not been reviewed for safety, effectiveness or quality
- Notes that its product image is stylised and does not reflect the actual label or vial size
Trade-offs
- Every published figure is quoted on a twelve-month plan, and no shorter-plan rate is published
- Says it serves all fifty states and, in the next breath, that some services may not be available in them
- Lists sermorelin and NAD+ with no price attached
- Names no dispensing pharmacy and no certificate of analysis is reachable
240. Nurture Wellness & Aesthetics
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Nurture Wellness prices two peptide programs at the same starting figure and names the compounds in neither, so the number buys a program rather than a drug.
Strengths
- Publishes a full pricing page rather than quoting only at consultation
- States a monthly starting figure for its programs rather than an unqualified number
- Prints its consultation fee separately instead of folding it into the program
- Keeps its peptide programs on the same page as the rest of its fee schedule
Trade-offs
- Neither peptide program names the compounds it contains
- Two different programs carry an identical starting figure with no stated difference in cost
- Publishes no corporate entity on any page read
- Publishes no state list and names no dispensing pharmacy
241. Premium Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Premium Health carries a February 2026 federal warning letter, names three pharmacies, prices both weight-loss molecules by the month — and ships them every ninety days.
Strengths
- Names three dispensing pharmacies for its weight-loss products
- States its dose ceilings and exactly what exceeding them adds to the price
- Says the membership fee includes the medication, the supplies and the shipping
- Publishes a street address and a disclaimer separating itself from a similarly named firm
Trade-offs
- Carries a February 2026 federal warning letter naming its own website
- Prices by the month while shipping every ninety days
- Calls its own products extremely safe and claims an extreme safety profile for the drug class
- Its NAD+ product is a two-compound blend, so it has no price for NAD+ alone
242. RegenCen
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
RegenCen argues against the research-use market by invoking FDA prohibition, and publishes its operator under a management-company name a reader would never guess.
Strengths
- States its position on research-use compounds explicitly rather than staying silent
- Publishes its operating company, even though the name shares nothing with the brand
- Runs a dedicated peptide-therapy treatment page separate from its IV line
- Names five distinct compounds across its treatment pages
Trade-offs
- Its legal name shares no words with its brand, so the operator is effectively hidden in plain sight
- Carries no figure on any of the six pages read
- Its regulatory claim about prohibited compounds is its own assertion with no source attached
- Publishes no state list and names no dispensing pharmacy
243. Relive Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Relive Health's terms name a franchising company rather than a clinical one, so the party on the other side of the contract is the brand owner.
Strengths
- Names the contracting company and publishes a postal address for it
- Names the company on the other side of the transaction rather than only a trading name
- Declares nine of the sixteen compounds this site tracks on pages a reader can reach
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its terms carry a last-modified date from nearly three years before this reading
- Publishes no figure for any compound on the pages read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
244. SALT. Hydration & Wellness
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
SALT. prices BPC-157 by the vial and says a vial is about four weeks, which is the rare case where a seller does the reader’s arithmetic for them.
Strengths
- Says how long a vial lasts instead of leaving the reader to guess
- Names Chiyu LLC as the operating company on the site itself
- Repeats the same figure on every city page rather than varying it by location
- Warns on its contact form not to send medical information through it
Trade-offs
- Prices only one tracked compound
- Directs buyers to a second domain to start, which the price page does not explain
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
245. Simply Direct Medicine
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Simply Direct Medicine publishes a real price list of membership tiers and a scheduling charge, and links a specials sheet whose file name carries the month it expires in.
Strengths
- Publishes membership pricing in clearly named tiers rather than on request
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- None of its published figures prices a compound, and its specials sheet is dated by month
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
246. South Florida Face & Body
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
South Florida Face & Body publishes a whole-menu price range instead of a price per compound, and says plainly that a quote far below the market usually means gray-market product.
Strengths
- Publishes a price range rather than refusing to discuss cost before intake
- States that consultation and baseline labs are quoted separately
- States that an outside licensed pharmacy fills prescriptions, rather than implying it dispenses in house
- Warns in its own words what an unusually low quote usually means
Trade-offs
- Its range covers the whole menu, so no compound has a price of its own
- Publishes no corporate entity, only a named clinician and a license number
- Charges for consultation and labs on top of the quoted range
- Publishes no state list beyond the one state it operates in
247. Spa Sydell
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Spa Sydell organizes its peptide menu three ways — by compound, by blend and by concern — and prices none of them; the numbers on its site belong to its skincare shop.
Strengths
- Lets a reader browse peptides by individual compound, by blend or by concern
- Names eleven tracked compounds across its browse pages
- Keeps its retail shop on separate pages from its therapy menu
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any of its four peptide browse pages
- Publishes no corporate entity on any page read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
248. Tyde Wellness
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Tyde Wellness publishes two company names and tells a reader which is the brand and which is the clinic — then sells access by membership and prices neither peptide.
Strengths
- Discloses both its brand company and its clinic company, and distinguishes them
- Publishes a separate notice of privacy practices as well as a privacy policy
- Publishes its membership terms rather than describing membership only in marketing copy
- Names sermorelin and NAD+ specifically rather than selling an unnamed protocol
Trade-offs
- Publishes no figure for either peptide it sells
- Sells through a membership, so a drug price and an access fee are two separate unknowns
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
249. Voxy Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Voxy Health prints four plan lengths for each weight-loss drug with the billing cadence written beside every rate, so a prepaid figure can never be mistaken for a monthly one. It sells three tracked peptides with no price attached to any of them.
Strengths
- Prints the billing cadence beside every rate, so a prepaid figure is never shown as a monthly one
- Publishes a street address and a telephone number in its footer
- Says compounded medications are not reviewed by the FDA for safety or efficacy, twice on the same page
- Says what each plan includes — medication, supplies, shipping and check-ins — rather than leaving it to checkout
Trade-offs
- Lists NAD+, glutathione and sermorelin as treatments and prices none of them
- Says availability may vary by state without publishing a list of states
- Names no dispensing pharmacy, saying only that it is 503A licensed
- Its batch-testing sentence is a claim; no certificate of analysis is reachable
250. Brello Health
$79/mo — per month, advertised as a special; the page also shows $117 as the undiscounted rate
Summary, strengths and trade-offs8 points
Brello Health advertises a three-month plan and then bills it every eleven weeks, which makes its cheapest peptide figures shorter-lived than they look.
Strengths
- Prints the discounted and undiscounted figure together rather than only the promotional one
- States the billing interval in plain words on the product page
- Prices sermorelin and NAD+ separately instead of bundling them into one plan
- Publishes a cancellation term — a $50 professional services fee after a prescription is written
Trade-offs
- Calls a plan "3 month" and bills it every eleven weeks on the same page
- Answers 200 at every path, so nothing about the site can be proven absent
- Publishes no operating company, no state list and no named pharmacy
- Its lowest figures are described as specials with no stated end date
251. NiceRx
$79/mo — every month thereafter; the first month is $29
Summary, strengths and trade-offs8 points
NiceRx names the four states it will not serve and prints a first-month rate beside the recurring one on every NAD+ format it sells.
Strengths
- Answers its own "all 50 states?" question by naming the four states it excludes
- Shows the first-month and recurring figure together on every product tile
- Names NiceRx LLC and its two affiliated professional entities
- Says its plans include the visit, the medication and shipping with no hidden fees
Trade-offs
- Does not serve Alaska, Mississippi, New Jersey or Kansas
- Sells only one tracked compound, in three formats
- Names no dispensing pharmacy
- No certificate of analysis is reachable
252. Taurus Meds
$79/mo — printed as "NAD+ Injection — Anti-Aging & Cellular Repair — $179 $79 /mo" with the higher figure struck through. A promotional figure: the anchor is $179 and the page states no expiry, so this number will decay
Summary, strengths and trade-offs8 points
Taurus Meds charges the same promotional figure for three different peptides against the same anchor, and the research-use language an automated scan finds on its site turns out to govern patient records, not products.
Strengths
- A dedicated peptide route with all three products, their anchors and their figures on one page
- Names the operating company, its state of registration and its street address in its own terms
- Names the clinical partner organization separately from the brand
- A flat price across three compounds, which removes the guesswork about which one is cheaper here
Trade-offs
- Every figure is promotional against the same anchor, with no expiry stated, so all three will decay together
- A flat cross-compound price tells a reader nothing about what any individual compound costs to supply
- No pharmacy named, no certificate of analysis, no state coverage list
- Its clinical partner stands behind other brands, so naming it distinguishes little
253. TMates
$88/mo — from, per month, in the open catalog
Summary, strengths and trade-offs8 points
TMates prices semaglutide, tirzepatide, NAD+ and sermorelin by the month in an open catalog, states plainly that it is not a compounding facility, and lists two branded drugs at a figure a fraction of their list price.
Strengths
- Publishes an open catalog with a price on every row and no intake in the way
- States in its own words that it is not a 503A or 503B compounding facility
- Says compounded medications are not evaluated by the FDA for safety, quality or efficacy
- Names TMates Inc as the operating company and prints trademark attributions for the branded drugs it lists
Trade-offs
- Lists two branded drugs at a figure a fraction of their published list price, with no explanation of what it buys
- Says it has doctors in all fifty states and, elsewhere, that it ships to most states
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
254. WellMedr
$99/mo — starting at; the page prints the same figure three times, once with a month marker and once in an answer that says the price includes the online consultation and is the same at every dose
Summary, strengths and trade-offs7 points
WellMedr publishes one figure for one compound and repeats it three times with the unit attached, and the lower range on the same page belongs to the market it is warning readers about.
Strengths
- Prints the same figure three times with the unit, and says it does not change with dose
- Names the company on the other side of the transaction rather than only a trading name
- Publishes a figure on its own site with the unit recorded beside it
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Offers a single tracked compound, so nothing else in this comparison can be bought here
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
255. Cielo Health
$115/mo — now starting at, per month on the 3 Month Plan; the same table publishes $149/Month on the Monthly Plan and strikes through "Regularly $199/month"
Summary, strengths and trade-offs8 points
Cielo Health publishes a two-rung monthly plan table for injectable NAD+ against a struck-through regular rate, and sells a Niagen injection beside it at identical figures — a precursor, not the same molecule.
Strengths
- Publishes both rungs of its ladder with a month on each, and prints the undiscounted rate beside them
- States that the price is the same at any dose, on the same card as the figure
- Distinguishes NAD+ from its precursor in its own copy rather than selling them as one thing
- Serves the whole site in English and Spanish from a language control in the header
Trade-offs
- Sells one tracked compound, and its neighboring product is a precursor at identical figures
- Describes "Regulated FDA pharmacy partners" — a phrase that names nobody and misstates what the FDA does
- Publishes no state list and no operating company
- Its own /faqs path returns a 404, so the FAQ is only reachable from the home page
256. TRT Nation
$120/mo — per month, footnoted "*2.5 months minimum purchase", so the smallest possible order is two and a half times this figure
Summary, strengths and trade-offs8 points
TRT Nation prices sermorelin, NAD+, glutathione and tirzepatide by the month and footnotes a minimum purchase of two and a half or three months beneath most of them, so the monthly figure is not the smallest commitment.
Strengths
- Footnotes the minimum purchase directly beneath the monthly figure rather than at checkout
- Says there are no membership fees that are not applied to the prescription
- Lists the specific blood tests it requires and how old they may be
- Notes on its own cards that California pricing may differ
Trade-offs
- Most of its monthly figures cannot be bought for one month
- Publishes no state list; its own FAQ poses the question as a heading
- Names no dispensing pharmacy
- No certificate of analysis is reachable
257. Alyve
$129/mo — from, per month
Summary, strengths and trade-offs8 points
Alyve prices seven tracked-compound products across injectable and sublingual forms, and runs a site-wide banner quoting a tirzepatide figure that matches neither of its own tirzepatide products.
Strengths
- Prices the injectable and the sublingual form of each molecule separately
- Says what the price includes — the vial size and a home kit
- States in bold on its own safety page that its compounded products are not FDA-approved
- Marks products that are not yet purchasable as coming soon rather than pricing them silently
Trade-offs
- Its site-wide banner quotes a tirzepatide price that matches neither of its tirzepatide products
- Names no dispensing pharmacy, only a "Pharmacy Network"
- Makes no state-coverage claim at all
- Its terms of service still carry an unreplaced template placeholder in the date line
258. OBU Health
$129/mo — the seller's own comparison table on the same page prints this as its starting price per month for the same product — it contradicts the figure in the product block above, and both are published
Summary, strengths and trade-offs7 points
OBU Health publishes two different figures for the same product on the same page, in two different units, and neither one corrects the other.
Strengths
- Publishes a monthly plan and a prepaid three-month plan side by side, with the terms stated
- Names the company on the other side of the transaction rather than only a trading name
- Publishes a figure on its own site with the unit recorded beside it
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its product block and its own comparison table give two different figures for the same product
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
259. VEVArx
$133/mo — the seller’s own stated equivalent of its $399 three-month plan
Summary, strengths and trade-offs8 points
VEVArx sells peptides only as three-month plans and prints the total and the per-month equivalent together, except for PT-141, which it also sells monthly.
Strengths
- Prints the prepaid total and the per-month equivalent on the same card
- Offers PT-141 month to month as well as on a three-month plan
- States plainly that compounded medications are not approved by the FDA
- Lists what each plan includes rather than only what it costs
Trade-offs
- Sells sermorelin, glutathione and NAD+ only in three-month blocks
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
260. Fitish
$149/mo — "NAD+ NASAL SPRAY / $149 / Pricing is for a monthly supply"; the FAQ reads "$149 for a monthly supply, including your provider consult, the medication if approved, and shipping"
Summary, strengths and trade-offs8 points
Fitish prices three of the compounds compared here across five preparations, says in one sentence what each figure covers, and is one of very few sellers on this roster that publishes the states it will not ship a product to.
Strengths
- Publishes the states one of its products will not ship to, which most sellers here do not do at all
- Says in one sentence that the figure covers the consult, the medication and shipping
- Prices two preparations of the same compound separately at two different figures
- States the dose options beside the compound rather than leaving them to the intake
Trade-offs
- Carries a federal warning letter that names its own domain
- Publishes a no-ship list on one product page and none on the other four
- Prints a zero inside its own price block, where a compare-at figure would sit
- Names no compounding pharmacy on any page read
261. Insta RX
$150/mo — starting at, per month, same price at every dose
Summary, strengths and trade-offs8 points
Insta RX publishes two NAD+ figures that differ by $115, and the higher one is conditioned on a twelve-month prepayment stated only in a footnote.
Strengths
- States "same price at every dose" beside its NAD+ figure
- Says plainly that it "does not produce compounded medications"
- Publishes a figure without an intake or an account
- Sells the injection and the nasal spray under one price rather than two
Trade-offs
- Publishes two NAD+ figures $115 apart on two of its own pages
- Hides a twelve-month prepayment condition in an asterisk footnote
- Prints a tirzepatide description underneath its NAD+ heading
- Publishes no operating company, no state list and no named pharmacy
262. Revel Health
$169/mo — the ongoing rate, printed as "from"; the same line prints a lower first-month figure beside it, so a reader who compares the first month against another seller's ongoing rate compares two different things
Summary, strengths and trade-offs8 points
Revel Health prints two figures on every product line — a first month and the ongoing rate — which is honest and is also the easiest way for a comparison to go wrong.
Strengths
- Labels the first-month figure as such rather than presenting it as the ongoing rate
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes no company name; the only corporate-looking string on the page is a pair of state abbreviations
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
263. TelePeptide
$169/mo — the month-to-month column, printed as "NAD+ Energy & Longevity — Shot · nasal spray · sublingual tablet — Monthly — No commitment — $169/mo". The same row publishes the alternatives with their upfront totals attached: "6-month — $834 upfront — $139/mo" and "Annual — Best — $1,548 upfront — $129/mo". One figure covers all three routes
Summary, strengths and trade-offs8 points
TelePeptide publishes a four-column ladder for each peptide — month-to-month, six-month and annual, each with the upfront charge printed beside the per-month division — which is the clearest price table found anywhere in this batch.
Strengths
- Publishes the upfront charge beside every discounted per-month figure, so no prepayment is disguised as a billing cycle
- Labels its month-to-month column "No commitment" rather than leaving the reader to infer a term
- States that the price includes clinician evaluation, prescription and shipping, and that nothing is billed until prescribed
- Names the trade name and the operating company and says the company does not itself practice medicine
Trade-offs
- The advertised range starts at a figure that requires a twelve-month prepayment, and only the table shows that
- Publishes a state count rather than a state list, so a reader cannot check their own state
- No dispensing pharmacy named and no certificate of analysis anywhere
- The three-month column is empty for both peptides, so the ladder jumps from a month to six
264. Momentum Health 360
$175/mo — per month, "Billed monthly", on the two-month plan; the shop catalog prints "Starting from $185.00" for the same product and the one-month lane prints no figure
Summary, strengths and trade-offs8 points
Momentum Health 360 carries a June 2026 federal warning letter that names its own website and its FDA establishment identifier, and its NAD+ page renders a price for the two-month plan while the one-month lane prints no figure at all.
Strengths
- Prices five tracked compounds individually on an open catalog with no intake in the way
- States in its own words that its compounded medicines are not FDA-approved
- Prints "Billed monthly" beside the one figure that is a monthly figure
- Offers plan lengths from one to six months on the product page itself
Trade-offs
- Carries a June 2026 federal warning letter naming its own website and establishment identifier
- Its NAD+ one-month lane renders no price at all, so the cheapest term cannot be seen
- The NAD+ product page and the shop catalog print different figures for the same product
- Its catalog floors name no billing period, so four of its five prices are periodless
265. Ivy Rx
$179/mo — starting rate, per month
Summary, strengths and trade-offs7 points
Ivy Rx is one of the few sellers here that prints a full plan table — one, three and six months, with the per-month figure for each — so the discount for prepaying is visible rather than implied.
Strengths
- Prints a three-row plan table on its sermorelin page giving the total and the per-month figure for one, three and six months
- Operates as a professional entity rather than a plain trading company, a structure its own terms of service name
- Includes free temperature-controlled shipping in the published price
Trade-offs
- The headline sermorelin figure is the six-month prepaid rate; a buyer paying month to month pays about a quarter more
- Its glutathione page gives a starting figure for an order containing one vial without saying what period it covers
- The compounding pharmacy is described as FDA-registered but is not named
- No state coverage list is published
266. YOURx Health
$199/mo — per month for the intranasal form, priced separately from the injection
Summary, strengths and trade-offs8 points
YOURx Health prices six tracked peptides by the month on one protocol page, and sells every one of its weight-loss medicines combined with vitamin B12, so none of those four carries a price scoped to the drug.
Strengths
- Prices six tracked peptides individually, each on its own card with its own figure
- Names YOURx Health LLC as the operating company in its footer
- Marks products that are not yet available as coming soon rather than selling them
- Says on the BPC-157 card that lab work is required before a prescription
Trade-offs
- Every weight-loss product is combined with vitamin B12, so none carries a price scoped to the drug
- Sells PT-141 only inside a three-ingredient troche
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
267. Try Invigor
$209/mo — starting at, per month, as the plan page states it; the consultation and the supplies are included in the figure
Summary, strengths and trade-offs8 points
Try Invigor names its operating company, its clinical groups and a street address, and prices four tracked compounds on plan pages — three of which name a billing period and two of which name none at all.
Strengths
- Names the operating company, its trading name and a service address in its own arbitration clauses, and names California as the governing law
- Names the two clinical groups it works with, separately from the company that runs the website
- Says in its own footer that it does not prescribe for bodybuilding, athletic performance or cosmetic purposes, which is a narrower scope than most sellers here claim
- Prices each compound in an injectable and an oral or nasal form on separate plan pages
Trade-offs
- Two of its five plan pages print a figure with no billing period at all, while the other three say per month
- The privacy policy still names a website address the company no longer serves
- No state coverage list, and the compounding pharmacy that fills an order is not named
- No lab work is described as included in any plan figure
268. Alan Health
$235/mo — per month, and true only on a two-month plan paid upfront — the page's own footnote reads "*Paid upfront with a 2-month plan. Actual price will depend on the product and plan purchased", a different commitment from the one under the same seller's glutathione figure
Summary, strengths and trade-offs9 points
Alan Health prints a per-month figure on each of three product pages and a footnote under each one that names a different prepayment term — six months, two months and three months — so the three numbers are not the same kind of number.
Strengths
- States the prepayment term under every published figure rather than printing a bare per-month number
- Names its operating company, its trading names and a notice address in its own terms, and names both the governing law and the venue
- Names the clinical groups it works with separately from the company that runs the website
- Sells each of its three compared compounds in more than one format — injection, nasal spray and patch on two of them
Trade-offs
- The prepayment term is different on each of its three product pages, so the three per-month figures are not comparable with each other
- Received an FDA warning letter in February 2026 over website labeling that presented the company as the compounder of drugs it does not compound
- Publishes no state list at all, and its terms say only that certain services are available in certain states
- One figure is shown as a reduction from a former price, and nothing on the page establishes that the former price was charged
- No compounding pharmacy is named and no lab work is described as included
269. BloomWell Rx
$249/mo — starts at, per month on the homepage; the product page prints $349/month
Summary, strengths and trade-offs8 points
BloomWell Rx prices NAD+ at $249 on its homepage and $349 on the NAD+ page itself, and says in its own words that it is not a pharmacy.
Strengths
- States on the product page itself that it "is not a state-licensed pharmacy nor a drug manufacturer"
- Tells patients in its terms they may direct a prescription to any pharmacy they choose
- Attaches the month to every peptide figure it publishes
- Prices glutathione consistently across its homepage and product page
Trade-offs
- Publishes two NAD+ figures $100 apart on two of its own pages
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
270. Elara MD
$249/mo — printed as "NAD+ Injection — Starts at $249/month", again with the unit stated where its template siblings omit it. A sublingual mini-troche appears in the same navigation at the same figure
Summary, strengths and trade-offs8 points
Elara MD publishes the same two figures as Kin Meds to the dollar, and is the only brand in that family that attaches the word "month" to either of them.
Strengths
- The only brand in its five-brand template family that attaches a period to its figures
- Names the route in the product title rather than leaving injection and troche to be inferred
- Publishes a phone number in the header of every product page
- Sells a sublingual troche alongside the injection and prices it separately
Trade-offs
- No operating company published anywhere reachable — its about page returns a not-found status
- Its arbitration clause is the same clause four sibling brands publish, which is where an entity search on this family goes wrong
- Identical figures to a sibling brand, so the two together are one price observation and not two
- No pharmacy named, no certificate of analysis, no state coverage list
271. GoodGirlRx
$249/mo — the one-month plan; three months is $183 a month, and that $183 is the figure this page mislabels as tirzepatide
Summary, strengths and trade-offs8 points
GoodGirlRx carries a February 2026 federal warning letter and prints a compounded-tirzepatide price on three product pages that do not sell tirzepatide — each one quoting that page's own figure.
Strengths
- Publishes a four-rung plan ladder for every product rather than a single floor
- Prices sermorelin in both an injectable and an oral form, separately
- Says plainly that it is not a pharmacy, a prescriber or a manufacturer
- Its discount arithmetic reconciles on all four ladders against the savings it prints
Trade-offs
- Carries a February 2026 federal warning letter naming its own website
- Three of its product pages label their own price as a compounded tirzepatide price
- Its headline figures are twelve-month prepay averages, not a month's price
- Names no dispensing pharmacy and makes no state-coverage claim
272. Vital Edge
$250/mo — per month, flat regardless of dose, with consultation and shipping included — the card prints "then $250/month"
Summary, strengths and trade-offs8 points
Vital Edge hides a five-compound peptide price list behind a tab on its homepage — nothing about peptides renders until that tab is clicked — and serves a different toll-free number on every page load.
Strengths
- States that the monthly fee is flat regardless of dose, so titrating up does not raise the bill
- Says the figure covers consultation, medication and shipping rather than medication alone
- Publishes what happens if treatment is declined: "If medication isn't prescribed, the tele-health consult fee is $80"
- Prices its GLP-1 line in the open too, brand and compounded side by side
Trade-offs
- Nothing about peptides renders until a tab is clicked, so the peptide prices are invisible on arrival
- A different toll-free number is served on each page load, so the contact number a reader notes down is not stable
- Names no compounding pharmacy and publishes no service-state list
- Its GHK-Cu card names no delivery format, so a reader cannot tell whether the figure buys an injection or a cream
273. JulyMD
$279/mo — from, per month
Summary, strengths and trade-offs8 points
JulyMD carries a 2025 federal warning letter, serves every state but one, and runs terms of service that hand your data to a pharmacy network belonging to a different brand.
Strengths
- Prices the injectable and the nasal form of both its peptides separately
- Names the single state it cannot serve rather than hiding behind a vague availability line
- Names its medical group in its terms
- Prints the standing rate beside the promotional first month
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Its terms ask consent to disclose your data to a pharmacy network belonging to another brand
- Publishes no statement that its compounded medicines are not FDA-approved
- No price carries a dose, and its injection and nasal spray cost the same with no explanation
274. Serotonin Centers
$299/mo — per month on the seller's "NAD+ membership at $299 per month, which includes a convenient 30-day supply of at-home injections" — a corporate-page figure at an independently owned and operated franchise
Summary, strengths and trade-offs8 points
Serotonin Centers is a franchised clinic chain that publishes one figure across its whole peptide and NAD+ menu — a monthly NAD+ membership with a stated supply length — and prices nothing else it sells.
Strengths
- Publishes a monthly membership figure with the supply length stated inside it rather than a bare rate
- Says outright that individual session pricing depends on delivery method and plan, instead of implying one exists
- Names its operating company and its trading name in its own terms
- Runs physical clinics, so a buyer who wants an in-person infusion rather than a mailed vial has that option
Trade-offs
- Prices nothing on its peptide menu — sermorelin and PT-141 are described at length with no figure anywhere
- A franchise of independently owned centers, so a corporate-page figure need not be the price at any one clinic
- Publishes no service-state list, only a clinic locator, so mail-order eligibility cannot be checked
- Names no compounding pharmacy anywhere on the peptide or NAD+ pages
275. Remi Meds
$349/mo — printed as "NAD+ 10 ml per week | $349/mo ~ starting dose". The label carries a volume, a dosing frequency, a month and a hedge about the dose in eleven words; the "~ starting dose" says the figure moves with titration and the page does not say by how much
Summary, strengths and trade-offs8 points
Remi Meds is the only brand in its template family that prints a volume and a dosing frequency beside the figure — and it puts a volume, a frequency and a month into a single price label.
Strengths
- The only brand in its template family that prints a volume and a dosing frequency beside the figure
- Publishes two volumes of the growth-hormone peptide at two figures rather than one "starting at"
- Attaches a month to both peptide figures where three siblings attach nothing
- Says the dose is determined by the licensed provider based on medical judgment
Trade-offs
- The "~ starting dose" hedge means the printed figure is a floor and the page never says what the ceiling is
- Its terms name only the arbitration provider, never an operating company
- Both requested product paths redirect, so a cited product URL must be the effective one
- No pharmacy named, no certificate of analysis, no state coverage list
276. HelloWellness
$79 — the card prints "$117 $79 Per Month" with the higher figure struck through, but the footnote on the same page reads "Plans starting at $79/month (3-month plan minimum. Automatically renews for $239 every 11 weeks, until cancelled)". The charge is $239 on an eleven-week cycle after a three-month minimum, so $79 is a division and not a billing period
Summary, strengths and trade-offs8 points
HelloWellness prints "Per Month" on every peptide card and, in a footnote further down the same page, says the plan renews every eleven weeks — which is neither a month nor a quarter.
Strengths
- Prints the plan minimum and the renewal interval on the same page as the price rather than burying them in terms
- Names the anchor figure and the charged figure together on every card
- Discloses the pharmacy category it works with rather than saying nothing about dispensing at all
- Sells the two peptides individually and as named bundles, each priced
Trade-offs
- Every card says "Per Month" and the renewal interval is eleven weeks, which is neither
- The two legal pages name different corporate forms for one brand
- The pharmacy is described only by its licensing category, never by name
- No certificate of analysis and no state coverage list anywhere
277. Citizen Meds
$91 — sold as a one-month supply; the hero anchors it against $299 and the product box against $249 on the same page
Summary, strengths and trade-offs8 points
Citizen Meds sells every product as a one-month supply and renews every twenty-three days, and its NAD+ page prints two different struck-through prices for the same product on the same page.
Strengths
- Prints the dose, the concentration and the injection count beside every figure
- Publishes a full titration ladder so a reader can see what month four costs
- Names the branded product it is not, rather than implying equivalence
- Prices NAD+ and glutathione as well as the two weight-loss molecules
Trade-offs
- Sells a "one-month supply" on a subscription that renews every twenty-three days
- Its NAD+ page prints two different original prices for the same product
- Names no dispensing pharmacy and makes no state-coverage claim
- Both weight-loss products are co-formulated with additives the copy treats as standard
278. VITAstir
$91 — the advertised current price of a home kit the page calls a 1 Month Supply; the same page prints $449.00 as the original price, and nothing on it establishes what that original price was charged at
Summary, strengths and trade-offs8 points
VITAstir is a vitamin-injection shop that carries two compounds compared here, sells both as home kits at an advertised sale price, and says a clinical review happens after payment rather than before it.
Strengths
- Each kit page lists what arrives — the number of injections, the dose per injection, the syringes and the alcohol pads — beside the figure
- Names the supply length on both products, one as a month and one as thirty days
- Names its operating company and its trading name in its own terms and conditions
- States the route of administration and where the injection is given, rather than leaving it to a later email
Trade-offs
- Both figures are sale prices against a stated original price, and the page gives no period over which the original was offered
- The page says a clinical review may happen within twenty-four hours of purchase, so payment comes before the decision
- The governing-law clause in its terms is an unfilled template, with the state name still inside square brackets in the live document
- Two compounds compared here sit inside a catalog that is otherwise vitamin injections, so this is not a peptide clinic
279. FitFlow Rx
$119 — the treatment page states no billing period
Summary, strengths and trade-offs8 points
FitFlow Rx charges one flat figure per compound at every dose, and prices a GHK-Cu foam lower than anything else it sells.
Strengths
- Repeats "same price at every dose" on every treatment page, so titration does not raise the bill
- Prices six separate formats rather than one figure per compound
- Says on every product page that compounded drugs are not FDA-approved
- Includes the provider consultation and shipping in the published figure
Trade-offs
- Its treatment pages omit the billing period its homepage states
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable for any product
280. Ascend Vitality
$149 — printed as "NAD+ Nasal Spray — Starting at $149/month — As low as with 6-month plan — NAD+ (900 mg or 1200 mg)". Two strengths share one figure, and the six-month condition applies as above
Summary, strengths and trade-offs8 points
Ascend Vitality sells named multi-peptide stacks as single SKUs, and every figure it publishes carries the same unfinished sentence: "As low as with 6-month plan".
Strengths
- Names the peptides inside each stack rather than selling a blend under a marketing name alone
- Prints the milligram strength beside the antioxidant and both available strengths beside the nasal spray
- Publishes the whole peptide catalog on one browsable page with a figure on every card
- Names the operating company and a street address in its own footer
Trade-offs
- Every figure carries the same incomplete sentence as its only qualifier
- Its stack SKUs cannot be compared against any single-compound price on this roster, because they are not the same product
- A promotional banner was live on the date read, so these figures are discounted ones
- Claims a third-party lab in its terms with no certificate reachable anywhere
281. MintRx
$179 — one-time purchase; the card offers $170.05 with Subscribe & Save and names a spray count rather than a period, so this figure carries no term
Summary, strengths and trade-offs8 points
MintRx publishes the most specific price disclosures in this batch — a strength, a container size and a supply length beside almost every figure — and names no operating company anywhere on its site.
Strengths
- Prints a strength, a container size or a spray count beside almost every figure, which is a more specific disclosure than most sellers here manage
- Names a 28-day supply and a 28-day refill cadence on its sermorelin cards rather than rounding either to a month
- Sells four tracked compounds in both an injectable and a non-injectable form, so the two routes can be compared on price directly
- Publishes a telephone number and a HIPAA notice alongside its terms and privacy policy
Trade-offs
- No operating company is named anywhere on the site — no corporate form, no street address, and no governing-law clause in the terms
- Six of its seven longevity and sexual-health products print their price only on another product's card, so a reader on one product page may see every figure except that product's own
- The same figure covers both PT-141 products on different terms, one described as a 30-day supply and the other as a single prescribed order
- No state coverage list, and the compounding pharmacy that fills an order is never named
282. June Health
$199 — "WELLNESS / NAD+ Tablets / PRICE / $199" \u2014 no billing period stated. The product is titled Tablets but its own description reads "Injectable or intranasal NAD+ restores cellular energy production", naming two routes the title does not. The banner above this block reads "Medical Weight Loss from $199/mo", the same number with a period attached, for a different compound entirely
Summary, strengths and trade-offs8 points
June Health prices two of the compounds compared here as flat figures with no billing period attached, and puts a weight-loss rate in a banner above every one of those pages that happens to equal one of the two prices exactly.
Strengths
- Prices both compounds as single flat figures with nothing bundled into a plan
- Says plainly that the card is only charged if a clinician approves the prescription
- Renders a distinct not-found document for an unknown product and for an unknown page
- Separates its peptide catalog from its weight-loss catalog in its own navigation
Trade-offs
- States no billing period beside either figure, so neither can be compared to a monthly rate
- Prints a weight-loss rate in the banner above every product that equals one of its own peptide prices
- Titles one product as tablets while its description names two other routes
- Publishes nothing at all in the page itself — the served document has no products in it
283. LevelUp Rx
$199 — starting at, with "Per month" printed beneath it — a floor rather than a quoted bill, on a page whose tagline is byte-identical to another roster seller's NAD+ page carrying a much lower figure the same day
Summary, strengths and trade-offs7 points
LevelUp Rx ships the same clinical product copy as another seller already on this roster — twenty-three byte-identical paragraphs on the sermorelin page alone, measured in one run — at roughly double the price, and publishes no operating company of its own on any of its three legal pages.
Strengths
- Every product page carries a figure in visible body text, with no account gate and no blur
- The catalog is grouped by condition, so the peptide lane is reachable in one click from any page
- The three peptide pages each print their figure in the same place and the same shape
Trade-offs
- No operating company appears anywhere on its about, terms or privacy pages — the only corporate names on them are the arbitration provider and an analytics vendor
- Its sermorelin page shows a one-month and a three-month option with a single price attached to neither
- Twenty-three of its thirty substantial sermorelin paragraphs are byte-identical to another seller on this roster, so the two rows are not independent readings of the market
- No compounding pharmacy is named, no state list is published, and no certificate of analysis appears on any page read
284. RyzeRx
$199 — the product-page price for "NAD+ Nasal Spray", printed as "$199 USD" beside "Add to cart" with no billing period, supply length or bottle size
Summary, strengths and trade-offs9 points
RyzeRx prices every product on its own page, from single peptides to vial-by-vial weight-loss strengths, and says on none of them what period or supply the figure buys.
Strengths
- Puts a figure on every product page, from single peptides to each weight-loss vial strength
- Publishes its site in English and Spanish from the same navigation
- Says its medicines come from United States licensed pharmacies
- Offers a free consultation before any commitment
Trade-offs
- No product page says what period or supply its figure buys, though its terms say subscription plans renew automatically
- Its homepage cards still lead with category starting figures that none of the named peptides carries
- Its fifty-state lines are a marketing statistic and a statement about provider licensure, not a coverage statement
- Names no dispensing pharmacy and no certificate of analysis is reachable
- The support phone line in its terms, "(800) 555-0123", has the shape of a placeholder number; the cancellation route the terms actually name is email
285. Tru2u
$199 — a bare "Regular price"; the listing names no dose, no strength and no billing period
Summary, strengths and trade-offs8 points
Tru2u runs a shopping cart on prescription drug products while its own terms state, in capitals, that it does not sell or dispense any drug product — and none of its prices carries a dose, a strength or a period.
Strengths
- Prices the oral and injectable forms of both weight-loss molecules identically and separately
- Says plainly, in capitals, that it is not a provider, a practice or a pharmacy
- Puts every figure in the open with no intake in the way
- Names its state of incorporation in its terms
Trade-offs
- Runs a cart on prescription products while its own terms say it sells no drug product
- No price carries a dose, a strength, a vial size or a billing period
- Its testing badges — lab tested, GMP certified — are unsupported by any document
- Names no dispensing pharmacy and makes no state-coverage claim
286. Mobile Care Health
$219 — The bottom of A published range ON A SUBSCRIPTION PRODUCT with no period stated — the product page prints "NAD+ $219.00 – $429.00 · Price range: $219.00 through $429.00 — available on subscription". The range is a set of selectable options; which option costs $219 is not published on the page, and the subscription interval is not named
Summary, strengths and trade-offs8 points
Mobile Care sells across three different hosts — a parent site, a treatments subdomain and a storefront on a separate registrable domain — and only the storefront publishes a price.
Strengths
- Publishes an open storefront with a price range on every product
- Prints the compounding disclaimer on the product page and again in its FAQ
- Says the medication is prepared by a state-licensed pharmacy for individual patients
- Marks which products are available on subscription
Trade-offs
- Splits one business across three hosts, only one of which publishes any price
- Publishes ranges with no indication of which option sits at either end
- Names no subscription interval on a product it sells by subscription
- Its parent site's copyright line has an empty year, so nothing there dates the content
287. BloomMD
$245 — a REFILL price, not a first fill: printed as "NAD+ Injections Refill — From $245.00" in the prescription-refills collection. No billing period is stated. The same collection also carries "Restorative Cellular (NAD+) Refill — $245.00" as a separate SKU at the same figure
Summary, strengths and trade-offs8 points
Every BloomMD peptide figure is a refill SKU rather than a first fill, and the only corporate name in its terms of service belongs to the software vendor that builds the site.
Strengths
- Prices copper-peptide, antioxidant and coenzyme refills separately and openly, which most sellers on this roster do not publish at all
- Puts every refill figure on one browsable collection instead of behind an intake
- Separates its brand-drug membership SKUs from the drug SKUs rather than blending them into one number
- Names the concentration inside the copper-peptide product label
Trade-offs
- Every peptide figure is a refill, so none of them is what a new patient pays first
- The only corporate name in the terms of service is a software vendor's
- The only third-party-testing language on the site sits on a supplement page, not on any peptide
- No dispensing pharmacy named and no state coverage list
288. ARSYNL Rx
$249 — the injection listing's bare figure; no period stated. Its NAD+ nasal spray is listed separately at a different figure on the same page
Summary, strengths and trade-offs8 points
ARSYNL Rx publishes a figure against every peptide it sells and a period against none of them — four product pages, four bare numbers, no billing cycle anywhere.
Strengths
- Names its operating company on its own pages rather than leaving a reader to guess
- Publishes a figure on the product page for each peptide it sells
- Keeps each compound on its own listing instead of burying prices in a plan grid
- Prices its nasal and injectable NAD+ separately rather than as one product
Trade-offs
- Attaches no billing period to any peptide figure, so none of them can be compared
- States no supply length or vial count beside a price
- One listed peptide product returns a gone status while the catalog still links it
- Publishes no state list and names no dispensing pharmacy
289. Kin Meds
$249 — printed as "Personalized NAD+ — In stock — Wellness — Energy +Mood — NAD+ — Starts At $249", with no period attached. The same catalog carries a nasal spray and a 200 mg troche at higher figures
Summary, strengths and trade-offs8 points
Kin Meds prints a bare "Starts At" figure with no period attached to it, publishes no operating company of its own, and carries an FDA warning letter issued the same day as one of its template siblings.
Strengths
- Prints, on the product page itself, that it is not a state-licensed pharmacy nor a drug manufacturer and that compounded medications are not FDA-approved
- Marks stock status on the product page
- Publishes more routes than most of its template siblings — an injection, a nasal spray and a troche, each priced
- Says in plain words that the medication is compounded and dispensed by a licensed third-party pharmacy
Trade-offs
- Neither figure carries a period, so nothing on the page says what the money buys
- No operating company is published anywhere on the pages read
- Carries an FDA warning letter for false and misleading claims
- Four other brands on this roster run the same page template, so its numbers are not an independent observation of the market
290. Ways2Well
$249 — per infusion at 250 mg; the same menu prices 500 mg at $449 and 1000 mg at $849, and the entry’s own heading adds "Featuring additional vitamins as advised by your clinician" while its ingredient line reads NAD+ alone
Summary, strengths and trade-offs8 points
Ways2Well publishes an actual list of the states its peptide program reaches — one of the few sellers here that does — and prices its glutathione and NAD+ infusions by the bag rather than by the month.
Strengths
- Publishes an itemised list of the states its peptide program covers, not just a count
- Flags with a footnote which of those states restrict certain peptide therapies
- Lists the ingredients of every infusion, so a single-ingredient bag can be told from a blend
- Says plainly that some therapies it offers may not be approved by the FDA
Trade-offs
- Its homepage state count and its peptide state list do not agree
- Prices infusions per bag, so nothing here is a monthly cost
- Its testing language is a claim; no certificate of analysis is reachable
- Names no dispensing pharmacy
291. Wellspring Longevity Clinic
$249 — printed as "NAD+ — Starts at $249", again directly beneath the pharmacy disclaimer, and again with no period attached
Summary, strengths and trade-offs8 points
Wellspring Longevity Clinic prints, above its own price on every product page, that it is not a state-licensed pharmacy nor a drug manufacturer — a disclaimer it shares with a brand running the same template.
Strengths
- Puts its own regulatory disclaimer above the price on every product page rather than in a footer
- States that compounded medications are not FDA-approved in the same sentence block as the price
- Says the medication is compounded and dispensed by a licensed third-party pharmacy
- Its figures sit in the middle of its template family rather than at the top
Trade-offs
- Neither figure carries a period, so the disclaimer is clearer than the price
- The disclaimer is shared with at least one sibling brand rather than being this seller's own editorial choice
- Its terms name only the arbitration provider, never an operating company
- No pharmacy named, no certificate of analysis, no state coverage list
292. Revitalize IV Solutions
$250 — The bottom of A per-INFUSION range — the IV therapy section of the pricing page reads "NAD+ $250-500". No infusion dose, no frequency and no billing period are published beside it
Summary, strengths and trade-offs8 points
Revitalize lists seventeen peptides on a page with no prices on it, prices two of them on a different page, and publishes the rest of the menu as a downloadable PDF — which does resolve.
Strengths
- Publishes a downloadable peptide menu from its own page, and the file actually resolves
- Prices its IV and injection lines in detail, with the gram options named
- Names seventeen peptides on one page, one of the widest declared catalogs in this batch
- Prices facial, IV, injection and laser lines on one public page
Trade-offs
- The peptide page itself contains no price at all — a reader has to find the pricing page or the PDF
- Only two of the fourteen compounds this site tracks carry a published figure
- Publishes no corporate entity; the footer has a year and no name
- Names no dispensing pharmacy and publishes no state coverage
293. Mojoon
$290 — an open-ended floor per course, struck through from $849; this page defines no period and publishes no ceiling
Summary, strengths and trade-offs8 points
Mojoon publishes its catalog in Chinese for the US market, prices five tracked-compound products by a course of treatment it never defines in days, and leaves two of the five open-ended with a plus sign.
Strengths
- Publishes its whole catalog and its prices in the language its readers use
- Prints the vial size and the concentration on both peptide products
- States its eligibility threshold openly on the weight-loss pages
- Sells an at-home blood test as its own separate, separately priced product
Trade-offs
- Prices by a course of treatment it never defines in days on its peptide pages
- Two of its five figures are open-ended floors with no published ceiling
- Publishes no statement that compounded medicines are not FDA-approved
- Its licensed-physician count and its pharmacy-license count are different numbers, and neither is a list
294. Celia Rx
$299 — Per item with no period stated — "NAD+ Injectable $299.00"; the oral troche is also $299.00, so route makes no difference to the price here
Summary, strengths and trade-offs8 points
Celia Rx runs an open storefront where every peptide carries a flat item price and the onboarding consultation is a line item of its own — and where one nasal spray is dearer than a bottle six times its concentration.
Strengths
- Publishes an open storefront with every item priced, rather than putting prices behind an intake
- Prices the onboarding consultation as its own line and states how long it is
- Prices every route of a compound rather than one headline form
- Names its operating company in the opening sentence of its terms
Trade-offs
- No item carries a billing period, so nothing on the storefront is comparable to a monthly rate
- Its oxytocin lines make the smaller bottle cheaper and far more concentrated, which reverses any per-milligram ranking
- Names no dispensing pharmacy, describing it only as "a qualified 503A pharmacy"
- Publishes no state coverage
295. Reset IV
$299 — per visit; there is no subscription and no billing period
Summary, strengths and trade-offs8 points
Reset IV carries a 2025 federal warning letter and is the rare seller here that prices NAD+ by the milligram — at a per-visit rate, in a handful of named cities, with no company name published anywhere.
Strengths
- Prices NAD+ at four separate doses with the milligrams printed on each
- States the infusion time beside every dose
- Charges per visit with no subscription and says there is no travel fee
- Names the cities it serves rather than implying national coverage
Trade-offs
- Carries a 2025 federal warning letter naming its own website
- Publishes no legal entity anywhere on the site; the federal letter is where the company name appears
- Prices its glutathione add-on at two different figures on two of its own pages
- Prints a blend's flat price directly under its NAD+ heading, where it reads like the NAD+ price
296. Joey Med
$300 — for a three-month supply, shown against a struck-through $350; the page mentions monthly and three-month options but offers only the three-month one
Summary, strengths and trade-offs8 points
Joey Med publishes a detailed article on what semaglutide costs — every figure in it about the market rather than about itself. Its own plan pages print a four-week price without naming the drug inside, and its NAD+ page prices a three-month supply.
Strengths
- Names MD Telehealth Platform LLC as the company trading as Joey Med, at the head of its own articles
- Distinguishes brand-name, generic and compounded routes in its own explainer rather than blurring them
- Says compounded versions are made by licensed compounding pharmacies and are not FDA-approved
- Dates its articles with both a published and an updated date
Trade-offs
- Its weight-loss plan pages price each plan without naming the drug it contains
- The semaglutide figures in its explainer describe what other companies charge, which is not a price a reader can act on here
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
297. Vital Harmony Rx
$339 — printed as "NAD+ — Energy + Mood — Starts at $339", with no period attached. Its template siblings publish $249 for the same product under the same label
Summary, strengths and trade-offs8 points
Vital Harmony Rx runs the same product template as four other brands on this roster and charges a hundred and thirty dollars more for the growth-hormone peptide than three of them.
Strengths
- Publishes a figure for both peptides on browsable product pages rather than behind an intake
- Uses the same category labels as its siblings, which makes the comparison against them straightforward
- Its requested terms path resolves to a real terms page rather than a soft redirect
- Prints tools — a protein and a carbohydrate calculator — beside the catalog rather than only a checkout
Trade-offs
- The highest figures of the five brands sharing its page template, on identically described products
- Neither figure carries a period, so nothing states what the money buys
- Its terms name only the arbitration provider, never an operating company
- No pharmacy named, no certificate of analysis, no state coverage list
298. The HCG Institute
$395 — "NAD+ Injections $395.00... Requires overnight shipping and must be refrigerated upon arrival. Unavailable in: MS" \u2014 no supply period and no strength stated. The catalog separately prices an "Ultra SermorLean - Sermorelin, Naltrexone, Ultra Lipotropic 10" at the same $395.00, which is a three-ingredient combination and not this compound
Summary, strengths and trade-offs8 points
The HCG Institute runs a forty-three item storefront where four of the compounds compared here carry list prices, states in a dropdown what each program length adds to the base figure, and names the one state it cannot ship to.
Strengths
- Publishes a list price against every one of forty-three catalog items
- Prints the longer-program cost as an uplift on the base figure rather than as a divided rate
- Names the one state it cannot ship to on each product page
- Lists exactly what a purchase includes, item by item, so what is missing is visible
Trade-offs
- Carries a federal warning letter that names its own domain
- Publishes no price on any of its compound-named editorial pages, only inside its store
- States no supply period or strength on four of its five priced items compared here
- Names no compounding pharmacy while stating it does not compound or dispense itself
299. The I.V. Doc
$799 — per visit for a single in-home 250 mg infusion, on the New York menu with the site's own location selector reading New York; the page states no billing period at all and this is not a monthly charge; a 500 mg "NAD+ Premium" infusion is $999 on the same menu
Summary, strengths and trade-offs9 points
The I.V. Doc publishes a full per-treatment menu for in-home infusions, with a laid-out figure beside each item and no billing period anywhere — because these are visit prices, not plan prices.
Strengths
- Publishes a per-treatment menu with a laid-out figure beside every item, which most clinic-model sellers compared here do not
- Prints the dose beside the two NAD+ tiers, so the higher figure is attached to a stated milligram amount
- Names its operating company and each of the seven treating practice entities it contracts with
- Sells glutathione in both an injection and two intravenous strengths, each priced separately
Trade-offs
- Its governing-law clause names no state: it points at "the law of the state of residence of the registered Administrative Contact", so the forum depends on who books
- The prices are the New York menu and the location control could not be driven, so whether they hold in other cities is unknown
- These are per-visit figures with no billing period stated, so they do not sit beside a monthly plan price without conversion
- Publishes cities rather than states, so a reader outside a listed metro learns nothing about eligibility
- No compounding pharmacy is named and no lab work is described as included
300. Aurelius Health Group
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Aurelius names the medical group that actually prescribes, separately from its own brand — and prints a rival's price range in the same table as its own.
Strengths
- Names the prescribing professional corporation separately from the brand company
- States both the introductory rate and the recurring rate in the same sentence
- Says full pricing is presented before any charge is made
- Cites the published trials behind the outcome ranges it quotes
Trade-offs
- Prints a competitor price range in the same table as its own, where a careless reader will merge them
- Its recorded figure is an introductory month, not the rate most buyers will pay
- Publishes no figure for the NAD+ line it also names
- Publishes no state list and names no dispensing pharmacy
301. AVArx
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
AVArx splits each peptide into an injectable and a sublingual or nasal listing, then prices none of the five — every page sells a provider evaluation instead of a product.
Strengths
- Separates injectable, troche and nasal forms of the same compound into distinct pages
- Names its operating company on two separate legal pages
- Frames each listing as a provider evaluation rather than as an over-the-counter purchase
- Publishes a clean hard error for a path that does not exist, so its pages can be trusted to exist
Trade-offs
- Carries no figure on any of its five treatment pages
- Gives a reader nothing to compare against another seller before intake
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
302. California Trim Clinic
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
California Trim Clinic advertises a monthly starting figure for each weight-loss drug and footnotes it with a three-month requirement, and lists thirteen tracked peptides on a therapy page that carries no price at all.
Strengths
- Says compounded medications are prepared for patient-specific use pursuant to an individual prescription and are not FDA-approved
- Names the city its practice is based in rather than only claiming to be nationwide
- Publishes a starting figure for both weight-loss drugs rather than hiding both behind an intake
- Publishes a free educational guide about what to ask before starting peptide or weight-loss care
Trade-offs
- Advertises a monthly figure whose own footnote attaches a three-month term
- Lists thirteen tracked peptides and prices none of them
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
303. CaroCare Wellness
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
CaroCare Wellness publishes a month-by-month price ladder for both weight-loss drugs, naming the dose at each step, and offers a three-month bundle priced below the sum of its parts.
Strengths
- Publishes the price for every month of the program rather than a starting figure
- Names the milligram dose at each step of the ladder
- Says ongoing provider support, supplies and delivery are included in each package
- Offers a three-month bundle priced below the sum of the months it covers
Trade-offs
- Its price rises on a fixed schedule, so the entry figure lasts one month
- Publishes no state list and names no dispensing pharmacy
- Mentions NAD+ with no figure attached to it
- No certificate of analysis is reachable
304. Carolina Health & Wellness
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Carolina Health & Wellness carries eight tracked compounds across a deep site and puts a figure on none of them.
Strengths
- Carries eight tracked compounds including MOTS-c and tesamorelin
- Exposes a deep, followable site rather than a thin landing page
- Keeps its peptide catalog visible without an account
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any of the eight pages read
- Publishes no corporate entity anywhere
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
305. Denver Peptide Clinic
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Denver Peptide Clinic publishes a certification seal and, beside it, the certifier's own lookup pre-filled with its address — a claim a reader can check rather than an image they must trust.
Strengths
- Publishes the certifier's own lookup link, not just a badge image
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its front page names no compound at all; the three declared here are on its questions page
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
306. Denver Regenerative Medicine
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
This clinic names the research-chemical market in order to distance itself from it, in a passage that trips every gray-market pattern a classifier can carry while saying the opposite.
Strengths
- Names the two facility classes its pharmacies operate under rather than saying "licensed"
- Names two clinicians and gives each of them their own page
- States its sourcing position under a heading a reader can find rather than in a footer disclaimer
- Names six compounds this site tracks on one service page
Trade-offs
- Publishes no price for anything
- Publishes no corporate entity
- Its copyright line is a year out of date
- Names no dispensing pharmacy and publishes no state coverage
307. Denver Wellness & Aesthetics Center
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
This clinic names eighteen compounds on one page, eleven of them tracked here, and the only company name on its legal page belongs to the agency that built the site.
Strengths
- One of the widest declared lists on this roster, in about five thousand characters
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its legal page carries its web agency's company name and none of its own
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
308. Dvida Spa
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Dvida tells readers, on its own peptide page, that two of the compounds it lists there appear on the FDA's bulk drug substances warning list and are not approved for human use.
Strengths
- Names the FDA bulk substances warning list against two compounds on its own menu, on the page selling them
- Answers "are peptides FDA-approved" with the word "No" and then explains
- Names its operating company in the first line of its terms
- Distinguishes compounded GLP-1s from branded products in the same note
Trade-offs
- Publishes no price for anything
- Publishes no state coverage and names no dispensing pharmacy
- Its own product URL carries a spelling error that a reader retyping the address will not reproduce
- The disclosure is strong but the catalog detail behind each compound is thin
309. Executive Medicine of Texas
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Executive Medicine of Texas names eleven tracked compounds in a service page of about six and a half thousand characters, one of the densest declared lists on this roster.
Strengths
- Names eleven tracked compounds in a page short enough to read in full
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own terms page names no company, so the absence rests on the page that should have carried it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
310. Fierce Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Fierce Health prices most of its catalog as multi-month programs and one tracked compound as a plain product, and its second tracked compound has no reachable page.
Strengths
- Publishes a plain per-item figure for one tracked compound rather than a program rate
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its second tracked compound is a named menu category whose own address returns not-found
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
311. Fresh Day Meds
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Fresh Day Meds prices its peptides by category rather than by drug — one figure covering two different products — and itemises its weight-loss lane to the dollar on the same site.
Strengths
- States "No membership fees" and "Transparent pricing" as headline commitments and prices its weight-loss lane to the dollar
- Names the operating company and the website it operates in its own privacy policy
- Discloses that it does not maintain a public-facing physical mailing address rather than leaving the absence unexplained
- Segments its weight-loss pricing by whether a patient is new or transferring, which almost nothing else on this roster does
Trade-offs
- Its peptide lane is priced by category, so no figure on the site belongs to any one peptide
- The category floor covers two unrelated products, and the cheaper of the two sets the number
- No certificate of analysis, no named pharmacy, no state coverage list
- The itemisation it applies to weight loss is not applied to the lane this site compares
312. Gameday Men's Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Gameday is a franchise operator, not a clinic — its terms name the franchising company as the party you contract with, and it refers to its own "Pharmacy Network" without naming a pharmacy in it.
Strengths
- Names the franchising company that actually owns and operates the site, in the terms' opening paragraph
- Publishes a per-compound service page for sermorelin and another for PT-141
- Publishes a notice address a reader can write to
- Distinguishes services it provides from services provided by affiliated practices
Trade-offs
- Publishes no price on any page read
- Refers to its own "Pharmacy Network" without naming a single pharmacy in it
- A franchise network means the clinic a reader visits is not the company they contracted with
- Publishes no state coverage
313. Genesis Lifestyle Medicine
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Genesis Lifestyle Medicine gives sermorelin and NAD+ their own pages inside a clinic menu that also sells branded weight-loss pens, and puts a price on none of it.
Strengths
- Separates the branded weight-loss products it lists by name from the compounded ones
- Gives sermorelin and NAD+ their own pages rather than a single peptide page
- Runs physical locations as well as a telehealth menu
- Groups its hormone offerings under a heading that says what they are for
Trade-offs
- Publishes no price anywhere across the pages read
- Publishes no state list
- Names no dispensing pharmacy
- No certificate of analysis is reachable
314. Glowlight Med Spa
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Glowlight's peptide page carries eight dollar figures and every one of them also renders on its privacy policy, which is what proves none of them prices a peptide.
Strengths
- Names five tracked compounds and keeps its weight-loss program visibly separate from them
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Every figure on the peptide page is a site-wide promotion that also renders on the privacy policy
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
315. Houston Men's Clinic
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Houston Men's Clinic trades under one name and puts a different one in its copyright line, with no corporate form attached to either.
Strengths
- Names four tracked compounds as services on a page a reader can take in at once
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes two trading names that do not match and no registered company behind either
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
316. Hybrid Medical Solution
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Hybrid Medical Solution names ten tracked compounds across goal-based sub-pages, links a storefront that sells supplements, and carries only its web agency's company name on the page.
Strengths
- Splits a ten-compound menu across goal-based sub-pages rather than listing everything at once
- Declares ten of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its linked storefront is open and sells supplements, so no compound on the menu is priced
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
317. InCare Integrated Medical Care
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
InCare prints the sentence most sellers avoid — that its own menu mixes prescription medicines with research-only compounds — and tags the entries one by one.
Strengths
- States on the menu itself that it mixes prescription and research-only compounds
- Tags individual entries by category rather than leaving the reader to guess
- Names eleven tracked compounds, one of the deeper menus here
- Says the menu is for education and not medical advice, on the menu
Trade-offs
- Reports a third-party testing claim as its supplier's, and links no certificate anywhere
- Publishes no company in corporate form, only a trading name
- Carries no figure on its peptide menu
- Publishes no state list and names no dispensing pharmacy
318. MedSol Rx
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
MedSol Rx publishes a plan ladder whose arithmetic reconciles at every rung, and separately tells readers on its own product pages that the same medicine typically costs two to eight times what it charges.
Strengths
- Every plan total reconciles exactly against its own per-month figure
- Publishes a month-to-month lane beside the prepaid ones instead of only the cheapest
- States in its own words that its compounded medicines are not FDA-evaluated
- Names the clinician network that makes the prescribing decision
Trade-offs
- Its own product pages quote a typical cost several times what it charges
- Declines to publish a NAD+ or sermorelin price, offering a quote on request instead
- Its oral semaglutide plan card lists a tirzepatide injection supply as its contents
- Says only that it serves patients nationwide, with no count and no list
319. MetroMed Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
MetroMed names eleven tracked compounds and sells some of them as kits, on a page that is nearly two megabytes of markup wrapped around about eight thousand characters of text.
Strengths
- Names eleven tracked compounds and runs a separate page for the kits it bundles them into
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- A kit is not a per-compound unit, and no figure is published on either page
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
320. Mojo Vitality
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Mojo Vitality names seven compounds including PT-141 and tesamorelin on a three-page site, and publishes no figure on any of them.
Strengths
- Names seven distinct tracked compounds on a small site
- Names its operating company in the footer of every page served
- Includes PT-141 and tesamorelin rather than only the common growth-hormone peptides
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page served
- Exposes only three followable pages, so nothing can be cross-checked
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
321. Muse Maven Med Spa
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Muse Maven appears under three different names across its own address, its terms and its footer, and sells three tracked compounds together as packages.
Strengths
- Names its three tracked compounds together in its own navigation rather than burying them
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes three different names for itself and no corporate form for any of them
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
322. R2 Medical Clinic
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
R2 publishes a regulatory-status and evidence-strength table against its own catalog, and tells readers in that table that the clinical evidence for some of what it sells is insufficient.
Strengths
- Publishes a regulatory status and an evidence strength for each peptide it sells, in a table
- States plainly that the human evidence for some of its own catalog is insufficient
- Distinguishes an approved indication from the use it is being sold for, compound by compound
- Says its medications come from compounding pharmacies and that they are not FDA-approved for all indicated uses
Trade-offs
- Publishes no price for anything
- Publishes no corporate entity
- Names no dispensing pharmacy and publishes no state coverage
- Its 404 page is nearly twice the size of its real terms page, so nothing on this host can be judged by weight
323. The Recovery Project
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
The Recovery Project carries twelve tracked compounds in its navigation, KPV and semax among them, and prices none of them anywhere on the site.
Strengths
- Carries twelve tracked compounds, one of the widest catalogs on this roster
- Stocks KPV and semax, which most sellers here do not name at all
- Exposes a deep followable site rather than a landing stub
- Returns a clean hard error with a tiny body for a path that does not exist
Trade-offs
- Carries no figure on any page read
- Publishes no corporate entity anywhere
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
324. REGENX Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
REGENX Health lists four peptides on a dedicated peptides page and puts a figure against none of them.
Strengths
- Runs a dedicated peptides page separate from its hormone lines
- Names four distinct compounds including tesamorelin and PT-141
- Names its operating company in its terms
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read, including the peptides page
- Its terms page also carries a second company name that is its web agency, not an operator
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
325. Renew Vitality
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Renew Vitality names its operating company and describes itself as a telemedicine provider in its own terms, and publishes no price on any page this pass could read.
Strengths
- Names its operating company and states what kind of provider it is in the same sentence
- Carries a terms page dated within six months, which most of this batch does not
- Publishes a dedicated sermorelin therapy page under its hormone service
- Says its prescribers build a plan combining approved and compounded medications
Trade-offs
- Publishes no price for anything
- Names no dispensing pharmacy
- Publishes no state coverage
- The peptide pages sit several levels below the hormone service, so the catalog is hard to take in at once
326. Rewind Anti-Aging of Miami
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Rewind Anti-Aging of Miami gives seven compounds their own service pages and prices none of them — and shares nothing but a brand word with the Rewinding RX already on this roster.
Strengths
- Publishes a service page per compound rather than one combined menu
- Names its operating company consistently on every page read
- Names ten tracked compounds including MOTS-c and tesamorelin
- Keeps its peptide pages separate from its weight-loss line
Trade-offs
- Carries no figure on any of the eight pages read
- Its brand words collide with an unrelated company already on this roster
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
327. Sage Wellness & Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Sage Wellness runs a numbered twenty-two entry per-compound library on its own domain, the largest structured compound reference any single seller on this roster publishes.
Strengths
- Publishes a numbered per-compound library on its own domain, each entry with its own address
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- The most detailed reference surface here and no figure anywhere on it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
328. Vitality Medical Wellness Center
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
This center's brand and its address have nothing in common, and both compounds recorded for it come from its infusion menu rather than a peptide catalog.
Strengths
- Publishes a detailed infusion menu that names both compounds recorded here
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Over twenty thousand characters on the peptide page and no compound catalog or figure in them
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
329. Strong Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Strong Health writes the research-use distinction into its own sales copy and puts a page behind each of eleven compounds, then prints no figure on any of them.
Strengths
- States in its own words that it will never supply a research-use vial
- Publishes a page per compound rather than a single undifferentiated peptide menu
- Publishes a comparison table naming the alternatives it is arguing against
- Says baseline and monitoring bloodwork are part of its model
Trade-offs
- Carries no figure on any of the seven compound pages read
- Publishes no corporate entity anywhere on those pages
- Publishes no state list and names no dispensing pharmacy
- Its comparison table describes rivals in categories it defines itself
330. Tablet Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Tablet Health lists NAD+ as a treatment on two of its own pages and prints no figure on either, while every GLP-1 it sells carries a monthly rate.
Strengths
- Marks its GLP-1 figures as monthly and as starting rates rather than flat prices
- Separates oral and injectable versions of the same molecule into distinct listings
- Names its operating company on two separate legal pages
- Publishes a single flat-plan floor rather than a ladder that climbs with dose
Trade-offs
- Publishes no figure at all for the peptide it lists, on either NAD+ page
- Requesting its bare domain rewrites to an interior path, so its front door is not its root
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
331. ThinWorks Weight Loss Centers
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
ThinWorks gives each compound its own service page named for a single town, and its only two figures are a discount code that also renders on its terms of service.
Strengths
- Runs a separate service page per compound rather than one undifferentiated menu
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its two published figures are a site-wide coupon, and its cost article quotes other companies
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
332. VIP Weight Loss & Anti-Aging
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
VIP publishes the same product page five times, once per town, all linked from one document — so anything that crawls this seller sees five candidates unless it notices.
Strengths
- Serves five towns and names eight tracked compounds across its catalog
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Duplicates every product page per town, which makes one seller look like five
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
333. Apollo Virtual Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Apollo Virtual Health names four tracked compounds on a single short page and pads the list with nothing it does not carry.
Strengths
- A short catalog that can be read in full in a couple of minutes
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- No company name, no state list and no figure anywhere on the pages read
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
334. BetterMe Rx
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
BetterMe Rx runs its NAD+ and sermorelin pages in English and Spanish, answers the cost question with a comparison rather than a number, and publishes no figure a reader can act on.
Strengths
- Publishes its NAD+ and sermorelin pages in English and in Spanish
- Says a video or telephone consultation may be required in some states
- Prints dosing instructions for the oral and injectable forms of both weight-loss drugs
- Separates its microdosing treatments from its standard ones by name
Trade-offs
- Answers its own cost question with a comparison instead of a figure
- Publishes no price on any page read, in either language
- Publishes no state list and names no dispensing pharmacy
- Runs a peptide menu of three tracked compounds with nothing priced on any of them
335. Brightmeds
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Brightmeds publishes a price for every product it sells — to search engines. The figures live in the page’s structured data and appear nowhere a reader can see them, so this record credits no published price.
Strengths
- Says compounded medications are not FDA-approved because they are made to an individual prescription
- Publishes dosing instructions for glutathione, NAD+ and sermorelin on their own pages
- Offers a full refund if a prescription is not approved
- Says plainly that it does not directly offer medical or pharmacy care
Trade-offs
- Publishes prices only in the page’s structured data, where no reader will see them
- Names the FDA as a recognizing authority in that markup for products it describes as compounded
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
336. EllieMD
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
EllieMD publishes two company names in one sentence and says which of them does what, which is a fuller answer to who is charging you than almost anything else on this roster gives.
Strengths
- Names both the operating company and the company services are offered on behalf of, in one sentence
- Names the company on the other side of the transaction rather than only a trading name
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- No product price is reachable without completing an intake
- Publishes no figure for any compound on the pages read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
337. IRON RX
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
IRON RX names four peptides on the only page it serves to a plain request, publishes no company name, no price, and no links onward.
Strengths
- Names four distinct peptides rather than selling one undifferentiated protocol
- Says coaching and dietitian visits are included in the program
- Serves a substantial page rather than a thin landing stub
- Redirects its bare domain to a single canonical host rather than serving two
Trade-offs
- Publishes no corporate entity anywhere on the page read
- Publishes no figure for anything it sells
- Exposes no followable links, so the rest of the catalog cannot be read without an account
- Publishes no state list and names no dispensing pharmacy
338. Peptides Clinic
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Peptides Clinic names its operating company on the only page it publishes, and that page carries three compounds and no price.
Strengths
- Names its operating company on the single page it serves
- Names three specific compounds rather than selling an unnamed protocol
- Describes itself as physician-led telehealth rather than a storefront
- Returns a clean hard error for a path that does not exist
Trade-offs
- Publishes no interior pages at all, so nothing can be checked against anything
- Carries no figure for anything it sells
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
339. telos rx
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
telos rx names its operating company beside its brand in the footer and names sixteen peptides on one page — and publishes no figure on that page for any of them.
Strengths
- Names the operating company beside the brand in its own footer
- States the regulatory position in short, unhedged sentences
- Names twelve compounds this site tracks on a single page
- Publishes editorial about the peptides rather than only product cards
Trade-offs
- No figure appears on the page read, although the page links its own pricing anchor
- The catalog and the checkout live somewhere this pass did not reach
- Names no dispensing pharmacy
- Publishes no state coverage
340. Vea Health
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Vea Health argues at length against gray-market peptide vendors, claims triple testing on its own coenzyme page, and publishes no price for any peptide anywhere this session could reach.
Strengths
- Attaches its third-party-testing claim to the peptide page itself rather than only to its weight-loss lane
- Names the operating company, a holding company and the clinical practice separately, and says which is which
- States plainly that it is a management services organization and not the practice delivering care
- Argues its own position on gray-market vendors in its own words rather than leaving the category unaddressed
Trade-offs
- No peptide figure on any of the three shop pages read — a reader cannot price either product without an intake
- The testing claim is made on the product page and no certificate is reachable from it
- Some shop paths redirect onto a separate funnel subdomain, so a requested URL is not reliably the page served
- No pharmacy named and no state coverage list, despite a strapline claiming fifty-state reach
341. Viking Alternative Medicine
Does not publish a NAD+ price.
Summary, strengths and trade-offs8 points
Viking runs a pricing page that refuses to price, and says why in words worth quoting — what it publishes instead is what it says its patients typically pay, which is not the same thing.
Strengths
- Says in its own words why it will not publish a flat rate, instead of publishing a rate that is not one
- Publishes what it says most patients actually pay, with the period attached
- Prices its missed-appointment charge, which most of this roster leaves unstated
- Names ten peptides across its own FAQ and dedicated compound pages
Trade-offs
- Publishes no price for any compound — the range on the pricing page describes patients, not products
- Publishes no corporate entity
- Names no dispensing pharmacy and publishes no state coverage
- A reader who takes the bottom of its patient range as a price will be quoting the wrong kind of number
